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Abstract 
 
The deconstruction of complex carbohydrates by glycoside hydrolases requires extensive enzyme consortia in 
which specificity is often conferred by accessory modules and domains that are distinct from the active site. The 
diverse mechanisms of substrate recognition were explored in this thesis using selected yeast, bacterial and 
plant polysaccharides as example substrates. 
  Carbohydrate binding modules (CBM) are non-catalytic modules that enhance the catalytic activity of 
their glycoside hydrolase counterparts through binding to polysaccharide. Normally CBMs are found attached to 
glycoside hydrolases that target insoluble recalcitrant substrates resulting in a moderate, 2-5 fold, potentiation in 
enzyme activity. A CBM, defined herein as CBMX40, is found at the C-terminal of a glycoside hydrolase family 
(GH) 32 enzyme, SacC, which displays exo-levanase activity. CBMX40 binds the non-reducing end of the levan 
chain targeting the disaccharide fructose- -fructose unit. Removal of CBMX40 results in a >100-fold decrease 
in catalytic activity against levan, compared to the full length native enzyme.  The truncated SacC catalytic 
domain acts as a non-specific exo-β-fructosidase displaying similar activity on β2,1- (inulin) and β2,6-linked 
fructose polymers, both polysaccharides and oligosaccharides. When CBMX40 was fused to a non-related exo-
β-fructosidase, BT 3082, it conferred exo-levanase specificity on the enzyme.  Thus CBMX40 is not only able to 
enhance catalytic activity but is also able to confer catalytic specificity. This led to the hypothesis that the CBM 
and the active site of the enzyme bind to different terminal residues of branched fructans such as levan. This 
results in enhanced affinity through avidity effects leading to the potentiation of catalytic activity.  
The gut bacterium Bacteroides thetaiotaomicron contributes to the maintenance of a healthy human gut. B. 
thetaiotaomicron is able to acquire and utilise complex carbohydrates that are not attacked by the intestinal 
enzymes of the host. B. thetaiotaomicron dedicates a large proportion of its genome to glycan degradation with a 
large expansion of  α-mannan degrading enzymes. The B. thetaiotaomicron genome encodes 23 GH92 α-
mannanosidases and 10 GH76 α-mannanases. While GH92 has recently been characterised the activities 
displayed by GH76 relies on the characterization of a single enzyme in this family. B. thetaiotaomicron organises 
the genes required to sense, degrade, transport and utilise specific complex glycans into genetic clusters defined 
as Polysaccharide Utilisation Loci (PULs). Transcriptomics revealed that two PULs are up regulated in response 
to yeast mannan, PUL 36 and PUL 68. These PULs contain both GH76 enzymes along with GH92 enzymes and 
other CAZy annotated enzymes. Biochemical analysis of the GH76 enzymes found in the two PULs show they 
are α1, 6 mannanases capable of hydrolysing the α1, 6 mannan backbone of yeast mannan, with the putative 
periplasmic enzymes generating small oligosaccharides, while  the surface mannanases releasing larger 
products. The three GH92 enzymes encoded by the two PULs have been shown to remove α1, 2 and α1, 3 
linked mannose branches from yeast mannan polysaccharide.  In addition PUL 68 also encodes a phosphatase 
that removes the phosphate from mannose-6-phosphate and glucose-6-phosphate but not from intact mannan. 
Therefore, this study describes the ability of B. thetaiotaomicron to target and degrade yeast α-mannans. 
The GH5 enzyme CtXyl5A from Clostridium thermocellum is an arabinoxylan specific xylanase that contains a 
GH5 catalytic module appended to several CBMs. The apo structure of the GH5 catalytic module appended to a 
family 6 CBM reveals a large pocket abutted to the -1 subsite of the active site. This pocket was thought to bind 
the arabinose decoration appended to the O3 of the xylan backbone. Here mutational and structural studies 
showed that the fulfilment of arabinose is this pocket is the key specificity determinant for the novel 
arabinoxylanase activity. Significantly the bound arabinose displayed a pyranose conformation, rather than a 
furanose structure which is the typical conformation adopted by arabinose side chains in arabinoxylans. This 
structural information suggests that CtXyl5A may be able to exploit side chains other than arabinofuranose 
residues as substrate specificity determinants. 
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Chapter 1: Introduction  
Carbohydrates are biologically important highly diverse molecules. As the term 
carbohydrates suggest the three defining elements of these molecules are carbon, 
oxygen and hydrogen. Other defining parameters of carbohydrates are the presence 
of a hydroxyl group and either a aldehyde or ketone group. Monosaccharides are the 
smallest and simplest sugars and provide the building blocks for more complicated 
oligosaccharides and polysaccharides. Monosaccharides with a carbon chain of 5 or 
more atoms adopt a cyclic form rather than an open chain conformation.  Cyclic 
sugars can either adopt a pyranose conformation, a six membered ring, or a 
furanose conformation, a five membered ring.  Monosaccharides are linked through 
a glycosidic bond where a sugar is bound through the anomeric carbon to the 
hydroxyl of another sugar. The complexity and diversity of polysaccharides is 
achieved through the range of diverse monosaccharides and the stereochemistry 
and location of the glycosidic linkages (Stryer , 2002). 
Carbohydrates have critical roles in many biological processes including central 
metabolism, cell signalling, protein folding and targeting, while also fulfilling a 
structural and storage function. Complex carbohydrates are the primary substrates 
for biofuel synthesis, and are important components of the pharmaceutical and food 
industries. A thorough knowledge of how polysaccharides are deconstructed in 
nature is vital to understanding how they can be exploited within an industrial 
context. This review of carbohydrate structure will focus on the polysaccharides that 
are targeted by the proteins analysed in this thesis. In addition the proteins and 
bacterial systems discussed in this introduction are relevant to the material analysed 
in this thesis.  
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1.1 Complex polysaccharides structures and functions  
1.1.1 Fructan polysaccharides  
Fructans, polysaccharides comprising predominantly of fructose units, are found in 
both microbes and plants. They are predominately used as storage polymers; after 
starch they are the most abundant non structural polysaccharides (Hendry, 1993). 
The β 2,1 fructose polymer, inulin, is found mainly in plants where is fulfils  a storage 
role. The inulin chains can be between 20-100 fructose (Fru) units and usually have 
a single glucose (Glc) linked through an α2,1-glycosidic bond, capping the reducing 
end of the fructan chain (Roberfroid, 2005). Sucrose is used as the starting block for 
the synthesis of the inulin chain, which accounts for the terminal glucose. The 
disaccharide is cleaved by a fructosyltransferase and the released fructose is linked 
2,1-to an acceptor Fru, which, in the first biosynthetic step, is a component of a 
sucrose (Suc) molecule to generate Fru-2,1-Suc (1-kestose). Each subsequent 
round of catalysis adds a further Fru to generate, for example Fru-2,1-Fru-2,1-Suc 
in the second round of catalysis leading to (Fru-2,1-Fru)n-α2,1-Suc after n rounds of 
catalysis (French, 1989).  Thus, the reducing end of the fructan chain is capped with 
a Glc residue.  In plants fructose is generally more efficiently transferred to the 
acceptor 1-kestose oligosaccharide from another donor 1-kestose rather than a 
sucrose molecule. Figure 1.1 shows the structure of  inulin. Therefore, as the chain 
elongates during the synthesis of inulin the efficiency to accept fructose increases, 
which results in the production of longer chain inulins rather than many small 
oligosaccharides (Franck and De Leenheer, 2005). The terminal Glc serves to 
prevent the inulin chains from spontaneous degradation. These two characteristics 
are important as inulin is exploited as an energy storage polysaccharide in plants. 
13 
 
Inulin is a linear polysaccharide and has the potential for branches at the C6 of the 
fructose units; this however is unusual in plants, but does occur in microbes, albeit at 
low levels. The small inulin oligosaccharides do not adopt any particular molecular 
conformation; however inulin chains of degree of polymerization (DP) 9 or above 
form a six fold helical structure that can pack into various isoforms. The molecular 
conformation of inulin is thought to be fairly variable and while the right handed helix 
is favoured it can also form left handed helices (French, 1988). 
 
 
Figure 1.1 Inulin and levan structure 
Figure taken from Sonnenburg et al., 2010 
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Figure 1.2 Predicted molecular conformations adopted by inulin.  
Helical conformations formed by inulin in solution, demonstrates the flexibility of inulin in solution. Figure taken 
from (French, 1988) 
 
Inulin, which is produced mainly in dicotyledons plants such as Jerusalem artichoke 
and chicory roots, has numerous applications both biologically and industrially 
(Hendry, 1993). Inulin traverses the human digestive system and reaches the large 
bowel and thus provides an energy source for the flora of the gut.  A balanced gut 
flora is very important in human health and has been linked both with obesity and 
diabetes. The food industry therefore markets inulin as a prebiotic as it promotes 
growth of “friendly” bacteria (Lopez-Molina et al., 2005). The food industry also uses 
inulin as a natural sweetener in low fat foods due to its sweet taste and indigestible 
nature (Stevens et al., 2001).  Medically inulin can be exploited in kidney test 
functions as, when administered intravenously, it is rapidly excreted but is not 
metabolised or reabsorbed, providing an effective way to measure glomerular 
filtration.  Inulin is able to form a gel in aqueous solution, a characteristic that is 
15 
 
utilised by pharmaceutical companies to deliver drugs to the colon (Vervoort et al., 
1997).  The protective layer of inulin gel is only destroyed once it reaches the 
bacteria in the large intestine and so releasing the desired drugs intact to the target 
location. Chemical applications of inulin include its microbial fermentation to ethanol 
and, more frequently, as a precursor to glycerol production (Fuchs, 1987). 
The β-2,6 fructose polymer levan, shown in Figure 1.1, is predominately found in 
microorganisms, but low molecular weight forms of the fructan can be synthesised 
by some monocotyledons plants (Han, 1990). Synthesis of levan occurs through the 
addition of fructose via a β-2,6 linkage to a sucrose acceptor molecule by 
levansucrases (Deonder, 1966, Fuchs, 1956). Each round of catalysis grows the 
fructan chain appended to sucrose as described for inulin. The smallest levan 
oligosaccharide is termed 6-kestose and is comprised of a sucrose molecule with a 
fructose attached through a β2,6 glycosidic bond. As plant levans are low molecular 
weight they are predominately linear chains with very little branching. However, the 
high molecular weight of microbial levans are highly branched through the 
attachment of β-2,6 fructose chains, through a β 2,1-linkage, to the polysaccharide 
backbone. The degree of branching and molecular weight of levans vary between 
microorganisms, although generally bacterial  levans have a high molecular weight 
and are highly branched. The conformation adopted by levans is thought to be more 
restricted than inulin, favouring a left hand helix.  
Plant levan like inulin is used as a storage polysaccharide and is also found mainly 
within roots (Pontis and Del Campillo, 1985). Microbial levan is secreted by bacteria 
to form part of the capsule and often a biofilm layer. Bacteria producing levan include 
soil Bacillus sp and oral prokaryotes such as Streptococcus salivarius,  which 
produce levan in dental plaque (Higuchi et al., 1970). Biologically levan exhibits 
16 
 
similar properties to inulin in that it is indigestible to human gut enzymes and so can 
be exploited in a similar way as prebiotics and low calorie food. Levan also has 
industrial applications, such as in the emulsification and stabilization of foods (Han, 
1990). However, in plants levan is not overly abundant and so this source of the 
polysaccharide is not used in biotechnological applications. Therefore levan 
microbes are more widely used, not just because it is more abundant but also 
because high and low molecular weight forms of the fructan can be produced. 
However, while microbial levan is favoured, this source of the polysaccharide is not 
entirely without difficulty. Firstly, the choice of microbe used to produce levan must 
take into account the complexity and molecular weight required as well as selecting 
an organism that produces a high yield of the fructan. The microbe must be grown in 
suitable sucrose medium at optimal growth conditions.  The levan is extracted fairly 
easily by alcohol precipitation (Tanaka et al., 1980, Han and Clarke, 1990). At a 
small scale laboratory level levan can be produced and isolated with ease. To 
produce quantities of levan needed at an industrial scale the process becomes 
logistically complex, financially and energy costly.  For these reasons levan is not 
utilised to its full potential and inulin is often preferred due to its availability.  
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Figure 1.3 Predicted molecular conformations adopted by levan 
The two allowed molecular conformations of levan in solution exhibits the restriction of levan structures in 
solution. Figure taken from (French, 1988) 
 
1.1.2 Mannan from Saccharomyces cerevisiae 
Saccharomyces cerevisiae and other yeasts produce a protective capsule termed 
the cell envelope. The cell envelope consists of three components: the cell wall, the 
periplasmic space and the plasma membrane. The cell wall is the outermost part of 
the cell envelope and one of the major constituents of the cell wall is 
polysaccharides. Glucans and -mannans (defined henceforth as mannans) are the 
major polysaccharides found in yeast walls, although there is a small amount of 
chitin.  
The mannan is attached to proteins within the cell wall mainly through an 
asparagine. The mannan polysaccharide comprises of two structures the core 
oligosaccharide and the outer chain oligosaccharide. Two N-acetylglucosamines link 
the polysaccharide to the protein. The first mannose of the core oligosaccharide is 
bound to the non-reducing N-acetylglucosamine through a β1,4 glycosidic bond. To 
the trisaccharide eight mannose units are attached though various α-1,6 ,α-1,3 and 
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α-1,2 linkages (Nakajima and Ballou, 1974). The core oligosaccharide is identical to 
the high mannose N-glycans found in higher eukaryotes, apart from an additional α-
1,3 linked mannose unit. From the core oligosaccharide the outer chain is linked 
through an α-1,6 mannose backbone with α-1,2 side chains that are generally 
capped with an α-1,3 linked mannose. Figure 1.4 depicts the yeast mannan structure 
(Hernandez et al., 1989a) .  The side chains of yeast mannans can also be 
phosphorylated. The regulation and synthesis of mannan is controlled by various 
glycosytransferases. The transferases localized at the endoplasmic reticulum 
synthesise the core oligosaccharide, while Golgi-localized transferases synthesise 
the outer chain (Kukuruzinska et al., 1987). The mannosyltransferases responsible 
for outer chain synthesis have been extensively characterised. Studies of the 
structures of mannan produced by mutant strains of S. cerevisiae, in which 
mannosyltransferases have been knocked out, have defined the role of each 
enzyme in mannan biosynthesis. The mnn1 mutation results in a mannan 
polysaccharide that lacks the α-1,3 linked mannose from both the core and outer 
chain. In the mnn2 and mnn5 mutants the transferases that synthesise, respectively, 
the first and second rows of the α-1,2 linked mannose branches of the outer chain 
are inactive. In the mnn9 mutant the transferase that elongates the outer chain α 1,6 
backbone is non-functional.  Phosphorylation of the mannan polysaccharide is 
controlled by enzymes lacking in the mnn4 and mnn6 mutants (Hernandez et al., 
1989a, Hernandez et al., 1989b, Lewis and Ballou, 1991, Nakajima and Ballou, 
1975, Romero and Herscovics, 1989).   
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Figure 1.4 Structure of Yeast Mannan  
M= mannose residues and numbers represent the linkage. Blue lines are an indication of the changes by mnn 
mutations which are labelled in red.  
 
People affected by Chron’s disease often have systemic antibodies against S. 
cerevisiae. These antibodies recognise the N-linked mannan found in the yeast cell 
wall and consequently yeast mannan is used as an antigen in a diagnostic ELISA to 
test for the presence of this antibody in patients (Sendid et al., 1998). Yeast derived 
mannan oligosaccharides are also widely used as a supplement to animal feeds 
(White et al., 2002). It is used both in farm animals such as pigs and chicken as well 
as domestic pets such as dogs. Animal feeds supplemented with mannan 
oligosaccharides have been shown, in a number of studies, to improve gut health 
and to prevent colonisation of the intestines by pathogenic bacteria. In fact mannan 
oligosaccharides are so effective they are now used as an alternative to the 
prophylactic use of antibiotics in animal feed (Baurhoo et al., 2007, Patterson and 
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Burkholder, 2003, Zhao et al., 2012). Mannan oligosaccharides are thought to 
prevent infection in the gut as they mimic the cell surface carbohydrates that 
pathogenic bacteria use as receptors prior to cell invasion. Thus, instead of 
pathogenic bacteria binding to cell surface carbohydrates and infecting the intestinal 
epithelium, they bind to the free mannan oligosaccharides in the gut and thus are no 
longer invasive.  
1.1.3 Major plant structural polysaccharides  
Arabinoxylan is a hemicellulosic polysaccharide found within the matrix of the plant 
cell wall. The plant cell wall comprises an array of polysaccharides. The major 
polysaccharide is cellulose, a β-1,4 linked glucose polymer that is the most abundant 
organic molecule on the planet. The linked glucose moieties are arranged in linear 
chains and are typically thousands of glucose units long (Carpita, 1997). They 
contain ordered inter- and intra-chain hydrogen bonds that result in the formation of 
microfibrils, which group together to form a highly crystalline structure. Cellulose is a 
structural component of the cell wall and the β linkage and crystalline nature make it 
highly inaccessible to enzymatic degradation (Beguin and Aubert, 1994).  The 
cellulose fibrils are embedded in a matrix of hemicelluloses, which are shorter 
branched polysaccharides that are derived from a number of monosaccharides, 
primarily mannose, arabinose, xylose, glucose and galactose.  
Xylans, a major hemicellulose in the plant cell wall, consists of a backbone of β-1,4 
linked D-xylose residues that can contain a range of decorations . Arabinoxylan 
consists of the β-1,4 linked xylose backbone with L-arabinose side chains linked     
-1,2 and/or -1,3 to the xylose residues.  In addition, the xylan backbone can also 
be decorated with a -1,2-linked  4-O-methyl-D- glucuronic acid.  The xylose 
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residues of the xylan backbone are in the pyranose configuration whereas the 
arabinose decorations are furanose sugars. In addition to the sugar decorations of 
the backbone, the polysaccharide can also be extensively acetylated and the 
arabinose decorations may be esterified to ferulic acid (Ebringerova et al., 2005) . 
Figure 1.5 shows the structure and substitutions of xylan. 
Figure 1.5 Xylan structure  
Structure of xylan showing possible substitutions. MeGlcA= 4-O-Methylglucuronic acid Xyl= Xylopyranose Ara= 
Arabinofuranose Ac= acetyl acid. Figure adapted from (Emami et al., 2009) 
 
Arabinoxylan is particularly prevalent in cereal crops. Wheat and rye arabinoxylan 
are important components in baking. The xylan backbone in wheat arabinoxylan is 
heavily substituted with single arabinose residues linked O3 and di-substituents at 
O2 and O3; a mono arabinofuranose substitution at O2 is very rare (Hoffman et al., 
1992). The degree of substitution affects the water solubility and water holding 
capacity of the polysaccharide which is important in baking. Wheat and rye  
arabinoxylan are also a major component of human dietary fibre. Arabinoxylans have 
been shown to be of particular interest in human health.  The addition of soluble 
arabinoxylan to the diets of patients with diabetes has been shown to decrease the 
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blood glucose levels and insulin levels; however, the mechanism by which this is 
achieved is unknown (Lu et al., 2004).  One common hypothesis is that the soluble, 
viscous arabinoxylan decreases the rate of gastric emptying and so delays the 
absorption of glucose and thus the level of glucose in the blood.  
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1.2 Glycoside hydrolase  
Glycoside hydrolases are a prevalent group of enzymes that hydrolyse glycosidic 
bonds that link the sugars in complex carbohydrates, or the linkage in glyco-
conjugates. Hydrolysis of the glycosidic bond proceeds through one of two acid-base 
assisted catalytic mechanisms (Sinnott, 1990). Bond cleavage can proceed through 
either a single displacement or a double displacement reaction. The single and 
double displacement mechanisms result in the inversion or retention, respectively, of 
the anomeric configuration at C1 at the site of bond cleavage. Both mechanisms 
require two carboxylate amino acids for catalysis, an acid/acid-base and a 
base/nucleophile.   
The single displacement or inverting mechanism proceeds through a one step 
reaction. The charged base extracts a proton from water, the newly formed hydroxyl 
group acts as a nucleophile and attacks the anomeric carbon of the glycone sugar. 
The uncharged catalytic acid donates a proton to the glycosidic oxygen encouraging 
leaving group departure leading to hydrolysis of the glycosidic bond. The hydroxyl 
must attack in the opposite orientation to the glycosidic bond leading to inversion of 
anomeric configuration.  
The double displacement mechanism is a two-step process that involves the 
formation of a covalently linked glycosyl-enzyme intermediate. The first reaction, 
glycosylation, results in the formation of the glycosyl-enzyme intermediate and 
release of the aglycone sugar from the active site. As with the single displacement 
mechanism the catalytic acid/base, which functions as the catalytic acid and is 
uncharged, donates a proton to the glycosidic oxygen promoting leaving group 
departure. The anomeric carbon is attacked by the charged amino acid nucleophile, 
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which is thus covalently attached to the glycone sugar through an ester bond in the 
opposite stereochemistry to the original glycosidic bond. Deglycosylation, the second 
reaction of the mechanism, results in the hydrolysis of the ester bond between the 
nucleophile amino acid and the glycone sugar. Deglycosylation results in the release 
of the second product of the reaction from the active site. Hydrolysis is achieved by 
the activation of a water molecule by the removal of a proton by the charged catalytic 
acid/base, which is now acting as the catalytic base. The newly formed hydroxyl ion 
can now attack the ester bond and release the glycone sugar, resulting in the 
regeneration of the catalytic nucleophile and replenishing the protonated catalytic 
acid-base.   
Both mechanisms proceed through a positive oxocarbeniuim transition state as 
leaving group departure and anomeric attack are asynchronous. This transition state 
is a very high energy molecule and the geometry of the sugar is distorted from the 
normal chair to a half chair or boat configuration. This results in C1 and the ring 
oxygen being in the same plane and are thus able to share a positive charge through 
a partial double bond.  The catalytic residues in both of the mechanisms are usually 
carboxylates but there is variation in the distance between these amino acids. In the 
single displacement mechanism the residues are less constrained and can be up to 
10 Å apart, whereas in the double displacement mechanism the catalytic residues 
are much closer together, at about 5.5 Å, and there is a little variation in the distance. 
This is due to the difference in the placement of the base or nucleophile in the active 
site rather than the catalytic acid. In the single displacement mechanism the distance 
between the catalytic base and sugar must be sufficient to allow the presence of a 
water molecule; in contrast the nucleophile in the double displacement mechanism 
25 
 
needs to be much closer as it mounts a direct attack on the anomeric carbon (Rye 
and Withers, 2000, Zechel and Withers, 2000). 
Figure 1.6 Catalytic mechanism for a) single displacement reaction, b) double 
displacement reaction  
The transition state is shown in brackets. Figure taken from (Rye and Withers, 2000) 
 
 Glycoside hydrolase enzymes have been grouped into sequenced based families in 
the CAZy database (www.cazy.org)(Cantarel et al., 2009). Presently there are 130 
glycoside hydrolase families (GHs). Each GH has a conserved fold, catalytic 
machinery and mechanism (Henrissat and Davies, 1997). The substrate specificity 
within some GHs, such as GH2, can be highly variable. However the 
stereochemistry and the regioselectivity of the target glycosidic bond are conserved. 
26 
 
In other GHs such as GH10 and GH11 substrate specificity is invariant. The mode of 
action of glycoside hydrolases, and thus to some extent their specificity is dictated by 
the topology of the active site. There are three main active site topologies displayed 
by glycoside hydrolases; (i) the open cleft, which accommodates internal regions of 
polysaccharides and thus these enzymes have an endo-mode; (ii) pocket topology, 
which accommodates typically a monosaccharide; (iii) tunnel topology, which is a 
feature of exo-acting processive enzymes where the polysaccharide chain is moved 
through the substrate binding tunnel, Figure 1.7.  The endo-mode of action 
generates a range of oligosaccharides, exo-acting enzymes generally release 
monosaccharides, while exo-acting processive enzymes often produce 
disaccharides (Davies and Henrissat, 1995).  
Figure 1.7 Glycoside hydrolase active site topology 
A) Open cleft;  B) Pocket; C) Tunnel. Active sites are shown in red. Figure adapted from (Davies and 
Henrissat, 1995)  
 
The CAZy database has also grouped the GHs into clans in which the structural fold, 
catalytic apparatus and mechanism are conserved, but members of the different 
families display very low sequence similarity (Henrissat and Davies, 1997). There 
are 14 GH clans on the CAZy website from GH-A to GH-N. The biggest clan is GH-A 
which contains 19 GHs all of which display the (β/α)8 barrel fold, and catalysis is 
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through a retaining mechanism. It is thought that the families within each clan have a 
common evolutionary ancestry (Cantarel et al., 2009). 
1.3 Carbohydrate Binding Modules  
Carbohydrate binding modules (CBM) are non-catalytic discreet modules usually 
attached to glycoside hydrolases. CBMs are differentiated from other sugar binding 
modules, such as lectins and sugar transport proteins, as they are components of 
enzymes. CBMs for the most part are components of enzymes that attack insoluble 
recalcitrant polysaccharides (www.cazy.org ). The first discovered CBMs were 
termed cellulose binding domains as they bound to crystalline cellulose (Tomme et 
al., 1988). Like glycoside hydrolases the CAZy database has grouped CBMs into, 
currently, 64 sequence-based families. Like GHs some CBM families display 
conserved ligand specificity, whereas in other families glycan recognition can be 
highly variable (Cantarel et al., 2009). CBMs have also been characterised into 
functional types. Type As are surface binding CBMs that usually target crystalline 
cellulose and chitin, Figure 1.8a. They have a flat hydrophobic binding surface that is 
thought to complement the planar surface of crystalline polysaccharides. Type A 
CBMs have little or no affinity for soluble ligands. CBMs grouped in the Type B 
category bind polysaccharide chains. The binding sites have a groove or cleft 
architecture capable of accommodating a single glycan chain.  Biochemical analysis 
of Type B CBMs shows that they prefer longer chains such as hexasaccharides as 
opposed to small oligosaccharides, Figure 1.8b. Type C CBMs bind small sugars 
such as mono-, di-, and tri-saccharides. Type C CBMs have a very similar 
architecture to Type B but the binding clefts of Type C proteins are shorter and have 
more of a pocket topology, Figure 1.8c. Type C CBMs appear to have more of a 
lectin-like binding property than Type A and Type B modules (Boraston et al., 2004).  
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Figure 1.8 Carbohydrate binding module structures.  
Type A, CBM2a from Cellulomonas fimi xylanase10A, the red areas show surface ligand binding sites. (PDB 
code 1XG). Type B, CBM15 from Cellvibrio japonicas xylanase10C, in complex with oligosaccharide ligand, 
showing the tunnel topology. (PDB code 1GNY). Type C, CBM9 from Thermotoga maritima GH10 xylanase, in 
complex with monosaccharide, showing the pocket topology. (PDB code 1I82). Figure taken from (Gilbert, 
2010) 
 
The primary role of CBMs is to enhance the activity of the appended enzyme against 
recalcitrant substrates. There are three routes proposed by which CBMs achieve 
this. The first and by far the most reported is the proximity effect. The binding of 
CBMs to their target ligands brings the enzyme into close and prolonged proximity to 
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the polysaccharide substrate. This effectively leads to an increase in enzyme 
concentration on the polysaccharide and thus more rapid degradation of the 
substrate. Removal of CBM from glycoside hydrolases results in a decrease in 
enzymatic activity against insoluble but not soluble polysaccharides (Bolam et al., 
1998).  
The second route by which CBMs can potentiate the activity of the attached enzyme 
is by a targeting effect. Instead of merely concentrating the enzyme onto the surface 
of the substrate, the CBM targets the enzyme to specific regions of the target 
polysaccharide that are particularly accessible to enzymatic attack. An eloquent 
example of a targeting CBM is the CBM9 that is a component of xylanase10A found 
in Thermotoga maritima. The CBM9 only binds the reducing ends of 
polysaccharides, suggesting that the CBM targets the enzyme to areas of the plant 
cell wall that are actively being degraded (Winterhalter et al., 1995).  
The final route by which catalytic enhancement can be achieved is through a 
disruptive effect. There is very little data reported on the disruptive effect of CBMs on 
polysaccharides. When the first cellulose binding domain (CBD) was isolated it was 
thought that it potentiated catalytic activity by disrupting the recalcitrant structure of 
cellulose making it more accessible to enzyme attack. The CBM2a from 
Cellulomonas fimi demonstrated a modest capacity to disrupt the structure of 
crystalline cellulose (Din et al., 1994). It is thought that it may disrupt the hydrogen 
bonds holding the cellulose microfibers together and so make cellulose chains 
accessible for degradation by the attached enzyme. The disruptive effect is viewed 
with some caution as it is extremely difficult to observe the disrupted structure and 
this mode of action has only been reported for a single cellulose binding domain and 
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a starch binding module, however, in both instances, the enhancement in enzyme 
activity was only 50% (Giardina et al., 2001).  
1.4 Glycoside Hydrolases acting on Fructan Polysaccharides 
Glycoside hydrolases that target fructan polysaccharides are grouped into two 
families GH32 and GH68. Both families are the only members of the GH-J clan and 
so have a 5-fold β propeller structure. Clan GH-J enzymes display a retaining 
mechanism, and the conserved catalytic machinery comprises a catalytic acid/base 
aspartate residue and a catalytic nucleophile glutamate. There is also another 
conserved aspartate which is thought to play in a role in transition state stabilisation 
(www.cazy.org ).  
1.4.1 Family GH68 enzymes 
Activities within GH68 include levansucrase, β-fructfuranosidase and inulosucrase. 
Levansucrases and inulosucrases act as fructosyltransferases to synthesise fructan 
polymers rather than mediate hydrolytic reactions. Levansucrases, at high 
concentrations of sucrose, catalyse transglycosylation reactions in which fructose 
residues are transferred to the sucrose acceptor resulting in the synthesis of levan 
oligosaccharides and the release of glucose (Ozimek et al., 2006). 
Transglycosylation occurs through the two step retaining mechanism. After the 
glycosylation reaction, in the deglycosylation step, instead of water acting as the 
acceptor,  a second sucrose molecule (or fructan in subsequent cycles of catalysis) 
acts as the acceptor (Edelman, 2006). The first GH68 structure solved (Protein Data 
Bank) was a levansucrase from Bacillus subtillis, shown in Figure 1.9.. The structure 
revealed a five-bladed β- propeller fold with the active site situated in the middle of 
the propeller (Meng and Futterer, 2003). Structural studies on bacterial sucrases 
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identified, as well as the conserved catalytic residues, a number of non-catalytic 
conserved amino acids. In the enzymes from gram-positive bacteria there is a 
conserved arginine, in gram-negative bacteria enzymes a histidine is conserved in 
the equivalent position. These conserved residues are crucial for transfructosylation 
and are involved in the specificity and efficiency of the reaction. Bacterial 
inulosucrases are mainly found in lactic acid producing bacteria while levansucrases 
are found in various different bacteria. Bacterial levansucrases produce levans that 
are soluble and have a high DP (Lammens et al., 2009). 
Figure 1.9 GH68 Levansucrase from B. subtilis  
a, shows the cartoon structure of the β-propeller fold with the active site found in the middle. b, shows the 
surface structure with the residues involved in catalysis coloured red. PDB code 1OYG, created using PyMol. 
1.4.2 GH32 enzymes 
GH32 has a broader range of characterised activities compared to GH68. The main 
characterised activities are fructan hydrolysing, for example exo- and endo- inulases, 
levanases and invertases. Inulases cleave β-2,1 linkages while levanases hydrolyse 
the β-2,6 linkage, while invertases cleave sucrose to glucose and fructose.  There 
are some enzymes with  transglycosylating activites such as levan 
fructosyltransferase.  The first solved structure of a GH32 family was an extracellular 
β-fructosidase from Thermotoga maritime, Figure 1.10 (Alberto et al., 2004). 
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Interestingly, GH32 enzymes have an extra C-terminal domain of unknown function. 
The C-terminal domain has a sandwich-like fold which consist of two six stranded 
anti-parallel β-sheets.  The C-terminal domain has been shown to be essential for 
protein stability, however it is not known if this is the main purpose of the domain 
(Altenbach et al., 2004). As with the GH68 enzymes, the active site of the GH32 
enzymes is in the middle of the β-propeller. Along with the three conserved residues 
in the active site there are various residues that play an important role in catalysis. 
Examples of this are the conserved tryptophan and phenylalanine residues at the rim 
of the active site.  The hydrophobic zone created by these residues is thought to be 
important in substrate binding and stability. Site directed mutagenesis studies have 
shown a marked increase in Km for sucrose when these aromatic residues were 
mutated (Le Roy et al., 2007). 
Figure 1.10 β-fructosidase from Thermotoga martima  
a, shows cartoon structure of the β-propeller and C-terminal β-sandwich domain. b, shows surface 
representation with residues involved in catalysis coloured red. PDB code 1UYP, created using PyMol. 
While the majority of GH32 enzymes are bacterial, there is still a large eukaryotic 
cohort of GH32 members, along with a small proportion found in archea. In both 
plants and bacteria GH32 enzymes most probably play a role in processing fructans 
that fulfil a storage or biofilm function.  
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1.5 Glycoside Hydrolase enzymes acting on Mannan 
polysaccharides 
In plant cell walls the mannan backbone is linked through 1,4-Man bonds, while in 
yeast mannans the backbone contains 1,6-Man linkages. As this study is 
concerned with mannan derived from S. cerevisiae, only GHs in which the enzymes 
act on α-linked mannose resides are discussed here.  
1.5.1 α-Mannosidases  
α-Mannosidases act in an exo fashion removing single mannose residues from the 
non-reducing end of a -mannan or oligosaccharides derived from the 
polysaccharide. Currently there are five GHs that contain characterised α-
mannosidases, GH38, GH47, GH92, GH99 and GH125. Of these five families the 
most extensively characterised are GH38, GH47 and GH92. By contrast only a 
single enzyme has been extensively characterised in GH99 and GH125. 
(www.Cazy.org ) 
1.5.1.1 Glycoside hydrolase family 38 
The GH38 family contains zinc dependent α-mannosidases which act through the 
acid-base  double displacement mechanism, leading to the retention of the 
conformation of the anomeric carbon (Numao et al., 2003). GH38 members display a 
(α/β)7 fold but are not currently assigned to a glycoside hydrolase clan, Figure 1.11.  
The catalytic residues of these enzymes are both aspartates. The eukaryotic GH38s 
are defined as class II α-mannosidases, which are either golgi α-mannosidase II or 
lysosomal α mannosidase (Liao et al., 1996, Moremen et al., 1991) .  
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Figure 1.11 Structure of a GH38 family enzyme  
Golgi α-mannosidase II from Drosophila melanogaster, zinc atom shown in red. PDB code 1HTY, created using 
PyMol. 
 
Golgi α-mannosdiase II are capable of hydrolysing both α-1,3 and α-1,6 linked 
mannose residues (Bonay and Hughes, 1991). The active site of Golgi α-
mannosidase II displays a requirement for a GlcNAc residue five sugar downstream 
from the cleavage site, for hydrolysis to occur. The Golgi α-mannosidase II enzymes 
are essential for N-glycan maturation in the Golgi apparatus, removing the α 1,3 and 
α 1,6 linked mannose from Man5GlcNAc2 leaving the Man3GlcNAc2 structure (van 
den Elsen et al., 2001).  Studies of mutant mice deficient in Golgi α-mannosidase II 
display a phenotype similar to human congenital dyserythropoietic anemia type II, 
suggesting that the enzyme is responsible for the loss of N-glycan synthesis in 
erythrocytes (Chui et al., 1997). 
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Lysosomal α-mannosidases are either non-specific, capable of hydrolysing α-1,2, α-
1,3 and α-1,6 glycosidic bonds, or are highly specific for the α-1,6 linkage (Park et 
al., 2005). Like the Golgi α-mannosidase II, the active site is a large open cleft, 
however the enzyme does not display tight specificity for structures downstream of 
the side of cleavage. Figure 1.12 shows an example of the GH38 active site.  
Figure 1.12 Surface representation of a lysosomal α-mannosidase  
From Bos taurus  in complex with ligand. Shows large open cleft of active site. PDB code 1O7D, created using 
PyMol. 
 
In eukaryotes lysosomal α-mannosidases are important in catabolism of N-glycans 
during glycoprotein turnover (Cenci di Bello et al., 1983). In bacteria they have a 
physiological role in glycan foraging and utilization. Deficiencies in humans and 
livestock lysosomal mannosidases give rise to a condition called α-mannosidosis. In 
humans it is caused by an autosomal recessive mutation, where as in livestock it is 
caused by chronic poisoning by swainsonine. The complete loss or reduction in 
functional α-mannosidase results in the build up of sugars and glycans in the 
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lysosome, which impairs cell function. At its most severe form, the disease leads to 
death in infancy due to degeneration of the central nervous system. Milder forms of 
the disease results in neurological degeneration along with a myriad of other 
symptoms (Gotoda et al., 1998). 
1.5.1.2 Glycoside Hydrolase family 47 
GH47 contains a group of class I α-mannosidases, which are calcium dependant 
inverting enzymes that display an (α/α)7 barrel fold, Figure 1.13. GH47 eukaryotic 
enzymes can be further divided into three sub-groups depending on their activity 
against Man9GlcNAc2 (Daniel et al., 1994, Herscovics, 2001).  
Figure 1.13 Structure of a GH47 family enzyme  
From Homo sapiens in complex with calcium (blue sphere) PDB code 1FMI, created using PyMol. 
 
The first sub-group include human and yeast endoplasmic reticulum (ER) α-1,2 
mannosidases that hydrolyse the Man9GlcNAc2 structure to the Man8B isomer. This 
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is an important step in N-glycan maturation (Camirand et al., 1991, Gonzalez et al., 
1999). This sub-group is also involved in protein quality control in the ER where 
misfolded proteins are translocated to the cytosol for degradation (Herscovics, 
2001). The role of ER associated α-mannosidases has been extensively 
characterised in both S. cerevisiae and mammalian cells. Studies showed that this 
group of enzymes have specificity towards the terminal mannose of the middle chain 
of the high mannose N-glycan on misfolded proteins, Figure 1.14. This results in the 
transportation of the proteins to the cytosol for degradation (Jakob et al., 1998). It 
was found in S. cerevisiae that 1-deoxymannojirimycin inhibited the activity of the 
class I α-mannosidase resulting in the inhibition of glycoprotein degradation. This 
suggests that the role of the enzyme in N-glycan trimming is crucial for glycoprotein 
quality control and subsequent degradation (Liu et al., 1999). 
The second sub-group consists of mammalian Golgi α-mannosidases IA,IB and IC 
along with enzymes from insect cells and filamentous fungi (Lal et al., 1994, 
Tremblay et al., 1998, Tremblay and Herscovics, 2000, Igdoura et al., 1999). The 
Golgi α-mannosidase I enzymes trim the α 1,2 linked mannose residues from Man8-
9GlcNAc2 to Man5GlcNAc2, Figure 1.14. The difference in the three types of 
mammalian Golgi α-mannosidases is mainly their tissue and cell-type specific 
expression (Igdoura et al., 1999). Golgi-α mannosidases I preferentially remove 
mannose residues from the N-glycan but only display a weak affinity for the 
mannose residue cleaved by the ER associated enzymes. Therefore this sub-group 
of enzymes display a complementary specificity to the ER associated α-
mannosidases. 
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Figure 1.14 Man9 glycan trimming by α-mannosidase  
Mannose residues are shown as green circles and GlcNAc residues are shown as blue squares. Mannose 
residues cleaved by α-mannosidases are outlined by a dashed box. Figure adapted from Zhu et al. (2010)  
 
The third group appear to have no mannosdase activity against Man9GlcNAc2 glycan 
but have a role in glycoprotein degradation. These proteins have been termed ER 
Degradation Enhancing α-Mannosidase like proteins (EDEM) (Hosokawa et al., 
2006). It has been reported that ER stress induces the overexpression of EDEM 
which speeds up the degradation of specific proteins (Hosokawa et al., 2001). The 
role and mechanism of EDEM is still unclear, the proteins while appearing to be 
inactive in vitro still posses conserved catalytic residues. Hypotheses of EDEM 
function include them acting as chaperones, preventing the formation of disulfide-
bonded dimmers (Hosokawa et al., 2006) or aggregation of misfolded glycoproteins 
(Olivari et al., 2006). This is significant as inhibition of aggregation is implicated in 
the degradation of misfolded glycoproteins. 
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1.5.1.3 Glycoside Hydrolase 92 
Specificity within GH92 is variable with α-1,2, α-1,3, α-1,4 and α-1,6 mannosidase 
activities found among the 23 Bacteroides thetaiotaomicron GH92 members.  Like 
GH38 and GH47, GH92 enzymes have a requirement for a metal ion, in this case 
calcium, for catalysis to occur. The GH92 enzymes work through the single 
displacement reaction and so invert the anomeric conformation at C1. GH92 
enzymes display a two domain structure; the N-terminal domain is a beta sandwich 
structure while the C-terminal domain is an (α/α)6 barrel fold, shown in Figure 1.15. 
The catalytic acid is predicted to be a glutamate while the catalytic base is harder to 
recognise but is thought to be an aspartate. Mutational studies have shown that 
mutants of the predicted catalytic acid and catalytic base were inactive, confirming 
their roles in enzyme action (Zhu et al., 2010) .  
Figure 1.15 Structure of GH92 family member 
From B.thetaiotaomicron in complex with calcium (shown in blue) PDB code 2WVX, created using PyMol.  
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The study of GH92 enzymes from B. thetaiotaomicron revealed activity against 4-
nitrophenyl-α-D-mannopyranoside and -linkedmannose disaccharides. In addition, 
a number of the enzymes were capable of releasing mannose from Man9GlcNAc2.  
In the human large bowel, the environment B.thetaiotaomicron inhabits, the likely 
substrates for the 23 GH92 enzymes are the N-glycans found on host and dietary 
glycoproteins (Zhu et al., 2010). Furthermore, transcriptome data for B. 
thetaiotaomicron showed that when the bacterium was cultured in the presence of 
the N-glycan mimic yeast mannan, 50% of the GH92 enzymes were upregulated 
(Bjursell et al., 2006, Martens et al., 2008). Indeed the upregulated GH92 are often 
co-transcribed with other enzymes necessary for full degradation of N-glycans. It 
should be emphasised, however, that it is also possible that a proportion of the 
GH92 enzymes may contribute to the degradation of extended N-glycan structures 
presented on the surface of yeast mannan, particularly those that are co-regulated 
with GH76 enzymes described below.  
 
1.5.2 α-Mannanases (Glycoside hydrolase family 76) 
GH76 is currently the only family in the CAZy database annotated as having an α- 
mannanase activity, a Bacillus circulans enzyme characterised as an α1,6 
mannanase. The B. circulans enzyme hydrolyses the α1,6 linked backbone of yeast 
mannan in an endo-mode of action,  releasing α1,6 mannosyl oligosaccharides 
(Nakajima et al., 1976). The other members of the family have been annotated as α 
1,6 mannanases, but have not been characterised. There is no reported information 
on the catalytic mechanism or the amino acids that contribute to catalysis or 
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substrate specificity. One structure of a GH76 enzyme from Listeria innocua has 
been solved and is shown in Figure 1.16. 
The genome of B. thetaiotaomicron encodes several GH76 enzymes, some of which 
are co-regulated with GH92 enzymes and other proteins that are predicted to 
contribute to α-mannan degradation. This suggests that the GH76 enzymes, and the 
other co-regulated enzymes, may have a role in degrading yeast α-mannan (Martens 
et al., 2008, Bjursell et al., 2006). 
 
Figure 1.16 Structure of a GH76 enzyme from Listeria innocua. 
PDB code 3K7X.  Solved and deposited by Northeast Structural Genomics Consortium, created using PyMol.  
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1.6 Xylanases  
Xylanases hydrolyse the β 1,4 xylan backbone in an endo fashion to produce a 
range of oligosaccharides (Harris et al., 1994). All GH10 and GH11 enzymes 
characterized to date are endo-acting xylanases.  All but two of the characterized 
235 GH10 members have β1,4 xylanase activity, the other two hydrolyse β1,3 linked 
xylan.  GH10 contains retaining enzymes that are members of clan GH-A, displaying 
a typical (β/α)8 barrel fold, Figure 1.17a (Harris et al., 1994). Experimental evidence 
has identified both of the catalytic residues as glutamates (Tull et al., 1991, MacLeod 
et al., 1994).  GH11 enzymes also act through a retaining mechanism; they display a 
β-jelly roll fold and are components of clan GH-C, Figure 1.18. As with GH10 both 
the catalytic residues have been reported as glutamates (Miao et al., 1994, Lawson 
et al., 1996). All 237 characterized GH11 enzymes were shown to be endo-1,4-
xylanases. As both the GH10 and GH11 enzymes are endo-acting xylanases and 
proceed through similar mechanisms, not surprisingly, their respective active sites 
show a similar architecture. The open cleft nature of the active site allows for multiple 
sugar (xylose) binding subsites, which is important for substrate recognition and 
catalysis (Charnock et al., 1998).  While most GH10 and GH11 xylanases hydrolyse 
un-substituted xylan chains, there have been reports of enzymes that can tolerate, or 
display absolute specificity for, decorated xylan side chains.  
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Figure 1.17 Structure of Xylanase10C from Cellvibrio japonicas 
a, cartoon structure in complex with xylo-oligosaccharide b, surface representation shows open cleft of active 
site. PDB code 1US, created using PyMol. 
                                            
Figure 1.18 Cartoon structure of GH 11 xylanase from Bacillus cirulans 
Substrate show in blue. PDB code 1BCX, created using PyMol. 
 
Other GHs that include xylanase activities are GH5, GH8 and GH30. Within GH30 
there are examples of highly specific xylanase enzymes. One of these enzymes is 
the glucuronoxylan specific xylanase found in the bacterium Erwinia chrysanthemi. 
This enzyme specifically hydrolyses xylan decorated with a 4-O-methyl--D-
glucuronic acid (MeGlcA) at the O2 position. Structural studies showed that MeGlcA 
decoration of the xylose positioned in the -2 subsite (glycosidic bond cleavage 
occurs between the xylose at the -1 and +1 subsites) (Davies et al., 1997) is vital for 
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substrate distortion and thus hydrolysis of the xylan backbone (Urbanikova et al., 
2011).  Recently a GH5 enzyme from Clostridium thermocellum was reported to be 
arabinoxylan specific, this activity is described in more detail in Chapter 6 (Correia et 
al., 2011).  
 
 
 
 
 
 
 
 
 
 
 
 
 
45 
 
1.7 Bacteroides thetaiotaomicron  
B.thetaiotaomicron is a Gram-negative bacterium and a prominent resident of the 
microflora of the human and murine gastrointestinal (GI) tract (Moore and Holdeman, 
1974). Like almost all of the other large bowel bacteria B. thetaiotaomicron is an 
obligate anaerobe. B. thetaiotaomicron develops prominence in the gut during 
postnatal development during weaning from mother’s milk to a diet rich in 
polysaccharides (Mackie et al., 1999). It is pivotal in the regulation of α-fucosylation 
of the distal intestine which directs microbial colonization of specific niches within the 
gut (Bry et al., 1996). This gut bacterium also affects the submucosal network of 
interconnected capillaries. Experiments in adult germ free mice showed that the 
colonization of B.thetaiotaomicron resulted in the full development of the capillary 
network within 10 days (Stappenbeck et al., 2002). B.thetaiotaomicron has also been 
shown to induce a Paneth cell protein, Ang4, that is secreted into the gut lumen and 
is bactericidal to Gram-positive bacteria. Ang4 expression protects the host from 
pathogens, while also benefiting B.thetaiotaomicron through its capacity to exert a 
degree of control of on its microbial environment (Hooper et al., 2003). B. 
thetaiotaomicron also has the ability to degrade and utilize nutrients, typically 
complex polysaccharides, that are not attacked by human gut enzymes. Degradation 
of indigestible plant polysaccharides by the human microbiome and their metabolism 
to short chain fatty acids such as propionate, butyrate and acetate, can account for 
up to 10% of human daily calorific intake (Xu and Gordon, 2003).  
1.7.1 The glycophilic nature of B. thetaiotaomicron  
B.thetaiotaomicron is a glycophile that dedicates a large proportion of its genome to 
polysaccharide utilisation. Currently, the genome of B. thetaiotaomicron is predicted 
46 
 
to encode 257 glycoside hydrolases, 16 polysaccharide lyases and 20 carbohydrate 
esterases (www.cazy.org ). This impressive repertoire of enzymes suggests 
B.thetaiotaomicron is capable of hydrolysing a diverse range of glycosidic linkages. 
Over half of these enzymes are predicted to be extracellular or periplasmic.  Whole 
genome transcription profiling of cecal bacteria from germ free mice inoculated with 
B. thetaiotaomicron fed on a simple sugar diet, or a rich-polysaccharide diet, detailed 
B. thetaiotaomicron’s capacity to forage for glycans. Those mice fed on a simple 
sugar diet showed that B.thetaiotaomicron could utilize host glycans as an energy 
source. Consistent with its repertoire of glycoside hydrolases, culturing strategies 
showed that B.thetaiotaomicron is able to degrade and grow on an extensive range 
of plant- and mammalian-derived polysaccharides (Sonnenburg et al., 2010).   
1.7.2 Polysaccharide utilisation by B. thetaiotaomicron 
Analysis of the B. thetaiotaomicrons genome revealed multiple gene clusters that 
encode all of the necessary machinery to sense and utilise host and dietary glycans. 
These genetic regions are termed Polysaccharide Utilisation Loci (PULs) (Bjursell et 
al., 2006). A typical feature of PULs is the presence of genes encoding a SusC/SusD 
(Starch Utilisation System) pair which, are co-localised with the genes encoding 
glycoside hydrolases. Extracytoplasmic function (ECF) σ factors or hybrid two 
component systems (HTCS) are also encoded within the PULs and are involved in 
signal sensing by B.thetaiotaomicron.  
The starch utilisation system (Sus) was the first PUL studied and characterised in 
B.thetaiotaomicron, a summary of this archetypal locus is shown in Figure 1.19. The 
Sus locus comprises seven genes SusABCDEFG and a transcription factor, SusR, 
which activates transcription of the seven Sus genes through a sensor/regulator role 
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(Hooper et al., 1999, Reeves et al., 1996, Reeves et al., 1997, D'Elia and Salyers, 
1996b). SusR spans the cytoplasmic membrane with the N-terminal domain 
extended into the periplasm and the C-terminal domain into the cytoplasm. The C-
terminal cytoplasmic domain contains a helix-turn-helix DNA binding motif. SusR 
only induces expression of the remaining Sus genes in response to the presence of 
maltose (D'Elia and Salyers, 1996b). SusABG are hydrolytic enzymes consisting of a 
neopullalanse, α-glucosidase and α-amylase, respectively. While SusG is located at 
the outer membrane and exposed to the external environment, SusAB are in the 
periplasm. SusDEFG are all lipoproteins localised to the outer membrane facing the 
external environment. SusD binds the incoming starch while SusG, an -amylase, 
cleaves the long -glucan chains which are subsequently transported through the 
membrane by the SusC protein (D'Elia and Salyers, 1996a, Shipman et al., 1999, 
Reeves et al., 1997, Shipman et al., 2000) .  
 SusC is a TonB dependent β barrel transport protein that spans the outer 
membrane. TonB proteins are a family of porins found in Gram-negative bacteria 
that span the outer membrane. Small molecules can diffuse through the protein while 
larger molecules are transported via active transport, the energy for which is driven 
by a protonmotive force through the TonB-ExbBD complex.  SusC transports 
oligosaccharides into the periplasm for further degradation (Koropatkin et al., 2008, 
Reeves et al., 1996).  
SusD in the starch utilisation system is responsible for binding starch at the cell 
surface, which is then hydrolysed by the α-amylase, SusG. SusD is a 
outermembrane lipoprotein tethered to the membrane by a N-terminal cysteine 
(Martens et al., 2008). A study of the structure of SusD reported that the protein is 
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optimized to bind to curved oligosaccharides. This curvature resembled the cyclic 
nature of starch. In addition the same study showed SusD bound cyclic ligands 
better than linear maltooligosaccharides.  From these data it is proposed that SusD 
recognises the helical nature of starch rather than the individual sugars or glycosidic 
linkages.  SusD is an α-helical protein, unlike the typical β barrel structure of CBMs, 
Figure 1.20 (Koropatkin et al., 2008). SusD posses an arrangement of 
tetratricopeptide repeat units (TPR), which have been implicated in protein-protein 
interactions, suggesting that the SusD TPR units could form the basis for the 
SusC/SusD complex.  The exact role of SusD is unclear but it is thought it may hold 
the maltooligosaccharides for threading through the SusC protein. Genetic 
knockouts of SusD revealed that the protein is required for the growth of B. 
thetaiotaomicron on maltooligosaccharides of 6 glucose units or more (Sonnenburg 
et al., 2006).  
Both SusE and SusF are thought to also be involved in polysaccharide binding but 
there is still uncertainty surrounding the roles of these proteins.  The PULs that 
orchestrate the degradation of other glycans direct the synthesis of a suit of 
enzymes, binding proteins, transporters and sensor  that are specific for the target 
polysaccharide (Martens et al., 2011). 
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Figure 1.19 Cartoon representation of Starch Utilisation System (SUS) of B. 
thetaiotaomicron  
Starch is bound at the surface by SusD and processed by SusG. The oligosaccharides are transported into the  
periplasm through the SusC. Further processing takes place in the periplasm by glycoside hydrolase enzymes. 
Finally glucose is transported through the inner membrane into the cytoplasm for utilisation. Figure taken 
from(Koropatkin et al., 2008) 
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.  
Figure 1.20 SusD in complex with maltoheptose.  
SusD from B.thetaiotaomicron. Maltoheptose is shown in blue, bound to the SusD in a helical nature.  PDB 
code 3CK9.  
 
1.7.2.1 Carbohydrate sensing and gene regulation 
The PULs of B. thetaiotaomicron are tightly regulated and while there is a basal level 
of expression of each PUL, upregulation only occurs in response to particular 
environmental cues. For this to occur each PUL posses a regulation system, which is 
able to sense particular carbohydrates and activate gene expression in response to 
these ligands.   
A type of regulator of PUL transcription are the Extracytoplasmic function (ECF)   
type σ factors that control gene expression by mediating DNA:RNA complexes. 
Upon detection of the activating ligand ECF type σ factor is released from its anti-σ 
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factor enabling the protein to interact with RNA polymerase to regulate expression of 
target genes (Helmann, 2002). ECF σ factors are generally grouped into two 
families, σ-70 and σ-54 (Wosten, 1998). The B. thetaiotaomicron genome encodes 
54 σ factors in total; two are σ-70 proteins and two belong to the σ-54 family. The 
other 50 σ factors are ECF type σ factors which belong to the alternative sigma 
factor group of the σ-70 family. In total 12 of these ECF type σ factors are located 
upstream of genes encoding SusC and Sus D homologs and enzymes that catalyze 
complex glycan degradation. None of these 12 loci are linked to any other 
transcription factors (Xu and Gordon, 2003).  
Hybrid two component systems (HTCS) are a molecular system for organisms to 
sense and respond to stimulus in the environment. HTCS incorporate all of the 
necessary proteins found in a classical two component system, but within a single 
polypeptide. This consists of the sensor kinase, histidine kinase, a phosphoacceptor 
domain and a DNA binding domain (Stock et al., 2000). The sensor kinase is a 
periplasmic domain situated at the N-terminus. It is interrupted by five predicted 
transmembrane domains with an additional three cytoplasmic segments, the 
histidine kinase, phosphoacceptor domain and the putative DNA binding domain. 
The putative DNA binding domain is of the AraC helix-turn-helix type (Lowe et al., 
2012). It has been proposed the DNA binding domain may be released from the 
protein upon activation, allowing the protein domain to bind DNA and regulate 
expression (Miyazaki et al., 2003). A mechanism for termination of regulation has 
currently not been proposed. In B. thetaiotaomicron 32 HTCS have been identified, 
23 of which are immediately upstream of polysaccharide utilisation genes. The 
sensor domains of HTCS are diverse binding different molecular cues that regulate 
gene expression, but their mechanism of signal transduction is conserved (Xu and 
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Gordon, 2003, Sonnenburg et al., 2006, Martens et al., 2011). A recent structural 
study of the periplasmic domain of BT4663 from a B.thetaiotaomicron HTCS 
reported a conformational change in structure upon ligand binding. The structure of 
the periplasmic domain of BT4663 displayed a β-propeller fold followed by a domain 
termed Y_Y_Y of unknown function. Upon binding of ligand the structure revealed a 
scissor blade like closing mechanism of the C-terminal Y_Y_Y domain, enabling the 
periplasmic domains of the protomers to mediate reciprocal phosphorylation. The 
study suggests a mechanism for signal transduction through the membrane that is 
different to the previously described piston and rotation models (Lowe et al., 2012).  
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1.8 Objectives  
 
The three main aims of this study are: 
1. To further elucidate the mechanisms by which CBMs contribute to glycoside 
hydrolase activity. By studying a novel levan binding CBM and its native GH32 
enzyme, this component of the project will explore how CBMs can contribute to the 
enzymatic degradation of soluble polysaccharides.  
2. To understand how B. thetaiotaomicron exploits co-regulated PULs to deconstruct 
α-mannans derived from S. cerevisiae.  Characterising the GH76 and GH92 
enzymes localised in α-mannan regulated PULs is designed to dissect the 
mechanism by which B. thetaiotaomicron hydrolyse and utilize α-mannans.  In 
addition the study of hypothetical proteins encoded within the PULs is designed to  
reveal additional enzymes involved in α-mannan degradation.  
3. To understand the active site specificity determinants that confers the specificity 
displayed by an arabinoxylan specific xylanase from Clostridium thermocellum.  
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Chapter 2: Materials and Methods 
 
2.1 Molecular Biology 
2.1.1 Bacterial Strains and Plasmids 
All Escherichia coli strains and plasmids used in this study are listed in Table 2.1 and 
Table 2.2 respectively.  
2.1.2 Media and Growth Conditions 
E. coli were cultured at 37ºC (unless stated otherwise) with aeration in a rotary 
shaker (180 RPM), in sterile Luria-Bertani Broth (LB) (1 % (w/v) BactoTryptone, 1 % 
(w/v) NaCl and 0.5 % (w/v) yeast extract, pH 7.4) (Sambrook et al., 1989) with 
appropriate antibiotic.  Agar plates were made by adding 2 % (w/v) agar 
(Bacteriological) to LB, autoclaving and then allowing it to cool prior to the addition of 
selective antibiotic. E. coli colonies were grown by spreading bacterial cultures 
across the surface of the plate with a glass spreader that had been sterilized by 
immersion in 100 % (v/v) ethanol and passing through the hottest part (blue) of a 
Bunsen flame. Bacterial plates were incubated invertedly at 37C for about 16 h in a 
stationary incubator (Laboratory Thermal Equipment Ltd). Longer incubation periods 
were avoided to prevent the formation of satellite colonies. 
2.1.3 Selective Media  
For antibiotic selection, antibiotics were used at 1000 fold dilution of stock solutions 
as shown in Table 2.3, added to the sterilizd growth media once it had cooled to less 
than 55°C. Isopropylthio-β-D-galactoside (IPTG) was added to strains containing 
lacIq either on plasmids or in the genome for induction of transcription of recombinant 
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genes controlled by lacO. IPTG stock concentration was made at 1 M in MQ H2O 
and, for most strains, added to liquid media to a final concentration of 1 mM. For 
Tuner E. coli strains IPTG was added to the media to a final concentration of 0.2 
mM. 
2.1.4 Storage of DNA and Bacteria 
 Bacterial colonies on agar plates were stored at 4 °C for a maximum of four weeks. 
DNA was stored at -20 °C in Elution Buffer (EB, 10 mM Tris/HCl buffer, pH 8.5). 
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Table 2.1 E.coli Strains 
 
 
 
 
 
 
Table 2.2 Bacterial Plasmids 
Antibiotic 
Stock 
concentration 
Working 
concentration Storage 
Ampicillin 
50 mg/ml in 
water 50 μg/ml 
4 °C for 
less 
than 4 
days 
Kanamycin 
50 mg/ml  in 
water 50 μg/ml -20 °C 
 
Table 2.3 Antibiotic concentrations, stock and final concentrations used in growth media 
 
 
E. coli 
Strain 
Description Use Reference 
BL21 (DE3) F
-
 dcm ompT hsdS(rB- mB-) gal 
l(DE3) 
Protein 
Expression 
(Studier and Moffatt, 
1986) 
Tuner (DE3) F
–
 ompT hsdSB (rB
– 
mB
–
) gal dcm 
lacY1 (DE3) 
Protein 
Expression 
Novagen 
One Shot
™
 
TOP10  
F´mcrA (mrrCB-hsdRMS-mrr) 80lacZ 
M15 lacX74 deoR recA1 araD139  
(ara-eu)7697 galU galK rspL endA1 
nupG 
DNA Ligation 
and Replication  
Invitrogen 
Plasmid Size (kb) Genotype Use in this study Reference 
pET21a 5.44 amp
r
, T7 lac lacI
q
 Expression vector Studier, 1990 
pET22b 5.49 amp
r
, T7 lac lacI
q
 Expression vector Novagen 
pET28a 5.37 kan
r
, T7 lac lacI
q
 Expression vector Novagen 
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2.1.5 Sterilisation 
 Solutions, media and glassware were sterilised by autoclaving in either an Astell 
Hearson 2000 Series Autoclave or a Prestige® Medical Series 2100 Clinical 
Autoclave at 121 ºC, 15 lb in-2 (psi) for 20 min. When necessary, solutions were filter 
sterilised using a 0.2 µm pore Millipore filter disc (Supor® Acrodisc® 3.2, Gelman 
Sciences) and a suitable sterile syringe (Plastipak®, Becton Dickinson). 
2.1.6 Chemicals, enzymes and Media 
Unless otherwise stated in the text all chemicals, enzymes and media are from 
Sigma Chemical Company. 18.2 MΩ, water produced from a Millipore Milli-RO 10 
plus water purification system, was used for all experiments. Water was used as the 
solvent for all solutions unless otherwise stated.  
2.1.7 Centrifugation 
Bacterial cells from cultures of 100 –1000 ml was harvested by centrifugation at 
5000 revolution per minute (RPM) for 10 min in 500 ml centrifuge tubes (Nalgene) 
using a Beckman J2-21 centrifuge with a JA-10 rotor. Bacterial cells from culture 
volumes 5-10 ml were centrifuged in 30 ml Sterilin universal tubes at 5000 g in a 
MSE Mistral 3000i bench centrifuge with a swing out rotor for 5-10min. 
Centrifugation of small volumes (<1.5ml) was carried out in 1.5 ml Eppendorf tubes 
at 13000 RPM in a Heraeus Instruments Biofuge pico. 
2.1.8 Chemically competent E. Coli 
E. coli strains were made competent for uptake of plasmid DNA using calcium 
chloride in a variation of the procedure described by Cohen et al. (Cohen et al., 
1972). A 1 ml aliquot of a 10 ml overnight LB culture of E. coli was used to inoculate 
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1 litre non-baffle flask containing 100 ml of LB. The culture was incubated (without 
antibiotic) at 37 °C (180 rpm) until log phase was reached (A600 = 0.4). After 10 min 
on ice, the cells were harvested by centrifugation at 5000 × g at 4 °C for 5 min. The 
medium was decanted and the cells gently re-suspended in 8 ml of ice cold 100 mM 
MgCl2. The previous step was repeated and the cell pellet re-suspended in 4 ml of 
ice cold 100 mM CaCl2. After 2 h on ice, the cells were competent for transformation 
with plasmid DNA. Aliquots of 100 μl were stored at -80°C with 25 % (v/v) glycerol in 
1.5 ml Eppendorf tubes. 
2.1.9 Transformation of E. coli 
A 50-100 μl aliquot of competent cell was gently thawed on ice for 5 min, and then 
Plasmid DNA (2 µl containing 0.1-1.0 µg DNA) was added in. The DNA and cells 
were gently mixed with a pipette tip and incubated on ice for 30 min. The cells were 
then heat-shocked at 42C for 1.5 min and immediately placed on ice for a further 2 
min. Transformations with the plasmid encoding antibiotic resistance were plated 
directly onto LB agar containing the appropriate antibiotic before being inverted and 
incubated at 37°C for 16 h. For transformation with plasmid DNA after a ligation, 250 
μl of 37°C LB medium were added and the cells were recovered for 1 h (37°C, 180 
rpm in a rotary shaker). Then the complete culture was plated onto appropriate 
selective media and incubated as before. 
 
2.1.10 Replication of DNA and rapid small scale plasmid preparation 
More plasmid DNA was produced by transformation of the DNA into Top10 cells and 
growth of colonies on selective LB agar plates. Single colonies were picked and 
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used to inoculate 5 ml of LB with appropriate antibiotic. The culture was incubated at 
37 ºC with aeration overnight, as described in Section 2.1.2. These cells were then 
harvested by centrifugation for 5 min and the supernatant was carefully removed. 
Plasmid DNA was extracted using a Qiagen QIAspin Miniprep kit as described in the 
manufacturer’s instructions. 
2.1.11 Restriction Digest of DNA 
Digestion of double stranded DNA with restriction endonucleases was performed as 
directed by the manufacturers’ (MBI Fermentas) instructions. Endonuclease 
restriction sites were identified using the tool on-line at http://rna.lundberg.gu.se/cgi-
bin/cutter2/cutter. 
2.1.12 Determination of DNA concentration 
DNA concentration was determined either by estimation from comparison of band 
size/intensity to quantified DNA ladders when electrophoresed on agarose gels or by 
scanning the absorbance of the appropriately diluted DNA  (in MQ H2O) between 
230 nm and 340 nm using a spectrophotometer (Pharmacia Biotech Ultrospec 4000, 
UV/vis) Double-stranded DNA at 50 μg/ml gives an A260 reading of 1.0, as does 
single-stranded DNA or oligonucleotide at 33 μg/ml..  
2.1.13 Agarose gel electrophoresis of DNA 
Separation and determination of the sizes of linear DNA fragments were carried out 
by electrophoresis through submerged horizontal gels (Myers, 1975).  
0.8% (w/v) agarose gels were made by adding 0.4 g of agarose in 50 ml of 1x 
Tris/Borate/EDTA TBE) buffer, boiling the solution til the agarose dissolved. Once 
the solution had cooled to about 50°C, ethidium bromide (1 μg ml-1 final) was adding, 
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to visualise the DNA. The gels were cast in mini-gel trays (Applied Biosystems) and 
once set the gel was covered in 50 ml of 1x TBE Buffer. DNA samples were 
prepared by the addition of loading buffer and pipette into the wells of the gel. DNA 
standard ladders (HyperLadder I or IV from Bioline) were also loaded. The DNA was 
electrophoresed at 60 mA for ~1 h.  
All buffer and reagent components are shown below in Table 2.4 
Buffer  Ingredient Amount  
Electrophoresis Buffer-TBE 
(pH 8.3 checked) 
Tris base 108 g l
-1
 
Boric acid 55 g l
-1
 
0.5 M EDTA pH 8.0 40 ml l
-1
 
DNA Loading Buffers   
DNA Sample Buffer Bromophenol Blue 0.25 % (w/v) 
Glycerol 50 % (v/v) 
TBE 10 x 
Table 2.4 Buffers for agarose gel electrophoresis (10 x stocks) 
 
2.1.14 Visualisation of DNA  
An image of the gel was obtained using a gel documentation system (Bio-Rad Gel 
Doc 1000, Molecular Analyst™/PC Windows Software, and photographs were 
produced by Mitsubishi Video Copy Processor (Model P68B) with Mitsubishi thermal 
paper. 
2.1.15 Determination of DNA fragment size 
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The size of linear double stranded DNA molecules can be determined because the 
migration rate through gel matrices is in effect inversely proportional to the log10 of 
the size of the nucleic acid. Therefore, the sizes of DNA fragments were determined 
by comparing their electrophoretic mobility with that of the DNA standards of known 
sizes. 
2.1.16 Purification of DNA fragments 
2.1.16.1 PCR Purification 
PCR products and restriction digested inserts were purified using QIAquick PCR 
Purification Kit (Qiagen) as described in manufacturer’s instructions. 
2.1.16.2 Gel extraction 
Restriction digested vectors were separated by agarose gel electrophoresis using 
high purity Seachem GoldTMagarose and TBE buffer. DNA was isolated from 
agarose gels by excising the required band from the gel with a clean scalpel blade. 
The DNA was then purified using a QIAquick Gel Extraction Kit (Qiagen) following 
the manufacturers’ protocol. 
2.1.17 Ligation of Insert DNA and Vector DNA 
Appropriately digested DNA extracted from an agarose gel were used for ligations. 
DNA molecules with cohesive ends were ligated with a final molar ratio of insert: 
vector of 3:1. The reaction mixture included 4 μl 5x ligation buffer (250 mM Tris/HCl, 
pH 7.6, 50 mM MgCl2, 25 μM ATP, 25 mM dithiothreitol, 25 % (w/v) polyethylene 
glycol 8000) and 1 μl (5U) T4 DNA ligase (Invitrogen) made up to a final reaction 
volume of 20 μl with MQ H2O. Ligations were performed at room temperature for 2 h 
using T4 DNA ligase (Invitrogen) as per the manufacturer’s instructions, then 2 μl of 
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ligation product was transformed into Top 10 (Invitrogen) E. coli cells as Section 
2.1.9 describes. 
2.1.18 Polymerase Chain Reaction 
The polymerase chain reaction (PCR) developed by Mullis and Faloona (Mullis and 
Faloona, 1987) was used to amplify target genes throughout this study. Two 
oligonucleotide primers are required for PCR, one complementary to each strand of 
the DNA molecule, at sites that flank the region of DNA to be amplified. A 
thermostable DNA polymerase catalyses the synthesis of the complementary DNA 
strand in the presence of dNTPs. Oligonucleotide primers were designed such that 
complementary sequences were normally 20 bases in length with a G/C content of 
approximately 40 % and a melting temperature (Tm) of >45 
oC and within 5 oC 
difference between the two primer.  Tms were calculated using the online tool 
“Oligonucleotide Properties Calculator” at 
http://www.basic.nwu.edu/biotools/oligocalc.html which uses the following calculation 
formular; 
Tm= 64.9 +41*(yG+zC-16.4)/(wA+xT+yG+zC) 
where w,x,y,z are the number of the bases A, T, G, C in the sequence, respectively. 
   If possible, primers were also designed such that they contain two or three G or C 
bases at both ends of the primer, which would make the primer termini anneal well to 
the template strand and increase the amplification efficiency. When required, 
restriction site sequences were added to 5´-ends of primers with the addition of the 
sequence CTCCAG at the extreme 5´-end to facilitate the restriction cutting of the 
PCR product for ligation into appropriate vectors. Primers were manufactured by 
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MWG-Biotech and supplied lyophilised. Primers were dissolved in sterile double 
distilled water to 100 pmol/μl. Control reactions lacking template DNA were always 
carried out. PCRs were made up in sterile 0.2 ml or 0.5 ml Eppendorf tubes as 
follows: 
The standard thermocycle was as follows: 
 
 
After thermocycling was complete, a 5 µl aliquot of each PCR was analysed by 
electrophoresis on a mini-gel (Section 2.1.13). 
5 µl 
10 × Buffer for KOD DNA Polymerase (10 × = 1.2 M Tris-HCl, 100 mM KCl, 60 mM 
(NH
4
)
2
SO
4
, 1 % Triton X-100, 0.01% BSA, pH 8.0)  
3 µl 25 mM MgCl2 
5 µl dNTPs (2 mM each)  
1 µl 50 µM oligonucleotide primer #1 
1 µl 50 µM oligonucleotide primer #2 
≈ 60 ng Template DNA 
up to 49 µl PCR Grade Water  
1 µl Novagen

KOD DNA Polymerase (2.5 U/μl)  
50 µl Total Volume 
1 cycle 95 °C for 1 min 
35 cycles 
95 °C for 1 min 
(Lower Tm of primer pair – 5 °C) for 1 min 
72 °C for 1 min/kb fragment size 
1 cycle 72 °C for 10 min and 4
 
°C for 24 h 
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2.1.19 Site Directed Mutagenesis  
Mutagenesis of single amino acids was carried using the site directed mutagenesis 
method. The site-directed mutagenesis method utilizes an appropriate double-
stranded recombinant plasmid DNA and two synthetic oligonucleotide primers 
(MWG-Biotech AG, Germany) containing the desired mutation flanked by 10-15 
nucleotides that fully complemented the DNA template. The oligonucleotide primers 
are extended during temperature cycling by using a thermostable KOD polymerase. 
Reactions were made up in sterile 0.5 ml thin walled Eppendorf tubes as follows 
Each reaction was overlaid with 30 µl mineral oil and transferred to the Thermal 
cycler (Techne PHC-3) and cycling reactions started.  The cycling parameters were 
as follows: 
 
5 µl 
10                       1 × Buffer for KOD DNA Polymerase (10 × = 1.2 M Tris-HCl, 100 mM KCl, 
60 mM (NH
4
)
2
SO
4
, 1 % Triton X-100, 0.01% BSA, pH 8.0) 
3 µl 25 mM MgCl2 
5 µl dNTPs (2 mM each) 
1 µl 50 µM oligonucleotide primer #1 
1 µl 50 µM oligonucleotide primer #2 
≈ 60 ng Template DNA 
up to 49 µl PCR Grade Water 
1 µl Novagen

KOD DNA Polymerase (2.5 U/μl) 
50 µl Total Volume 50 μl 
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After thermocycling the reactions were placed on ice for 2 min, 1 µl of DpnI 
(Fermentas 10 U) was pipetted directly to each amplification reaction below the 
mineral oil and mixed gently by pippetting the solution up and down several times. 
The reaction mixtures were spun down in a microcentrifuge for 1 min and incubated 
at 37 ºC for 1 h in order to digest parental methylated DNA but not the unmethylated 
amplified DNA. The DNA was then transformed into E. Coli  TOP10 supercompetent 
cells (Section II.1.10). 
2.1.20 Automated DNA Sequencing 
DNA sequencing was conducted using the Value Read service from MWG Biotech 
AG, Ebersberg, Munich, Germany using ABI 3700 sequencers and Big dye 
technology (Applied Biosystems). Each clone was sequenced in both the forward 
and reverse direction. Plasmid DNA (1.5 μg) was dried by vacuum lyophilization at 
room temperature in 1.5 ml tubes. Plasmids were usually sequenced with T7 
promoter and T7 terminator. Genes encoded in pGEX vector were sequenced with 
pGex forward primer and pGex reverse primer, all primer sequences are shown in 
Table 2.5 shown below.  
 
 
 
1 cycle 95 °C for 1 min 
18 cycles 
95 °C for 1 min 
55 °C for 1 min 
68 °C for 1 min/ kb of plasmid length 
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Plasmid 
type Forward primer Reverse primer 
pET 
plasmids 
T7 promoter T7 terminator 
TAATACGACTCACTATAGGG CTAGTTATTGCTCAGCGGT 
Table 2.5 Plasmid sequencing primer  
 
2.1.21 Expression of Proteins  
E. coli strain BL21 or Tuner was transformed with recombinant plasmids conferring 
corresponding antibiotics resistance. Cells were plated onto LB-antibiotics agar 
plates and incubated overnight at 37 ºC. Colonies inoculated into 5 ml of LB-
antibiotics which was incubated overnight at 37 ºC in a shaking incubator. The 5 ml 
cultures were inoculated into 1 L LB containing appropriate antibiotics (in a 2 L 
baffled flask), which was grown at 37 ºC in a shaking incubator until an OD600 of 0.4-
0.6 was reached. The flasks were then transferred into a shaking incubator at 16 ºC 
and allowed to equilibrate for 1 h before induction with 0.2 mM IPTG for 16 h. Cells 
were harvested by centrifugation at 5000 rpm and resuspended in TALON buffer ( 
20mM Tris , 300mM NaCl pH 8.0). The cell suspension was sonicated for 2 min 
using a B. Braun Labsonic U sonicator set at low intensity ~42 watts and 0.5 second 
cycling, then transferred to a 50 ml centrifuge tube (Nalgene) and cell debris pelleted 
at 15000 rpm for 30 min at 4 oC, and the supernatant comprising the cell-free extract 
(CFE), was retained for further use. The cell debris-containing pellet (insoluble 
fraction) was resuspended in 10 ml of TALON Buffer. For biochemical assays target 
proteins was purified by Immobilised Metal Affinity Chromatography (IMAC) with 
TALON Resins (Clontech). 
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2.1.22 Purification of Proteins  
2.1.22.1 Immobilised Metal Affinity Chromatography (IMAC) 
His-tagged proteins can be purified by (IMAC) as the Histidine side-chain interacts 
with electropositive transition metal immobilised in a column, this interaction can be 
disrupted by imadizol. The His-tag protein can be eluted from the column matrix 
using an imadizole gradient.  
   TALON™ (Clontech Laboratories Inc.) columns with 2 ml TALON™ resin 
containing cobalt ions were prepared by washing in 10 volumes water and then 
TALONTM buffer (20 mM Tris/HCl buffer, pH 8.0, containing 300 mM NaCl). Cell free 
extracts (CFEs) were filtered (0.45µm) and poured through the column. The column 
was washed with 4 x 5 ml of TALONTM buffer. The protein was eluted with  2 x 5 ml 
of TALON™ buffer containing 10 mM imidizole followed by 2 x 5 ml of TALONTM 
buffer containing 100 mM imidizole. Analysis by SDS-PAGE of each stage of the 
purification indicated which fractions contained the purified protein. 
2.1.22.2 Gel Filitration Using FPLC 
The column (HiLoad™ 16/60 Superdex™ 200 Prep grade, GE Healthcare) was 
washed with 150 ml of Buffer A containing 150 mM NaCl at 1 ml min-1. The protein 
was concentrated to a volume of 5.5 ml and filtered (0.45 µM) before being loaded 
onto the column. The automatic system (Bio-Rad) eluted the proteins in 165 ml of 
Buffer A containing 150 mM NaCl at 1 ml min-1. The fractions above a threshold 
value of 0.02 Absorbance Units at a wavelength of 280 nm were collected and 
analysed by SDS-PAGE. 
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2.1.23 SDS PAGE  
SDS-PAGE method described by Laemmli (Laemmli, 1970) was used to analyse the 
size, relative purity and relative quantity of protein. Gels consisting of 10 – 15 % 
polyacrylamide (Acrylogel 3; BDH Electran) were typically used dependent on size 
of protein of interest. The gels are composed of two parts, namely the resolving gel 
and the stacking gel (Table 2.6). The system used was the AE-6450 apparatus from 
ATTO Corporation (Genetic Research Instruments) which employs 12 cm x 10 cm 
glass plates. The resolving gel was poured into the plates covered with water and 
allowed to polymerize. The water is then removed and the stacking gel poured on 
top of the resolving gel. This is allowed to polymerize with a comb in place. The 
comb and the rubber seal around the glass plates were removed when the gel was 
set. Protein samples were prepared by mixing 15 μl of appropriately diluted protein 
solution, 7 μl of loading buffer (Table 2.6) and boiling for three min. The plates were 
placed in the gel tank that was filled with running buffer (Table 2.6). The samples 
were loaded into the well of the gel, which was then electrophoresed at a current of 
30 A per gel.   
After electrophoresis, the gel was soaked in Coomassie Blue stain (0.4 % 
Coomassie Brilliant Blue R, 10 % (v/v) glacial acetic acid, 40 % (v/v) methanol) for 
60 min with gentle shaking. The gel was then destained in a solution consisting of 40 
% (v/v) methanol and 10 % (v/v) glacial acetic acid until all of the protein bands were 
visible and recorded using a digital camera (Canon PowerShoot A75). The Mr of 
proteins separated by SDS-PAGE was estimated by comparing their electrophoretic 
mobility with protein standards of known Mr. 
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2.1.23 Determination of Protein Concentration  
Pure protein concentration was determined using published methods (Gill and von 
Hippel, 1989, Pace et al., 1995).  The absorbance between 280nm and 320nm of the 
appropriately diluted pure proteins was measured with a spectrophotometer and the 
data were used to calculate protein concentrations, using the formula:  
A = εClD 
Where  A = absorbance 280 nm- oefficient, l = 
length of light path (cm), D = dilution factor and C = molar concentration of sample. 
The ProtParam program (www.expasy.com) was used to calculate the molar 
extinction coefficient of protein. The length of the light path was always 1 cm. 
2.1.24 Concentration Protein  
Protein solutions were concentrated using 20 ml or 2 ml Vivaspin™ centrifugal 
concentrators (VivaScience) with 10 or 30 kDa molecular weight cut off filters as 
appropriate after filtering (0.22 μm). Centrifugation was performed at 3500g using a 
MSE Mistral 3000i bench centrifuge with a swing out rotor at 10 ºC. 
 
 
 
 
 
70 
 
 
Table 2.6 Composition of resolving gel, stacking gel and loading buffer for SDS-PAGE 
 
 
 
Resolving gel 
0.75 M Tris/HCl buffer, pH 8.8 with 0.2 % SDS  9.4 ml 
40 % (w/v) Acrylogel (BDH Electran; acrylamide, 3 % (w/v) bisacrylamide) 5.8 ml 
d.d. H2O 3.5 ml 
10 % (w/v) Ammonium persulphate   90 l 
TEMED 30 l 
Stacking gel 
0.25 M Tris/HCl buffer, pH 8.8 with 0.2 % SDS  3.75 ml 
40 % (w/v) Acrylogel, 3 % (w/v) acrylamide, bisacrylamide 0.75 ml 
d.d. H2O 3.0 ml 
10 % (w/v) Ammonium persulphate  60 l 
TEMED 20 l 
Loading buffer 
SDS 10 % (w/v) 
0.25 M Tris/HCl buffer, pH 6.8) with 0.2 % SDS  5 ml 
Glycerol 25 % (w/v) 
β-mercaptoethanol 2.5 ml 
Bromophenol blue dye 0.1 %  
Running buffer  
Tris/190 mM glycine, pH 8.3 32 mM 
SDS 0.1 % 
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2.2 Bioinformatics 
2.2.1 Alignments 
Amino acid sequence searches were carried out using the Basic Local Alignment 
Search Tool (BLAST) (Altschul et al., 1997),  using the NCBI (National Center for 
Biotechnology Information) version hosted at the European Bioinformatics Institute 
(EBI) website (http://www.ebi.ac.uk). Amino acid sequences were aligned using 
ClustalW at the EBI website.  
2.2.2 Prediction of prokaryotic signal peptides 
The presence or absence of signal peptides, and the signal peptide cleavage 
position, was predicted using the SignalP 3.0 software hosted at 
www.cbs.dtu.dk/services/SignalP/(Bendtsen et al., 2004).  
2.3 Biochemistry  
Unless otherwise stated all enzyme assays were carried out at 37°C. All assays 
were repeated at least twice. 
 2.3.1 Enzyme assays  
Unless otherwise stated, all enzyme assays were performed at, and all reagents and 
cuvettes pre-warmed to, 37 °C. All assays were repeated at least three times. 
Graphs were plotted in GraphPad Prism 5.0 which was also used to calculate 
slopes, gradients and standard errors. The non-linear “one-site” binding model was 
used to fit kinetic data to estimate Km and kcat. 
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2.3.1.1 Fructose detection using Fructose assay kit (megazyme) 
Unless otherwise stated substrates used in fructose detection assays were levan 
and inulin. The standard reaction was carried out in 500 µl at 37°C in 50 mM Sodium 
phosphate, 50 mM sodium acetate pH 5.5. Various substrate concentrations were 
used in order to calculate the kinetic parameters of the enzymes. Fructose release 
was measured over 20 mins using a fructose assay kit from megazyme. The kit 
utilises three linker enzymes to measure the fructose liberated from polysaccharide. 
The liberated fructose is phosphorylated to fructose-6-phosphate (F-6-P) by 
Hexokinase (HK). Fructose-6-phosphate is converted to glucose-6-phosphate (G-6-
P) by Phosphoglucose isomerase (PGI). In the presence of glucose-6-phosphate 
dehydrogenase (G6P-DH) glucose-6-phosphate is oxidised by nicotinamide-adenine 
dinucleotide phosphate (NADP+) to gluconate-6-phosphate. This leads to the 
formation of reduced nicotinamide-adinine dinuclecotide phosphate (NADPH). The 
amount of NADPH formed is stoichometric with the amount of fructose released this 
is measured by the increase in absorbance at 340 nm using the extinction coefficient 
of 6300 M-1 cm-1.   
2.3.1.2 Fructose detection using HPLC analysis 
Standard reactions were carried out in a total volume of 1500 µl at 37 °C in 50 mM 
sodium phosphate, 50 mM sodium acetate pH 5.5. Various substrate concentrations 
were used in order to calculate the kinetic parameters of the enzymes. Assays were 
incubated for 30 min and four 200 ul time points were taken, each aliquot was heat 
inactivated by boiling for 10 min. Following inactivation the samples were centrifuged 
at 13000 RPM for 10mins to pellet any undigested material. The samples were then 
diluted 5-fold and subjected to HPLC analysis . Each reaction contained a fucose 
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internal standard and all data obtained was normalised to this standard and 
converted to a fructose concentration using a fructose standard curve.  
2.3.1.3 3, 5-Dinitrosalicyclic acid assay (DNSA) 
The rate of hydrolysis was monitored by the increase in reducing sugar formed over 
time. The free anomeric carbon at the end of a polysaccharide can open from its 
more common cyclic conformation and act as a weak reducing agent. Each time a 
glycosidic bond is hydrolysed a new reducing end is formed, the concentration of 
which can be determined with the DNSA reagent using the Miller method (Miller, 
1959) A 500 µl aliquot of an enzyme reaction was added to 500 µl DNSA reagent (1 
% (w/v) DNSA, 0.2 % (v/v) phenol, 1 % (w/v) NaOH, 0.002 % glucose, 0.05 % (w/v) 
NaSO3) to terminate the reaction. The tube was then boiled 20 min, placed on ice for 
10 min, equilibrated to room temperature and the absorbance read at 575 nm. A 
standard curve of 0-1000 μg/ml monosaccharide (plus polysaccharide substrate) 
was used to quantify the released reducing sugar. 
2.3.2 Thin Layer Chromatography (TLC) 
A TLC plate (Silicagel 60, 20 × 20, Merck) was cut to the desired size (the minimum 
height should be 10 cm). Between 5 and 10 µl of samples were spotted on the plate, 
separated by 10 mm. Solvent (50 ml) comprising freshly made 1-butanol/acetic 
acid/water (2:1:1, v/v) was poured into a glass chromatography tank (23 × 23 × 7.5) 
and covered tightly. Vapours were allowed to equilibrate for at least 2 h before use. 
The TLC plate was placed into the tank and samples allowed to migrate until the 
running buffer reached ≈ 1 cm to the top of the plate. The plate was dried carefully 
using a hairdryer and put back in the tank for another run. The plate was dried again 
and immersed for a few seconds in an orcinol sulphuric acid reagent (sulphuric 
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acid/ethanol/water 3:70:20 v/v, orcinol 1 ‰), dried carefully and heated until sugars 
were developed, at 120 °C (5 -10 min). Plates were recorded using a digital camera 
(Canon PowerShoot A75). Standards consisting of known monosaccharides and 
oligosaccharides were spotted on the TLC plate . In order to detect the presence of 
sugar in a sample quickly, 5 µl were spotted on a section of TLC plate and immersed 
for a few second in orcinol sulphuric acid reagent, dried carefully and heated until 
sugars were revealed, as previously described. 
2.3.3 High Pressure Liquid Chromatography (HPLC) 
Enzyme catalysed hydrolysis reactions of polysaccharides were analysed using an 
analytical CARBOPAC™ PA-100 anion exchange column (Dionex) equipped with a 
CARBOPAC™ PA-100 guard column. The fully automated system (ICS-3000 
gradient pump, detector compartment, electrochemical detector, auto sampler) had a 
loop size of 100 µl, flow rate of 1.0 ml/min, room temperature, pressure of ≈ 2000 psi 
and sugars were detected by pulsed amperometric detection (PAD). The PAD 
settings were E1 = +0.05, E2 = +0.6 and E3 = -0.6. Typical elution conditions used 
were 0-10 minutes 66 mM NaOH, 10-25 min 66 mM NaOH with 0-75 mM sodium 
acetate linear gradient. After each run the column was washed with 500 mM sodium 
acetate for 10 min and then 500 mM sodium hydroxide for 10 min and then 
equilibrated with 66 mM sodium hydroxide for 10 min. Appropriate monosaccharides 
(200 µM ) were used as standards and enzymatic reaction was diluted 5 fold before 
being loaded on to the column. Data were collected and manipulated using 
Chromeleon™ Chromatography Management System V.6.8 (Dionex) via a 
Chromeleon™ Server (Dionex). Final graphs were drawn with Prism 5.0 (GraphPad). 
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2.3.4 Isothermal Titration Calirometry (ITC) 
The thermodynamics and binding affinities of carbohydrate protein interaction were 
investigated by ITC using a MicroCal™ VP-Isothermal Titration Calorimeter. ITC 
measurements were made at 25 °C following standard procedures. The proteins 
were dialyzed extensively against buffer and the ligands were dissolved in the 
dialysis buffer to minimize heats of dilution. Degassed protein solution (1.4331 ml) at 
high concentration (80 - 145 µM) was equilibrated in a reaction cell maintained at 25 
°C. To this solution, 28 aliquots (10 µl) of ligands at an appropriate concentration 
were automatically injected, with rapid stirring (307 rpm), at 200 s intervals. Typically, 
oligosaccharides ligands were titrated at ≈ 10 mM and soluble polysaccharide 
ligands at 10 mg/ml. Binding was monitored by measuring heat released (exothermic 
binding) or absorbed (endothermic binding) for each aliquot of ligand. During the 
titration, the difference in electrical power required to maintain the temperature of the 
reaction cell versus the temperature of the reference cell was recorded, and from 
these differences the heat change on binding calculated. 
The molar concentration of binding sites present in polysaccharide ligands was 
determined following the method of Szabo et al. (Szabo et al., 2001). After 
determining that the test protein contained a single binding site, by titrations with 
oligosaccharides of known molarity, the molar concentration of polysaccharide 
ligands was fitted in an iterative fashion until the n-value was as close as possible to 
one. Integrated heat effects, after correction for heats of dilution, were analyzed by 
nonlinear regression using a single site-binding model (Microcal Origin, version 7.0). 
The fitted data yield the association constant (Ka) and the
 enthalpy of binding (ΔH). 
Other thermodynamic parameters were calculated using the standard 
thermodynamic equation: 
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-RTlnKa = ΔG = ΔH-TΔS 
where R is the gas constant (1.99 cal.K-1.mol-1), T is the temperature in degree 
absolute (298.15 K), ΔG is the change in free enthalpy and ΔS is the entropy of 
binding. 
2.3.5 Affinity Gel electrophoresis 
An affinity electrophoresis method using native polyacrylamide gels containing 
soluble ligand sugars was developed based on the method of Tomme et al (1996). A 
continuous gel system was used with the same gel apparatus (ATTO Corporation) 
as used for SDS-PAGE (Section II.1.25).  Gels contained 7.5 % (w/v) acrylamide 
(Acrylogel 3; BDH Electran™) in 25 mM Tris, 250 mM glycine buffer, pH 8.3, which 
comprised the Running and Sample buffers. For ligand-containing gels, appropriate 
polysaccharides were added at 0.001 - 0.1 % (w/v) final concentration prior to 
polymerisation.  Pure proteins (6 µg) in 7 µl of loading buffer, containing 5 % (v/v) 
glycerol and 0.0025 % Bromophenol, Blue final concentrations, were 
electrophoresed at 10 mA/gel at room temperature for 2.5 h.  Proteins were then 
stained in 0.4 % (w/v) Coomassie Blue, 40 % (v/v) methanol, 10 % (v/v) glacial 
acetic acid for ≈ 1 h and then destained in 40 % (v/v) methanol, 10 % glacial acetic 
acid. Gels with and without ligands were run in the same gel box with identical 
samples loaded on each. BSA (15 µg) was used as a negative, non-interacting 
control. 
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2.3.6 Analytical Ultracentrifugation (AUC) 
All analytical Ultracentrifugation experiments were carried out by Dr Alexandra 
Solovyova in the pinnale laboratory in the Institute of Cell and Molecular 
Biosciences. Below is a brief description of the AUC method.  
Sedimentation velocity (SV) experiments were carried out in a Beckman Coulter 
(Palo Alto, CA, USA) ProteomeLab XL-I analytical ultracentrifuge using interference 
optics. All AUC runs were carried out at the rotation speed of 48,000 rpm and 
experimental temperature 20C; the velocity scans were taken 1 second apart, 600 
scans in total. The sample volume was 400 l. The concentrations of BT3082 were 
used as follows: 200M, 150M, 100M and 50M and combined with X40 added in 
1000 times in excess. The partial specific volumes ( v ) for the proteins were 
calculated from the protein amino acid sequence, using the program SEDNTERP 
(Laue et al., 1992) and extrapolated to the experimental temperature following the 
method as described in (Durchschlag 1986). The density and viscosity of the buffer 
(50 mM phosphate pH7.0, 200 mM NaCl) at the experimental temperature was also 
calculated using SEDNTERP.  
The distributions of sedimenting material were modelled as a distribution of Lamm 
equation solutions (Schuck, 1998) where the measured boundary a(r,t) was 
modelled as an integral over differential concentration distributions c(s): 
 
   ds)t,r,D,s()s(c)t,r(a   (1) 
where  is the noise component, r is the distance from the centre of rotation and t is 
time. The expression (s, D, r, t) denotes the solution of the Lamm equation (Lamm, 
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1929) for a single species by finite element methods (Demeler and Saber, 1998). Eq. 
1 is solved numerically by discretisation into a grid of 200 sedimentation coefficients 
for both interference data and the best-fit concentrations for each plausible species 
are calculated according to a linear least squares fit (as implemented in SEDFIT 
(http://www.analyticalultracentrifugation.com)). The sedimentation velocity profiles 
were fitted using a maximum entropy regularisation parameter of p = 0.95. The data 
were fitted for the position of the meniscus, value of the friction coefficient (f/f0) and 
both the time- and radial-independent noise. The weight average sedimentation 
coefficient was calculated by integrating the differential sedimentation coefficient 
distribution (Schuck, 2003). The absolute values of sedimentation coefficients and 
molecular masses were estimated by integration of the peaks on c(s) and c(M) 
distributions respectively (Dam and Schuck 2004).  
The program HYDROPRO (Garcia de la Torre et al., 2000) was used to calculate the 
sedimentation coefficient values for BT3082 and X40 the basis of their atomic 
coordinates. Crystallographic symmetrical dimer of BT3082 was built using the 
program PyMol (DeLano Scientific) and its sedimentation coefficient was calculated 
using HYDROPRO. 
2.3.7 Purification of oligosaccharides by size exclusion chromatography 
1 g of Levan was resuspended in 10 ml of H20, and incubated in 50 mM HEPES pH 
7.5 with an endo β2,6 fructanase (BT1760) at 37 °C to partially digest the 
polysaccharide. The reaction was heat inactivated by boiling for 10 min.  Aliquots 
were taken at appropriate time points and analysed by TLC to follow the reaction. 
The sample was freeze dried and resuspended in 3 ml of H2O for size exclusion 
purification. The partially digested levan products were were separated by size 
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exclusion chromatography using P2 Bio-gel (Bio-Rad) matrix packed in 2 Glass 
Econo-Column™ (2.5 cm × 80.0 cm) with a flow adaptor (Bio-Rad) at 0.2 ml/min in 
degassed MQ H2O.The partially digested levan products was loaded directly onto 
the columns, which was then run with MQ H2O as mobile phase at 0.2 ml/min using 
a peristaltic pump (LKB Bromma 2132 microperpex™). The 2 ml fractions were 
collected continuously 16 h after loading for 39 h using a Bio-Rad model 2110 
fraction collector. A 2 µl aliquot of every three fraction was analysed by TLC 
identifying fractions of interest to be pooled and freeze dried for further analysis. 
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Chapter 3: The Effect of CBMX40 on the Catalytic 
Activity of its Native Enzyme SacC 
 
3.1 Introduction  
Many glycoside hydrolases, particularly those that target insoluble substrates, 
contain non-catalytic carbohydrate binding modules (CBMs) (Boraston et al., 2004). 
As with the glycoside hydrolase families, CBMs have also been grouped into 
sequence-based families in the CAZY database (www.cazy.org). Prior to the start of 
this project a group of sequence-related X modules (where the X signifies a module 
of unknown function) were identified in a subset of glycoside hydrolases by Bernard 
Henrissat. This family of X modules was termed X40, and Figure 3.1 illustrates the 
new family as a phylogenetic tree. A notable feature of the phlyogenetic tree is that 
many of the X40 sequences are found in glycoside hydrolase family 32 (GH32) 
enzymes. Numerous enzymes in GH32 have been characterised and shown to 
hydrolyse fructan polysaccharides, such as inulin and levan, through an exo- or 
endo-mode of action (Lammens et al., 2009). Although a CBM that binds specifically 
to the β-2,1-linked fructose polymer, inulin has been identified (Lee et al., 2004),  
there have been no reports of CBMs that bind levan, a predominantly β-2,6-linked 
fructose-containing polysaccharide. It is potentially significant, therefore, that an X40 
module is appended to a Bacillus subtilis GH32 enzyme, SacC, which displays exo-
levenase activity (Wanker et al., 1995). It is possible that the X40 module in SacC 
(defined henceforth as CBMX40) may comprise the first example of a levan-specific 
CBM. To test this hypothesis recombinant CBMX40 was expressed in Escherichia 
coli and its capacity to bind to complex carbohydrates was assessed (experiments 
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carried out by Dr James Flint).  Isothermal titration calirometry (ITC) showed that 
CBMX40 bound to levan but not to inulin or fructose, Figure 3.2. The data also 
showed that the protein displayed higher affinity for levanbiose (KA 16.9 X 10
3 M- 1), 
the disaccharide derived from levan, than the parent polysaccharide (KA 3.3 X 10
3 M-
1), Table 3.1. The crystal structure of CBMX40  (determined by Dr James Flint), 
Figure 3.2, revealed a canonical jelly roll fold, while mutagenesis studies showed 
that the ligand binding site is  between the loops connecting the β sheets, Table 3.1 
and Figure 3.2. The structure of the protein in complex with ligand was not obtained. 
3.2 Objectives 
The objective of this chapter is to explore the ligand specificity of CBMX40 in greater 
detail and to characterise its role in the SacC enzyme.  
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Figure 3.1 Phylogenetic tree of putative X40 containing protein sequences  
SacC is highlighted in red box. Tree made with the CAZyBox (in house program interfaced with the CAZy database); 
sequences were aligned with MUSCLE and a distance matrix was calculated using the BLOSSUM62 substitution parameters. 
The matrix was then used as input for WMV-SECATOR for making clusters (subfamilies). The leaves of the tree are labelled 
with the accession numbers, the species, and the modular structure of the proteins. If a protein has more than one X40, it 
appears more than once on the tree
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Figure 3.2 CBMX40 binding to Levan 
Panel A- Example ITC of CBMX40 binding to levan using 10mg/ml Levan in the syringe and 50 µM CBMX40 in 
the cell. The top frame shows the raw heats and the bottom shows the integrated peak areas fitted to a one 
site model using Microcal origin software. Panel B- Cartoon representation of CBMX40 molecule. The protein 
displays a β canonical jelly roll fold, the amino acids potentially involved in binding are shown in stick formation 
and colour coded to correspond with the affinity gel in Panel C. Panel C- Affinity gel showing the binding of 
CBMX40 mutants to levan. Each amino acid is illustrated in the structure in Panel B. Amino acids coloured red 
are essential for binding; orange, while not essential, still effect binding; those coloured pink do not affect levan 
binding. BSA is shown as a non interacting control . Data in figure from a personal communication from Dr 
James Flint.  
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Table 3.1 Affinity and thermodynamics of the binding of wild type and mutants of CBMX40 to levan and 
levan oligosaccharides.    
NDB- No detectable binding. nd- not determined. ITC traces fitted to a single site model. For polysaccharides 
when molar concentrations were unknown the traces were fitted to an N value as close to one as possible by 
varying the molar concentration of the polysaccharide. All data was from a personal communication from Dr 
James Flint. 
 
 
 
CBMX40  Ligand Ka (x10
3  
M
-1
)  
ΔG (x103 
kcal/mole) 
ΔH (x103 
kcal/mole) 
TΔS 
(kcal/mole) 
N 
Wild type Levanbiose 16.9 -5.8 -12.1 -6.3 1.1 
Wild type Levantriose 10.6 -5.5 -11.2 -5.7 1.1 
Wild type Levantetraose 8.2 -5.3 -12.3 -6.9 1.0 
Wild type Levanpentaose 8.8 -5.4 -13.4 -8.0 1.0 
Wild type Levan 3.3 -4.8 -18.4 -13.6 1.0 
N16A Levan 1.4 -4.3 -12.5 -8.2 1.0 
D33A Levan NDB - - - - 
K73A Levan 2.9 -4.7 -13.1 -8.4 1.1 
N79A Levan NDB - - - - 
D81A Levan <1.0  nd nd nd 1.0 
H84A Levan 3.2 -4.8 -13.3 -8.5 1.0 
K88A Levan NDB - - - - 
W151A Levan NDB - - - - 
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3.3 Results  
3.3.1 Gene Cloning, Protein expression and purification. 
To characterise the effect of CBMX40 on the activity of SacC two gene constructs 
were designed encoding mature SacC (SacCM; residues Asp 23 to Ser677 of full 
length), lacking its signal peptide, and the GH32 catalytic domain (SacCCD; residues 
Asp23 to Gly521 of full length SacC), respectively, Figure 3.3. The genes encoding 
full length SacC and SacCCD were cloned into the E. coli expression vector pET28a, 
CBMX40 (residues Thr522 to Ser677 of full length SacC) was previously cloned into 
the E. coli expression vector pET22a by Dr James Flint. The appropriate DNA 
fragments were amplified by the polymerase chain reaction (PCR) from genomic 
B.subtllis DNA using primers designed to bind to the 3’ and 5’ regions of the SacC 
gene, shown in Table 3.2. The PCR fragments were digested with BamHI and XhoI 
and ligated into the appropriate vectors as described in Section 2.1.17. 
Transformants containing plasmid DNA were tested for the presence of insert by 
digestion with BamHI and XhoI and visualised by agarose gel electrophoresis, 
described in Section 2.1.13. An example gel showing positive transformants 
containing the desired insert is shown in Figure 3.4. The clones were sequenced (by 
MWG; data not shown) to confirm that no mutations were introduced during PCR 
amplification. The proteins encoded by these plasmids contain a C-terminal His6-tag. 
All the recombinant proteins were expressed in BL21(DE3) E. coli cells; cultures 
were grown at 37 °C to mid-exponential phase (A600nm 0.6) and recombinant protein 
production was induced with 1 mM IPTG at 16 °C and incubation for 16 h. The 
proteins were purified by IMAC to apparent electrophoretic homogeneity. Figure 3.5 
shows an SDS-PAGE of the purification of SacCM and SacCCD and CBMX40.A 
mutation (W152A), which inactivates CBMX40, was introduced into SacCM. The 
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primers that contained the mutation (listed in Table 3.2), were used in the site-
directed mutagenesis PCR (Section 2.1.19) in which SacCM-pET28a (contains 
SacCM) was the template. 
 
Table 3.2 Primers utilised to clone genes encoding SacCM, SacCCD and SacCM:W152A.  
Restriction sites are shown in bold type 
 
 
 
 
 
 
Primer name Sequence Restriction site 
SacCM FWD CCG CTA CAC GGA TCC gat gca gcc gat tca agc tac BamHI 
SacCM REV CTC CAG CTC GAG AGA CTC CTT CGT TAC ATT CTG AAA GAC XhoI 
SacCCD FWD CCG CTA CAC GGA TCC gat gca gcc gat tca agc tac BamHI 
SacCCD REV CTC CAG CTC GAG CGT TCC CCA TAC CTT TTT TAA AGG GTG XhoI 
SacCM W152A 
FWD 
TTT GGC TTG AAT GTG GCG GAC GCG ACT GCT GTC 
 N/A 
SacCM W152A 
REV 
GAC AGC AGT CGC GTC CGC CAC ATT CAA GCC AAA 
 N/A 
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Figure 3.3 Cartoon representation of SacC constructs 
A- SacCM: Mature protein (residues 23-677 ) comprising both the GH32 catalytic domain and CBMX40, but 
lacking the signal peptide. B- SacCCD Truncated SacC comprising the GH32 catalytic domain only (residues 
23-521). C- CBMX40 (residues 522-677) . Images made using ProSITE my domains image creator. 
 
 
 
Figure 3.4 Agarose gel showing restriction digest of SacC constructs 
M- DNA marker. Lanes 1 and 2 contain positive sacCM clones showing the insert at about 1800bp. Lanes 3 and 
4 contain a truncated derivative of sacCM encoding SacCCD showing the insert at about 1500bp. 
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Figure 3.5 SDS PAGE gel showing IMAC purification of SacC constructs 
Panel A shows IMAC purification of SacC mature protein . Panel B shows IMAC purification of SacC catalytic 
domain. Panel C shows IMAC purification of CBMX40. CFE= cell free extract, FT= Flow through from column, 
W= buffer wash, E1,E2 and E3= 10mM imadizole elution, E4 and E5= 100mM imadizole elution. 
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3.3.2 Further Biochemical analysis of LevX40 
Prior to this project CBMX40 was characterised as a levan binding CBM that 
preferred the disaccharide unit of the levan polysaccharide.  However, the mode of 
binding and polysaccharide coverage of CBMX40 was unknown. For example, it is 
possible, given that the appended enzyme is a exo-acting fructosidase, that the CBM 
targets the non-reducing end of levan, rather than binding to internal regions. To test 
this hypothesis CBMX40, and an inactive mutant (D147A) of the exo-acting Bacillus  
levanase BT 3082 (Sonnenburg et al., 2010), which thus binds exclusively to the 
non-reducing end of polysaccharide, were titrated against levan from Serratia 
levanicum  using ITC, Figure 3.6. From the resultant data, it was calculated that both 
the BT 3082 D147A mutant and CBMX40 bound once every 24 fructose residues of 
the polysaccharide. To calculate the stoichiometry the concentration of ligand was 
changed until an N value of 1 was achieved as there is only 1 binding site for each 
protein. The amount of ligand used in the ITC experiment in grams per litre was 
divided by the molecular weight of fructose thus giving a concentration of fructose 
this was then divided by the concentration of ligand which gave an N-value of 1, 
resulting in the number of sugars. An example is shown for the BT 3082 D147A 
mutant below. 
  0.25% Levan used as ligand in ITC = 2.5 g/L   
Concentration of levan to fit ITC to N-value of  1= 0.063 mM 
Fructose molecular weight – molecular weight of water= 162 
  2.5/162= 0.0154 = 15.4 mM 
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  15.4/0.63= 24 fructose residues       
 so 1 BT 3082 D147A binds per 24 fructose residues 
The similar stoichiometry values for the two proteins suggest that, similar to BT 
3082, CBMX40 also binds to the non-reducing end of levan chains. This view was 
confirmed by the resolution of the crystal structure of CBMX40 in complex with 
ligands (see Discussion).   
 
 Figure 3.6 Example ITC traces  
Panel A- shows 50 µM X40 in the cell and 1% Levan in the syringe. Panel B- shows 50 µM 3082 D147A in the 
cell and 0.25% Levan. As the concentration of levan was unknown the molarity of the polysaccharide was 
iteratively fitted to obtain an N value of 1.  
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3.3.3 Effect of CBMX40 on SacC catalytic activity against levan  
3.3.3.1 SacC activity against fructan polysaccharides 
In order to dissect the role of CBMX40 on the catalytic activity of the SacC enzyme, 
SacCM,CBMX40 and SacCCD were including in enzyme assays in which fructose 
release was either measured using a fructose assay kit or by HPLC analysis as 
outlined in Section 2.3.1.1 and 2.3.1.2, respectively. Experiments were carried out at 
37 °C in 50 mM sodium phosphate-acetate buffer pH 5.5. This buffer was used as 
previous studies on SacC showed that the pH optimum of the enzyme was between 
5.5 and 6. 
To test whether SacCM and SacCCD were active, the capacity of the enzymes to 
hydrolyse sucrose was evaluated using the glucose release assay. The data, 
presented in Table 3.3, showed that there was no significant difference in the activity 
of the two enzymes. This was expected as CBMX40 does not bind to sucrose and 
thus is unlikely to influence activity against the disaccharide. The data, however, 
confirms that the truncated catalytic module has folded correctly and that the integrity 
of the active site has not been compromised by the removal of the CBM.  
To assess the activity of the two enzymes against levan from Erwina herbicola, 
SacCM and SacCCD were incubated with the polysaccharide and the fructose 
released was analysed by HPLC over time. The initial rates were plotted in 
GraphPad prism and analysed by non-linear regression to calculate the kinetic 
parameters of the two enzymes. Examples of the chromatography, initial rate plots 
and non-linear regression curves are shown in Figure 3.7 and Figure 3.8 
respectively, while the kinetic data are reported in Table 3.3. 
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 Although both SacCM and SacCCD were active on levan, they displayed very different 
kinetic parameters against the polymeric substrate.  Thus, the Km and kcat of SacCCD 
are, respectively higher and lower than the corresponding kinetic parameters of 
SacCM.  The catalytic efficiency kcat/Km of the truncated enzyme against E. herbicola 
levan is 120-fold lower than the full length fructosidase. Interestingly, SacCM appears 
to display substrate inhibition kinetics whereas SacCCD displays typical Mechalias-
Menten kinetics. In contrast to the difference in activity against E. herbicola levan, 
the catalytic efficiency of SacCCD was only 20-fold lower than SacCM when the levan 
from S. levanicum was deployed as the substrate, with both enzymes displaying 
typical Mechalias-Menten kinetics. These data suggest that CBMX40 influences the 
activity of SacC against levan, although the effect of the levan binding protein 
modules varies depending on the source of the polysaccharide. This implies that 
there are significant differences in the structure of the two sources of levan. When 
inulin was utilised as the substrate, there was no significant difference in catalytic 
activity between SacCM and SacCCD, consistent with the observation that CBMX40 
displays no affinity for the β-2,1-linked fructan .  A third derivative of SacC, SacCM 
W152A, in which CBMX40 is inactive, displayed activity against Levan that was 
similar to SacCC, Table 3.3. This supports the view that the low activity of SacCD 
against levan reflects the loss of the CBM, and not through any structural changes to 
the catalytic module.  
 
93 
 
 
Figure 3.7 Example HPLC traces and initial rate graphs for SacCM vs Levan from 
E.herbicola 
HPLC traces plotted in Graphpad prism. Each graph shows the HPLC trace for each time point for the relevant 
substrate concentration. Peak 1 shows the fucose internal standard, Peak 2 shows the fructose released. Initial 
rate graphs show the fructose released in µM as a function of time.
94 
 
Table 3.3 Kinetic values for wild type and derivatives of SacC
 
SacCM SacCCD SacCM W151A 
 
Km µM Kcat s
-1
 Ki Kcat/Km M
-1 
s
-1
 Km µM 
Kcat 
S
-1
 Kcat/Km M
-1 
s
-1
 
Km 
µM 
Kcat 
s
-1
 
Kcat/Km M
-1 
s
-
1
 
Substrate 
          
Sucrose 
34400 
± 
5793 
152.3 
± 7.96 
 
443 
42300 
±9255 
135.4 
±9.83 319 
   
Levan from Erwinia herbicola 
272 
±154 
135 ± 
48.2 
915 
± 
595 4.9 x 10
5
 
1120 ± 
472 
4.6 ± 
1.03 4.1 x10
3
 
1079 
± 
472 
12.1 
± 
1.03 1.10 x 10
4
 
Levan from Serratia levanicum 
57.23 
±8.4 
27± 
0.43 
 
4.7x10
5
 
221.7 
±124.8 
4.99 
± 
1.09 2.2x10
4
 
   
Inulin 
621 
±188 
12.5 
±2.18 
 
1.9 x 10
4
 
701 ± 
104 
7.5 ± 
0.69 1.0 x 10
4
 
   
Levanbiose 
3400 
± 
4879 
149 ± 
173 
 
4.3 x 10
4
 
1900 ± 
991 
54 ± 
19.9 2.8 x 10
4
 
   
Levantriose 
1537 
± 264 
16.6 ± 
1.3 
 
1.0 x 10
4
 
2770 ± 
1065 
13.1 
± 2,3 4.7 x 10
3
 
   
95 
 
 
Figure 3.8 Example of kinetic analysis for SacCM and SacCCD against various substrates.  
Initial rates derived from either glucose or fructose release using the Megazyme assay kit or by HPLC analysis, were plotted in Graphpad prism using either the Mechalias-menten equation 
or substrate inhibiton equation. All assays were carried out in 50mM sodium phosphate-actetate buffer pH 5.5 at 37°C
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3.3.3.2 SacC activity against levan derived oligosaccharides 
In order to attain levan derived oligosaccharides 1g of levan from E. herbicola was 
partially digested by 1µM Bt 1760, an endo β2,6 fructanase (Sonnenburg et al., 
2010), giving a range of oligosaccharide products. This crude oligosaccharide 
mixture was purified by size exclusion chromatography as described in Section 
2.3.7. The fractions from the purification are shown in Figure 3.9. 
 
Figure 3.9 TLC analysis of P2 purified levan oligosaccharide fractions.  
6 µl of every tenth (5ml) fraction from the P2 colums subjected to TLC analysis. Every second fraction was also 
analysed by TLC for a more accurate analysis and to decide which fractions to pool together.  
The activity of SacCM against levan-derived oligosaccharides (Table 3.3) showed 
that the enzyme displayed similar activity against levanbiose and levantriose, 
indicating that the enzyme contains only two substrate binding sites, -1 and +1. The 
activity of SacCD against the two levan-oligosaccharides was similar to SacCM, 
providing further support for the view that CBMX40 does not directly contribute to 
substrate binding in the active site (-1 and +1 subsites) of the enzyme. It should be 
noted, however, that the kinetic parameters for SacCM against levanbiose and 
levantriose are similar to the corresponding kinetic parameters of SacCCD against 
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levan from E. herbicola.   It appears, therefore, that CBMX40, through its capacity to 
bind levan, potentiates the activity of the enzyme against the polysaccharide, but not 
against oligosaccharides.  
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3.3.4 Catalytic activity of SacCCD in the presence of CBMX40 
The previous section detailed the ability of CBMX40 to potentiate the activity of the 
catalytic domain of SacC when in a single polypeptide. Given the potentiation of the 
catalytic domain by CBMX40 it is interesting to explore whether CBMX40 can 
enhance the activity of SacCCD when the two protein modules are not covalently 
linked. To do this SacCCD was incubated with levan from both E. herbicola and S. 
levanicum in the presence of CBMX40, and the intial rate of fructose release was 
measured by HPLC. A control experiment was carried out in tandem in which 
SacCCD was incubated with the two levans in the absence of CBMX40. 
When SacCD was incubated with levan from E. herbicola in the presence of CBMX40 
the rate of substrate hydrolysis increased. At the highest concentration of CBMX40 
to SacCCD, 20 µM to 10 nM, respectively, there was a 25-fold enhancement in the 
rate of hydrolysis, Figure 3.10. However, even at this extremely high ratio of 
CBMX40: SacCCD the rate did not reach the level of SacM activity against levan. 
Interestingly, when this experiment was repeated with levan from S. levanicum, the 
elevation in activity was only 1.5-fold, suggesting that there is a difference in the 
structure of the two types of levan. These data indicate that CBMX40 acts directly on 
levan to aid enzymatic hydrolysis, or that CBMX40 and SacCCD interact to form a 
complex, even when not physically attached. 
3.3.5 SacCCD interacts with CBMX40 when not physically attached 
Analytical ultracentrifugation (AUC) was utilised to investigate if there is an 
interaction between SacCCD and CBMX40 when the two protein modules are not 
covalently attached. All AUC experiments were carried out and analysed by Dr 
Alexandra Solovyova as described in Section 2.3.6. 
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The two proteins combined in a 1:1 ratio were subjected to sedimentation velocity 
AUC. Sedimentation velocity experiments are run at high rotor speeds and measure 
how proteins sediment in response to centrifugal force, which gives information on 
molecular weight and shape of the proteins. Calculations from the expected 
molecular weight and atomic coordinates of the proteins give S-values that 
correspond to the SacCCD and CBMX40 and a SacCCD/CBMX40 complex. The data 
are displayed in Figure 3.11; three peaks were identified in the experiment. The first 
peak, at an S-value of 2.08 and a molecular weight of 19.4 kDa, corresponds to the 
predicted molecular mass of CBMX40. The second peak at an S-value of 4.25 and a 
molecular weight of 56.8 kDa corresponds to the predicted size of SacCCD. The third 
peak has an experimental S-value of 4.99 and a molecular weight 72.5 KDa. Given 
that the calculated molecular weight of a SacCCD/CBMX40 complex is 75.9 KDa it 
can be assumed this peak comprises a heterodimer of the two proteins. 
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Figure 3.10 Initial rates for SacCCD in trans with CBMX40 
Panel A shows the activity of SacCCD with various CBMX40 concentrations against 715 µM Levan from E. 
herbicola. Panel B shows the activity of SacCCD with CBMX40 against 715 µM Levan from S. levanicum. Both 
experiments were measured by HPLC analysis of fructose release.  
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Figure 3.11 AUC showing SacCCD/CBMX40 complex 
All experiments were centrifuged run at 20 °C in 50 mM Na-HEPES, pH 7.5, containing 150 mM NaCl 
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3.4 Discussion 
The data presented in this chapter illustrates the characterisation of CBMX40 as a 
novel levan binding domain. CBMX40 binds the disaccharide unit of the levan 
polysaccharide chain. The ITC results, described in Section 3.3.2 are indicative of 
CBMX40 binding to the non-reducing chain end. CBMX40 displays the same binding 
pattern as an inactive exo-acting levanase, BT 3082 D147A. BT 3082 D147A must 
bind the non reducing end of the levan chain for catalysis, therefore, CBMX40 must 
also bind the non reducing ends of the levan chain. A structure in complex with 
ligand would confirm the mode of binding. Through the duration of this project 
attempts were made to attain this structure, however none of these attempts were 
successful. To this aim a new construct was designed swapping the current C-
terminal His-tag for an N-terminal clevable His-tag, primers shown in Table 3.4. The 
new construct was cloned and the protein purified and, after removal of the His-tag, 
crystallised by Mr Carl Moreland. The structure of the tagless CBMX40 in complex 
with fructose and levanbiose has recently been solved by Dr Arnaud Basle.  
 
Table 3.4 CBMX40 primers for pET 16b construct 
 
The structures of CBMX40 in complex with both fructose and levanbiose are shown 
in Figure 3.12. The structure of CBMX40 in complex with levanbiose shows that 
Asp33, Asn79, Asp81 and Lys88, shown previously to be essential for binding 
through mutagenesis studies, Table 3.1, make direct polar contacts with the bound 
Primer name Sequence Restriction site 
CBMX40 FWD CCG CTA CAC CAT ATG Acg aca cct ttt atg tcc NdeI 
CBMX40 REV CTC CGA CAT CTC GAG tta aga ctc ctt cgt tac XhoI 
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fructose. Phe 91 and Trp 151 sandwich the fructose and thus make hydrophobic 
contacts with the two faces of the furanose ring, shown in Figure 3.13. The surface 
representation of CBMX40 in Figure 3.12 shows that the O6 of the fructose is buried 
deep into the pocket of CBMX40 and therefore CBMX40 is only capable of binding to 
the non-reducing end of the levan chain, consistent with the ITC-determined 
stoichiometry of binding.  
 
It seems curious that while, in the crystal structure, CBMX40 binds fructose, ITC 
experiments revealed no evidence that the protein binds the monosaccharide.  In 
solution fructose exists in equilibrium between the pyranose and furanose form of the 
sugar. This equilibrium favours the pyranose form but, in the crystal structure, 
fructose binds in the furanose form. To bind the furanose form in solution would be 
energetically unfavourable as there would be a loss of entropy. At the non-reducing 
end of levan polymers fructose is held in the furanose conformation, preventing a 
loss of entropy upon binding CBMX40 resulting in an elevation in affinity, compared 
to the monosaccharide.  
 
CBMX40 makes only one polar interaction with the second fructose of levanbiose 
through His-84, although hydrophobic interactions between Trp-151 and the second 
sugar are evident. Specificity for levan rather than inulin must be conferred by the 
second fructose. The mutagenesis studies show that when His-84 is mutated to 
alanine it has very little effect on binding. If this interaction is not specific for levan 
than it seems puzzling that CBMX40 does not bind inulin. The specificity for levan, 
rather than inulin, may be conferred through hydrophobic interactions between Trp-
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151 and the second fructose, although it is possible that the 2,1-linked furanose 
sugar makes steric clashes with the protein. 
 
Figure 3.12 Structure of CBMX40 in complex with fructose and levanbiose 
Panel A shows the surface representation of CBMX40 in complex with fructose. Panel B shows the surface 
representation of CBMX40 in complex with levanbiose. Created in Pymol.  
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3.13 Interactions to levanbiose in the binding site of CBMX40 
Binding site of CBMX40 showing polar interactions with levanbiose. Asp-33, Asn-79, Asp81 and Lys-88 make 
polar contacts with the fructose in the binding pocket and Phe-90 makes hydrophopic contacts. His-84 makes 
polar contacts with the second fructose protruding out of the binding site. Trp -151 makes hydrophobic contacts 
with the terminal fructose and the adjacent sugar in the oligosaccharide. Created in PyMol. 
The kinetic data presented in this chapter suggests that CBMX40 plays a pivotal role 
in the ability of the catalytic domain to hydrolyse levan, in the context of full length 
SacC. This potentiation is more marked with levan derived from E. herbicola, 
compared to the polysaccharide produced by S. levanicum. The potentiation in 
activity by CBMX40 reported here is considerably larger than other studies, which 
have studied the influence of CBMs on the activity of enzymes acting on insoluble 
substrates (Bolam et al., 1998). It is particularly surprising; therefore, that CBMX40 
has such a dramatic influence of the hydrolysis of a soluble polysaccharide.  The 
reduced potentiation of activity against levan from S. levanicum is also interesting. 
The actual activity of SacCM against levan from S. levanicum and E. herbicola are 
similar. SacCCD, however, is higher against levan from S. levanicum than the 
corresponding E. herbicola polysaccharide. This result suggests that there is a 
difference in the structure of levan from the two microorganisms, with the S. 
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levanicum levan more accessible to enzymatic attack than the E. herbicola polymer. 
In fact the literature suggests that microbial levan is more highly branched than plant 
levan. Indeed, it has been reported that levan from S. levanicum is less branched 
and has a shorter chain length than typical microbial levans (Kojima et al., 1993). In 
contrast, levan from E. herbicola is characterised as having longer chains and 
around 1 in 30 fructose residues is branched through a β-2,1-linkage (Blake et al., 
1982). 
Kinetic studies using levan derived oligosaccharides as substrates show that SacCM 
is more active against the polysaccharide than the oligosaccharides, whereas the 
activity of SacCCD is similar against the two types of substrate. This may indicate that 
CBMX40 enhances affinity of the enzyme for the polysaccharide by binding, in 
harness with the active site of the fructosidase, to the branched regions of the levan.  
In essence the CBM is functioning as a distal sugar subsite, similar to the multiple 
subsites present in the substrate binding cleft of endo-acting glycanases, which 
greatly enhance affinity for the target polysaccharide (Charnock et al., 1998). The 
mature SacC protein displays substrate inhibition kinetics against levan from 
E.herbicola, compared to the typical Mechalias-Menten kinetics displayed with the 
other substrate tested. As levan from E. herbicola is highly branched as the 
concentration increases the aggregation also increases and thus making the 
CBMX40 less effective and the catalytic activity decreases. The in trans experiments 
showing the rescue of SacCCD activity by CBMX40 indicate the CBMX40 may disrupt 
the structure of levan increasing the access of the polysaccharide to enzyme attack, 
rather than just deliver the catalytic domain to the substrate. However, the AUC 
experiments show that, when not covalently linked, SacCCD and CBMX40 are 
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capable of forming a complex, which would support a delivery mechanism rather 
than CBMX40 acting directly on the levan.  
From the data presented in this chapter the following hypothesis has been 
developed. The literature reports that levan is made up of relatively long chains with 
various branch points, which aggregate together to form a spherical bundle 
(Ingelman and Siegbahn, 1944). This aggregation could reduce the access of levan 
to enzyme attack. CBMX40 binds levan at the non-reducing end, bringing the 
catalytic domain into proximity with other chain ends, allowing it to attack the 
polysaccharide. The complex formed between SacCCD/CBMX40, revealed by AUC, 
suggests that there are possible avidity effects driving the observed potentiation of 
enzyme activity. As the chain length of the levan and number of branch points 
increases the polysaccharide aggregates, reducing access to SacCCD and thus the 
activity of the enzyme.   
3.5 Future work 
Bacillus subtilis produces its own levan as part of its bacterial capsule. This levan 
has been characterised and found to be more highly branched and complex than the 
levan from E. herbicola. Utilising levan from B.subtillis as a substrate for SacCM and 
SacCCD may reveal a bigger difference in activity due to the increased complexity of 
the polysaccharide. Also, as SacC is thought to be a capsule processing enzyme, 
such experiments are more likely to reveal the biological role of CBMX40 
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Chapter 4: How Does CBMX40 Effect the Catalytic 
Activity of a Unrelated Exo- Fructosidase  
4.1 Introduction 
CBMX40 is a newly characterised non-catalytic carbohydrate binding domain (CBM) 
that binds the β-2,6 linked fructose polymer, levan. In the glycoside hydrolyse family 
(GH) 32 enzyme, SacC, CBMX40 potentiates the activity of the catalytic domain 120-
fold. SacC is found in the soil bacterium Bacillus subtillis, where it is thought to be 
involved in capsule processing. Although there are a number of GH32 enzymes, the 
vast majority do not appear to have a CBMX40 module, or any other known CBM. 
BT 3082 is a GH32 exo-acting fructosidase, capable of hydrolysing both levan and 
inulin, expressed by the human gut bacterium Bacteroides thetaiotaomicron. BT 
3082 is co-regulated with a polysaccharide utilization locus (PULfru) that targets 
dietary fructose-based polysaccharides. PULfru is controlled by a hybrid two 
component system in which fructose is the only activating ligand (Sonnenburg et al., 
2010). However, the outer membrane endo-acting GH32 enzyme, BT 1760, is only 
active against the β2,6 linked levan with no detectable activity against β 2,1 linked 
inulin. This explains why B. thetaiotaomicron is capable of growing on levan and not 
inulin and, as BT 3082 is localized to the periplasm, the fructosidase will encounter 
levan oligosaccharides, but not reaction products of inulin degradation. 
BT 3082 and SacC are expressed by very different bacteria and encounter fructan 
polysaccharides and/or oligosaccharides in differing biological contexts. While both 
enzymes are capable of hydrolysing levan and inulin polysaccharides, BT 3082 may 
only encounter levan oligosaccharides, and probably not long chain levans. SacC as 
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a capsule processing enzyme would, encounter long chain levan, but not inulin, 
which is generally thought to be a plant storage polymer. CBMX40 has a 
considerable effect on SacC activity; however, it is unclear what effect, if any, the 
CBM would have on BT 3082 an exo-acting fructosidase from a non related 
bacterium, which functions within a different biological context.  
4.2 Objectives 
The objective of this chapter is to explore whether CBMX40 has the capacity to 
potentiate the activity unrelated GH32 enzymes. 
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4.3 Results 
4.3.1 Gene cloning, protein expression and purification 
To explore the ability of CBMX40 to potentiate activity of a non-related GH32 
enzyme, a number of constructs were designed and utilised. Wild type BT 3082 was 
cloned into pET22a by Dr Zheng (Sonnenburg et al., 2010). A fusion protein of 
CBMX40- BT 3082 was also designed.  The primers are shown in Table 4.1. DNA 
encoding BT 3082 and CBMX40 were amplified by Polymerase chain reaction (PCR) 
and ligated into a pET22b variant, pET22jf, that contains a modified multi cloning site 
to give two separate multi cloning sites divided by a sequence encoding a 15 residue 
proline/theronine linker sequence; the map of pET22jf is shown in Figure 4.1. The 
modified vector was made by Dr James Flint. CBMX40 was cloned into the first multi 
cloning site using the KpnI and HindIII restriction sites. BT 3082 was then cloned in 
the second multi cloning site using the EcoRI and XhoI restriction sites. Cartoon 
representations are shown in Figure 4.2.  All enzyme constructs were expressed in 
BL21(DE3) Escherichia coli cells by induction of mid-exponential cultures with 1mM 
IPTG and  incubation at 16 °C overnight. The enzyme constructs contained a C-
terminal His6 Tag, encoded by the vector (thus the stop codon was omitted from the 
reverse primer), and thus Immobilised Metal Affinity Chromatography (IMAC) was 
used to purify the enzymes.  
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Table 4.1 Primers used in the cloning of CBMX40-BT 3082 fusion protein. 
. 
 
Figure 4.1 Modified pET22jf vector map 
Protein fusion vector containing two multi-cloning sites separated by a PT-linker and a C-terminal His tag. 
 
Figure 4.2 Cartoon representation of BT 3082 constructs 
Panel A shows CBMX40-BT 3082 fusion protein. Panel B shows wild type BT 3082. Panel C shows CBMX40 
image created with Prosite MyDomain. 
 
 
 
Primer 
Name Sequence 
Restiction 
site 
Bt3082 Fwd CAA CAC GAA TTC GGA GAA GTA TCT TTT AAA ATA ACC EcoRI 
Bt 3082 Rev CAA CAC CTC GAG CCA AAT GGA TTC TAC GGA AAA GAC Xho I 
LevX40 Fwd CAA CAC GGT ACC ATG ACG ACA CCT TTT ATG TCC AAT ATG kpn I 
LevX40 Rev CAA CAC AAG CTT AGA CTC CTT CGT TAC ATT CTG AAA Hind III 
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4.3.2 Effect of CBMX40 on activity of BT 3082 
To investigate if CBMX40 is capable of potentiating the activity of BT 3082 against 
levan, both the wild type BT 3082 and the CBMX40-Bt3082 fusion protein were 
expressed and purified. Their activity against levan from Erwinia herbicola, and inulin 
from chicory, was measured by monitoring fructose release using a fructose assay 
kit from Megazyme International. All experiments were carried out at 37 °C in sodium 
phosphate buffer pH 7.5.  Non-linear regression plots are shown in Figure 4.3 and 
kinetic data are reported in Table 4.2.  
 
The data showed that CBMX40-BT 3082 was considerably more active against E. 
herbicola levan than wild type BT 3082. Kinetic parameters Km and Kcat were lower 
and higher respectively for CBMX40-BT 3082, compared to wild type BT 3082. The 
Kcat/Km, or catalytic efficiency, of CBMX40-BT 3082 was 52-fold higher than that of 
BT 3082. This potentiation in catalytic efficiency is less than that seen by CBMX40 in 
wild type SacC, but is still significant, showing that CBMX40 is able to potentiate the 
activity of a non-related exo-acting frucotsidase. Once again, as with SacCM, 
CBMX40-BT 3082 displayed substrate inhibition kinetics against E. heribicola levan, 
whereas BT 3082 displayed typical Michaelis-Menten kinetics, suggesting this 
inhibition is due to CBMX40 binding to levan. The activity of BT 3082 and CBMX40-
BT 3082 against inulin showed no significant difference in activity, around 30-fold 
lower than the catalytic efficiency of CBMX40-BT 3082 against levan, consistent with 
the data from the previous chapter. 
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  CBMX40-BT 3082 BT 3082 
  Km µM Kcat s
-1
 Ki Kcat/Km M
-1 
s
-1
 Km µM Kcat s
-1
 Kcat/Km M
-1 
s
-1
 
Substrate               
Levan from Erwinia herbicola 
26.3 
±11.4 
49 ± 
2.9 
490 ± 
266 1.8 x 10
6
 
205 ± 
80.9 7 ± 1.1 3.4 x 10
4
 
Inulin 
360 
±108 
22 
±3.4   6.2 x 104 481 ± 129 26 ± 4 5.4 x 104 
Table 4.2 Kinetic values for CBMX40-BT 3082 and BT 3082 
 
 
Figure 4.3 Example of kinetic analysis of CBMX40-BT 3082 and BT 3082 against levan 
and inulin 
Initial rates derived from fructose assay kit from Megazyme International were plotted in GraphPad Prism using 
Michaelis-Menten or substrate inhibition equation.  
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4.3.3 Catalytic activity of BT 3082 in the presence of CBMX40 
CBMX40 has the ability to enhance the activity of an unrelated exo-fructosidase BT 
3082 when physically attached. The previous chapter showed CBMX40 could rescue 
the activity of SacCCD when not covalently attached to the enzyme. To investigate if 
CBMX40 is able to rescue the activity of BT 3082, both proteins were incubated with 
levan from E. herbicola and Serratia levanicum. The release of fructose was 
measured by HPLC analysis. Control experiments with BT 3082 in the absence of 
CBMX40 was also measured concurrently. The experiments were analysed by 
HPLC as the addition of high concentrations of CBMX40 resulted in a interference 
when measuring absorption at 340 nM using the megazyme fructose assay kit. 
Plotted initial rates are shown in Figure 4.4. 
When BT 3082 was incubated with levan from E.herbicola in the presence of 
CBMX40, at a ratio of 200 nM to 100 μM, respectively, the rate of substrate 
hydrolysis increased compared to BT 3082 in the absence of CBMX40. The 
enhancement was estimated to be 145-fold, although this value must be viewed with 
some caution as the activity of BT 3082 against E.herbicola levan was very low and 
thus difficult to measure accurately. The rate of fructose release by BT 3082 in the 
absence of CBMX40 against levan from S.levanicum was much higher in 
comparison to the rate of release from the levan from E.herbicola. The enhancement 
in rate against levan from S.levanicum  in the presence of CBMX40 was much 
smaller than the enhancement against E.herbicola. The actual enhancement in rate 
measured for BT 3082 in the presence of CBMX40 against levan from S.levanicum 
was only 1.2 fold higher compared with the rate in the absence of CBMX40. 
CBMX40 had little influence in potentiating the activity of BT 3082 against levan from 
S.levanicum as BT 3082 is able to effectively degrade the levan in the absence of 
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CBMX40. The difference in activity of BT 3082 against the two levans is due to the 
differing structures from S.levanicum and E.herbicola. The levan produced by 
S.levanicum has found to be short chained with very few branch points, making it 
highly accessible to the enzyme attack (Kojima et al., 1993). Whereas, the   levan 
produced by E.herbicola  is made up of longer chains that have branch points 
occurring at about 1 in 30 fructose residues (Blake et al., 1982). These results 
suggest as with the results in Chapter 3 that CBMX40 can potentiate the activity of 
enzyme against complex levan but not as effectively against less complex levans.  
 
Figure 4.4 Initial rates for BT 3082 in trans with CBMX40 
Panel A shows initial rates for 500 nM BT 3082 and 200 μM CBMX40 against 715 μM levan from E.herbicola 
Panel B shows initial rates for 500 nM BT 3082 and 200 μM CBMX40 against 715 μM levan from S.levanicum 
 
 
 
A 
B 
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4.3.4 Can BT 3082 form a complex with CBMX40  
CBMX40 potentiates the activity of BT 3082, both when covalently attached, and 
when the proteins are added to the same reaction. To determine if this potentiation is 
a result of BT 3082 and CBMX40 associating into a complex, analytical 
ultracentrifugation was utilised. All AUC experiments were carried out and analysed 
by Dr Alexandra Solovyova as described in Section 2.3.6. Figure 4.5 and Figure 4.6 
shows the results from the AUC experiments. 
BT 3082 and CBMX40 were mixed in a 1:1 ratio and subjected to sedimentation 
velocity AUC. Sedimentation velocity reactions give information on size and shape of 
the proteins. As with AUC experiments in the previous chapter S-values were 
calculated from atomic coordinates and molecular weight of the proteins. In this 
experiment there were only two peaks present, the first at an S-value of 2.009 which 
corresponds to CBMX40. The second peak was found at an experimental S-value of 
6.4 and corresponds to a BT 3082 dimer which has a calculated S-value of 6.68.  
This would  mean that there is no complex formed between BT 3082 and CBMX40, 
suggesting that the potentiation seen when CBMX40 and BT 3082 are not attached 
is not by CBMX40 acting on BT 3082 but by acting on the substrate, levan. 
However, when BT 3082 and CBMX40 are mixed in a 1:1000 ratio and subjected to 
sedimentation velocity AUC three peaks are attained. The first again at an S-value of 
around 2 is identified as CBMX40. The second peak is found at an S-value of 4.25 
and is a monomer (1:1) of BT 3082:CBMX40 in complex. The third peak at an S-
value 6.5 relates to the dimer configuration (2:2) of BT 3082:CBMX40 complex. At a 
high ratio of CBMX40 to BT 3082 a complex is formed between the two proteins. 
Interestingly, when CBMX40 is at a large excess and at lower concentrations of BT 
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3082 not only is a dimer complex formed but a monomer complex also. When BT 
3082 is subjected to AUC in the absence of CBMX40 only one peak is revealed at a 
S-value of 6.65 indicative of a BT 3082 dimer, displayed in Figure 4.6. The 
concentration of BT 3082 subjected to AUC were comparative to those used when in 
large CBMX40 excess. Therefore, the presence of BT 3082:CBMX40 monomer 
complex is due to CBMX40 being in large excess as there is no monomer BT 3082 
peak displayed in the absence of CBMX40.  
In addition to the AUC experiments, isothermal titration caliromety was also utilised 
to determine if there is a measurable interation between BT 3082 and CBMX40. 
CBMX40 was injected into BT 3082 which was present in the cell. Figure 4.7 shows 
the resultant ITC trace from the titration. ITC measures the thermodymanics of 
binding interactions by measuring the increase or decrease in tempreature against a 
reference cell. The absence of any uniform peaks show that there was no 
measurable association between CBMX40 and BT 3082. 
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  Figure 4.5 AUC trace for CBMX40 and BT 3082                
All experiments were centrifuged at 20 °C in 50 mM Na-HEPES, pH 7.5, containing 150 mM NaCl. 
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Figure 4.6 AUC of BT 3082 trace in absence of CBMX40 
All experiments were centrifuged at 20 °C in 50 mM Na-HEPES, pH 7.5, containing 150 mM NaCl. 
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Figure 4.7 ITC trace showing CBMX40 titrated against BT 3082 
77 μM Bt 3082 in cell and 580 μM CBMX40 present in syringe carried out at 25 °C 
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4.4 Discussion 
The previous chapter detailed the binding of levan to CBMX40, and the positive 
effect the protein module had on the catalytic domain of its native enzyme, SacC. 
The data in this chapter show that when BT 3082 and CBMX40 are fused together, 
the CBM once again potentiates the exo-fructosidase activity of the enzyme against 
levan from E.herbicola.  In its native protein, CBMX40 potentiates the activity of the 
catalytic domain against levan 120-fold, while, when fused to BT 3082, it potentiates 
the activity only 52-fold. This likely reflects the fact that BT 3082 is not the parent 
enzyme of CBMX40, and thus the position of the two protein modules is not 
optimized for achieving maximum synergy. Indeed in the artificial constructs 
CBMX40 and Bt3082 are separated by a flexible 15 residue linker, while in SacC 
there is no obvious linker suggesting that the 3D structure of the enzyme ensures 
that the position of the enzyme and CBM are optimized to achieve maximum 
synergy.  Not only does CBMX40 enhance the activity of BT 3082 against levan but, 
by doing so, BT 3082 now has a preference for the β 2,6 linked polysaccharide, 
levan, rather than the inulin, a  β 2,1 linked fructan. This conclusion is drawn from the 
kinetic data, which reveals very little difference in the kinetic parameters of wild type 
BT 3082 against levan and inulin. Whereas, the kinetic values for CBMX40-BT 3082 
differ greatly between levan and inulin the Kcat/Km or catalytic efficiency of 
CBMX40-Bt 3082 for levan is 29 times that of CBMX40-BT 3082 against inulin.  
Once again the In trans experiments show that CBMX40 can rescue the activity of 
BT 3082 against levan from E. herbicola when the two proteins are not physically 
attached. The enhancement in rate is 145 fold compared to BT 3082 in the absence 
of CBMX40. It should be noted that BT 3082 it less active against complex long 
chain, branched levans such as E. herbicola, compared to less highly branched 
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forms of the polysaccharide produced by S. levanicum. This is illustrated by the 
increased activity against the shorter chained, less branched levan from 
S.levanicum. Therefore the enhancement in rate is less notable when BT 3082 is 
incubated with this levan in the presence of CBMX40.  
The previous chapter showed that the rate enhancement of SacCCD in the presence 
of CBMX40 was as a result of a complex formed as detailed by analytical 
ultracentrifugation, results are summarised in Table 4.3. When CBMX40 and BT 
3082 were subjected to analytical ultracentrifugation at a 1:1 ratio, no complex was 
exhibited between the two proteins. However at a 1:1000 ratio of BT 3082 to 
CBMX40 both a monomer and a dimer complex are exhibited. In the absence of 
CBMX40, BT 3082 is present only as a dimer. This would suggest that the BT 3082 
monomer is observed due to the interaction of CBMX40 with BT 3082. The 
SacCCD:CBMX40 complex reported in the previous chapter was also a monomer 
complex and SacCCD appeared to only be present in solution as a monomer and not 
a dimer. This is significant as SacCCD displays a higher enzyme activity than BT 
3082 against levan from E.herbicola this could be attributed to BT 3082 being a  
dimer in solution while SacCCD is a monomer.  ITC experiments could not find any 
measurable interaction between BT 3082 and CBMX40 this suggests that any 
interaction formed is very weak as it must be out of the limits of the ITC experiment.   
The data presented in this chapter provides information on possible mechanisms for 
potentiation of catalytic activity by CBMX40. Levan is a complex polysaccharide 
which forms long chains with various branch points. These chains aggregate to form 
spherical bundles that make them inaccessible to enzyme attack (Ingelman and 
Siegbahn, 1944). However, it is possible that, within this structure an equilibrium 
between a closed state, where there are very few chain ends available for attack, 
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and the polysaccharide chains are tightly bound, and a slightly more open structure 
where the chain ends are more accessible to enzyme attack. CBMX40 can bind the 
non reducing chain ends of the levan chain when in the open state, forcing the 
equilibrium in favour of the open state, allowing BT 3082 to access the chain ends 
for productive hydrolysis.  In the absence of CBMX40, levan is less accessible to BT 
3082 attack and therefore the rate of hydrolysis is slower. However as CBMX40 is 
capable of interacting with BT 3082 to form a complex it seems unlikely that 
CBMX40 would act directly on the levan polysaccharide. It seems more feasible that 
the complex formed delivers BT 3082 to the chain ends of the levan polysaccharide 
through CBMX40 binding to the non-reducing end of another levan chain.  In the 
highly branched levan from E. herbicola the ability of CBMX40 to increase BT 3082 
activity is increased due to the effects of the chain ends being in close proximity due 
to the amount of branches and chain ends. It still may be possible that while 
CBMX40 does not act directly on the levan polysaccharide it may increase BT 
3082’s access to the polysaccharide through decreased aggregation of the 
polysaccharide chains.  
As with full length SacC, CBMX40-BT 3082 also displays substrate inhibition kinetics 
when incubated with levan from E. herbicola. This is because the levan is highly 
branched and so is highly aggregated. As the concentration of substrate increases 
the aggregation also increases and so is less accessible to attack. Despite the 
aggregation of the substrate there are still sufficient available ends for BT 3082 to 
hydrolyse as the catalytic activity of BT 3082 is so low. Therefore,  BT 3082 does not 
display such inhibition.   
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Table 4.3 Summary of the enhancement of rate by CBMX40 on SacCCD and BT 3082 and the ratios of 
enzyme to CBMX40 in experiments 
Shows the enhancement in rate for each construct against E. herbicola levan. *compared to rate of SacCCD. 
**compared to rate of BT 3082. ≠ rate is exgerated as BT 3082 activity is very low. The ratio of 
enzyme:CBMX40 is shown for both the intrans assays and AUC experiments  
 
4.5 Future Work 
This chapter detailed the effect of CBMX40 on a non related GH32 exo-acting 
fructosidase. However, what effect would CBMX40 have on a GH32 endo acting 
levanase? By fusing the CBMX40 to, for example, BT 1760, the outer membrane 
endolevanase encoded by PULfru, would it have a positive or negative effect on the 
activity of the enzyme. Also, testing BT 1760 in trans in the presence of CBMX40 
would provide insight into weather the proposed substrate disruptive action of 
CBMX40 can affect the endo-activity of BT 1760.Therefore exploring further the 
mechanism of action of CBMX40. 
  
 
 
Enhancement in rate 
against E. herbicola 
levan 
Ratio of enzyme:CBMX40 
intrans experiment 
Ratio of 
enzyme:CBMX40 
in AUC experiment 
SacCCD 0 
  SacCM 120 fold* 
  Intrans 
SacCCD:CBMX40 25 fold* 1:2000 1:1 
BT 3082 0 
  CBMX40-BT 3082 52 fold** 
  Intrans BT 3082 
:CBMX40 145 fold**
 ≠
 1:500 1:1000 
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Chapter 5: Yeast Mannan Utilisation by Bacteroides 
thetaiotaomicron  
5.1 Introduction  
Bacteroides thetaiotaomicron is a beneficial bacterium found within the microbiota of 
the human gut. The bacterium forages on dietary and host polysaccharides found 
within the environment of the gut. B. thetaiotaomicron produces numerous 
glycanases that deconstruct polysaccharides, which are not attacked by enzymes 
produced by the human host. The genes encoding these B. thetaiotaomicron 
enzymes are organised into clusters termed Polysaccharide Utilization Loci (PULs). 
PULs contain all the machinery required for sensing, transport and deconstruction of 
specific polysaccharides encountered within the environment of the human gut 
(Bjursell et al., 2006). The genome of B. thetaiotaomicron genome encodes 10 
glycoside hydrolase family (GH) 76 enzymes and 24 GH92 enzymes, annotated on 
the CAZy database, described in Section 1.2. The B.thetaiotaomicron GH92 
enzymes have recently been extensively characterised as α-mannosidases able to 
hydrolyse a number of α-mannosidic linkages present in various glycans (Zhu et al., 
2010) . GH76 enzymes have not been extensively characterised; only a single GH76 
member, from Bacillus circulans, has been investigated, which was shown to by an 
endo-α1,6-mannosidase (Nakajima et al., 1976). The genes encoding these 
enzymes in B. thetaiotaomicron are located in PULs, and transcriptomic data 
suggest that some of these PULs are upregulated by α-mannans and host glycans 
(Martens et al., 2008, Bjursell et al., 2006). In this study there are two GH76-
containing PULs of particular interest PUL 36 (BT 2615-BT 2623) and PUL 68 (BT 
3773-BT 3792) Figure5.2. Both of these PULs are regulated by a hybrid two 
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component system and both contain SusC and SusD homologs. SusC and SusD 
were first characterised in the Starch utilisation locus. SusD is annotated as a outer 
membrane starch binding protein and SusC a TonB-dependent transporter which 
transports starch oligosaccharides into the periplasm (Koropatkin et al., 2008, 
Reeves et al., 1996, Reeves et al., 1997, Shipman et al., 2000). The HTCS is 
located across the inner membrane between the periplasm and cytoplasm and acts 
as a sensor regulator. In essence both PULs contain all the required elements to 
sense, acquire and utilize yeast mannan. Both of these PULs are largely un-
characterised; although the GH92 enzymes have been investigated (Zhu et al., 
2010), their activities against yeast mannan degradation have not been extensively 
analysed. The GH76 enzymes are yet to be characterised but could provide useful 
insight into yeast metabolism by B.thetaiotaomicron.  
Yeast mannan is a complex polysaccharide produced by Saccharomyces cerevisiae. 
It is an α mannan that comprises an α1,6 mannose linked backbone with α1,2 
mannose side chains that are capped with an α1,3 linked mannose residues. It can 
also have a varying degree of phosphorylation. S. cerevisiae employs a myriad of 
enzymes to construct the mannan polysaccharide. For this reason mutant S. 
cerevisiae strains lacking vital enzymes that catalyse the synthesis of the 
polysaccharide produce various different mannan structures. The wild type and the 
mutant mannan structures are shown in Figure 5.1 
5.2 Objectives  
The objective of this chapter is to investigate the enzyme activities against yeast 
mannan found within the two -mannan activated B. thetaiotaomicron loci, PUL 36 
and 68.  
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Figure 5.1 Yeast Mannan structure  
Blue lines are an indication of the changes by mnn mutat ions which are labelled in red.
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B 
 
Figure 5.2 Yeast mannan degrading Polysaccharide Utilisation Loci (PUL) 
A- PUL 36 map  B- PUL 68 map. Grey boxes are opening reading frames. Blue boxes are CAZy 
enzymes. Pink boxes are HTCS. Purple boxes are SusC like proteins and orange boxes are SusD like 
proteins. 
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5.3 Results 
5.3.1 Gene Cloning, Protein Expression and Purification  
Of the 10 genes encoding the B.thetaiotaomicron GH76 enzymes 8 were amplified 
by PCR using the bacterium’s genomic DNA as template, and cloned successfully 
into either of the E. coli expression vectors pET28a (N-terminal His6 tag)  or pET32b 
(N-terminal Trx Tag and His6 Tag). An example of an agarose gel of PCR fragments 
is shown in Figure 5.2. Primers, which were designed to the 3` and 5` regions of the 
gene, are shown in Table 5.1. PCR fragments were digested with the appropriate 
restriction enzymes and ligated into the chosen vector. Plasmids from transformants 
were tested for the presence of B.thetaiotaomicron inserts by digestion with 
appropriate restriction enzymes and visualised by agarose gel electrophoreses. The 
expression of the proteins encoded by the recombinant plasmids in Escherichia coli 
BL21 cells were induced by the addition 1 mM IPTG at 16 °C to mid-exponential 
phase cultures, and incubation overnight with aeration. Proteins were purified from 
cells by immobilised metal ion affinity chromatography (IMAC) and purification was 
visualised by SDS PAGE gels. An example of an SDS PAGE showing expression 
and purification is shown in Figure 5.3 
Other proteins utilised in this chapter were cloned into appropriate E. coli expression 
vectors by various different people.  BT 2631 was cloned by Dr Joanna Norman. Dr 
Yanping Zhu cloned all of the GH92 enzymes used. BT 3783 was cloned by Carl 
Moreland. All of the above proteins were expressed and purified as described above 
for the GH76 enzymes. 
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Figure 5.3 Agarose gel of GH76 PCR fragments  
L- ladder, 1- BT 1883. 2-BT 3521, 3- BT 3782, 4- BT 3301, 5- BT 2623, 6- BT 3524, 7- BT 2949, 8- BT 3792 
 
Figure 5.4 Example SDS PAGE of BT 3792 expression and purification 
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IMAC purification of BT 3792, purified in E1 ,E2, E3 and E4 fractions. L= Ladder CFE= cell free extract, I= 
Insoluble fraction, FT= Flow through from column, W= buffer wash, E1, E2 = 10mM imadizole elution, E3 and 
E4= 100mM imadizole elution.
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Table 5.1 Primers for GH76 cloning 
Restriction sites are shown in bold 
Primer Name Sequence Restriction site Vector 
BT2949FWD CAA CAC GCT AGC GGC TGT GAT GCC ACT GTA CAG GAT ATC NheI pET 28a 
BT2949REV CAA CAC CTC GAG TTA ATC GTT GAG TAT TCT TTT GTA ATT XhoI pET 28a 
BT2623FWD CAA CGC GCT AGC GAT GAA AAG TAT GAT ATA TTA GAA AGA TAC BamHI pEt 32b 
BT2623REV CAA CAC CTC GAG CTA CTC CTG AAA ACA TCC AAG TTG TTC CAA XhoI pET 32b 
BT3301FWD CAA CAC GCT AGC TCA  ACA  AAG CAG GCA GAC TCA GAT TCA BamHI pET 32b 
BT3301REV CAA CAC CTC GAG TTA TTG TAT AGT TGC TAG TCG GCT ATA XhoI pET 32b 
BT3501 FWD CAA CAC GCT AGC TGC GGA GAA GGA GGA AAC GAT AAT TAC NheI pET 28a 
BT 3501 REV CAA CAC AAG CTT TTA TTC TAA CCT AGC TAT CCC CTC CAT Hind III pET 28a 
BT3521FWD CAA CAC GCT AGC GAT GAT AAA GAA GCT AGA CCT TAT NheI pET 28a 
BT3521REV CAA CAC CTC GAG TTA TTT ATC GGT TGG AAA CAA TAA XhoI pET 28a 
BT3524FWD CAA CAC GCT AGC GCT GAT AGC TCA GAA AAA ACG AAC BamHI pET 32b 
BT3524REV CAA CAC CTC GAG TTA TTT TTC TGC CGG AAA CAG AAG XhoI pEt 32b 
BT3782 FWD CAA CAC GCT AGC AAA ATC ACT TAT CTG GCA GGC GGA Nhe I pET 28a 
BT3782REV CAA CAC CTC GAG TTA TTT CTC GAT TTC AGC GAA CAG XhoI pET 28a 
BT3792 FWD CAA CAC GCT AGC GCT ATC AGC AAA GCC GGC AAG NheI pET 28a 
BT3792REV CAA CAC CTC GAG CTA TCG GTT TTC ACG TTC CAA TAC XhoI pET 28a 
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5.3.2 Characterisation of Glycoside hyrdrolase 76 enzymes 
Of the eight soluble GH76 enzymes produced, only four were shown to be 
catalytically active. While the enzymes were not active on mannan produced from 
wild type S. cerevisiae four were active on mannan produced from the mnn2 
S.cerevisiae mutant. This mutant lacks the α 1,3 and α 1,2 branches in the outer 
chain of the polysaccharide leaving only the α1,6 linked  mannose backbone, as 
shown in Figure 5.1. Thin layer Chromatography (TLC) shows that BT 2623, BT 
2631, BT 3782 and BT 3792 produce a range of oligosaccharide products when 
incubated with the mnn2 mutant mannan, Figure 5.4. This is indicative of an endo 
acting mode of action, in which the enzyme cleaves the polysaccharide within the 
chain rather from the end of the chain, thus producing a number of different sized 
products. Inspection of the reaction by TLC over a 24 h reaction shows that while all 
of the enzymes are active on the mnn2 mutant mannan, BT 2631 and BT 3782 have 
a similar mode of action in which they produce smaller oligosaccharides. BT 2631 
produces mainly di- and tri-saccharide sugars with a small amount of mannose and 
larger oligosaccharides. The reaction appears to be over after 60 min. While BT 
3782 also generates mainly small oligosaccharides from the mnn2 mutant yeast 
mannan, the reaction product profile shows subtle differences to BT 2631. BT 3782 
generates more of the monosaccharide unit along with the di- and tri-saccharide 
units, and the reaction is over after 30 min. However, BT 2623 and BT 3792 are also 
similar producing larger oligosaccharides. BT 2623 generates mostly tri-sacharides 
and bigger oligosaccharides  which are not very well defined. The reaction seems to 
be over after about 2 h, suggesting the enzyme is slow acting. BT 3792 generates 
more defined oligosaccharides with a small quantity of di-sacchrairde product but the 
tri-, tetra- and pentose-oligosaccharide are the major products generated. The 
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reaction is finished after 1 h, at which point well defined oligosaccharide products 
were evident.   
Kinetic data for each enzyme were determined by incubating the enzymes with the 
Mnn2 mutant mannan at 37 °C in 50 mM MOPS buffer pH 7.5. The rate of reducing 
sugar released was determined using the 3, 5-dinitrosalicyclic acid assay. In the 
assay the number of free reducing ends is proportional to absorbance at 575 nm due 
to the reduction of 3,5- dinitrosalicyclic acid to 3-amino,5-nitrosalicylic acid by the 
free reducing ends of the oligosaccharides created by hydrolysis of the 
polysaccharide. The assay is explained in more detail in Section 2.3.1.3. Initial rates 
were plotted in GraphPad Prism 5.0 and kinetic parameters calculated by non-linear 
regression. Data are shown in  Figure 5.5 and Table 5.2. 
The Km and kcat for BT 2631 against the mnn2 mannan could not be calculated as 
the Km was beyond the limits of this assay. For this reason the Kcat/Km of BT 2631 
against the Mnn2 mannan was calculated. This was achieved by measuring the 
initial rate of the reaction against various substrate concentrations, the initial rates 
were plotted and kcat/Km calculated by linear regression. The Kcat/km for BT 2631 is 
relatively large against Mnn2 mannan compared to the other GH76 enzymes. This 
indicates that BT 2631 is efficient at degrading Mnn2 mannan.  BT 3782 has a 
similar mode of action to BT 2631, however the Km and kcat were able to be 
calculated . BT 3782 displays a high affinity for the Mnn2 mannan substrate as 
indicated by the low Km measured. The high kcat indicates a good turnover of 
substrate by BT 3782. Thus, the ability of BT 3782 to degrade Mnn2 mannan is 
reflected in the high kcat/Km . The kcat/Km for these enzymes indicates that BT 3782 is 
more effective at deconstructing Mnn2 mutant yeast mannan than BT 2631.  BT 
2631 has an immeasurably high Km’s this may be attributed to the aggregation of 
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mnn2 mutant yeast mannan in solution causing accessibility problems for the 
enzyme. In addition BT 2631 and BT 3782 both generate small reaction products 
from the polysaccharide, and are predicted to be periplasmic, Mnn2 mutant yeast 
mannan may not be the preferred substrate for the two enzymes. 
BT 2623 and BT 3792 hydrolyse the Mnn2 mutant yeast mannan generating long 
chain oligosaccharides. The data for BT 2623 show that the enzyme is fairly good at 
hydrolysing Mnn2 mutant yeast mannan. The low Km of the enzyme is indicative of a 
high affinity for the substrate. The turnover number of the enzyme, however, is quite 
low, which has a negative impact on the catalytic efficiency of the enzyme. BT 3792 
also displays a low Km suggesting a high affinity for the Mnn2 mutant yeast mannan. 
However, the Kcat for BT 3792 is relatively high signifying a faster rate of hydrolysis. 
Thus, the catalytic efficiency of BT 3792 against Mnn2 mutant yeast mannan is far 
superior to that of BT 2623.  
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Figure 5.5 TLC of GH76 enzymes against Mnn2 18hr timeline 
Each enzyme (1 μM) was incubated with Mnn2 mannan (1 mM) at 37 °C in 50 mM MOPS pH 7.5. Aliquots were 
taken at timed intervals and the reaction stopped by heat inactivation and subjected to TLC analysis. 
Note that the activity seen in the 0 min time point for BT 3782 is due to an experimental error and the enzyme 
not being fully inactivated immediately. M= Mannose
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Figure 5.6 Example of kinetic analysis of GH76 enzymes against Mnn2 mutant yeast 
mannan 
Initial rates derived from DNSA were plotted in GraphPad Prism 5.0 using Michaelis Menten equation or linear 
regression. 
 
 
 
 
 Table 5.2 Kinetic values for GH76 enzymes against Mnn2 mutant yeast mannan  
nd= Not determined. 
 
Protein Name  Km  mg ml
-1
 kcat  s
-1
 kcat/Km  s
-1
 mg
-1 
ml 
BT 2623  1.892 ± 0.399 297 ± 19.07 157 
BT 2631 nd nd 743 ± 8.048 
BT 3782 0.4315 ± 0.333 705± 219 1633 
BT 3792  2.425 ± 1.136 1263 ± 262 521 
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5.3.3 Characterisation of GH76 containing PULs 
The characterised GH76 enzymes BT 2623, BT 2631 and BT 3782, BT 3792 are 
expressed as components of PULs regulated by α-mannan. This section describes 
the characterisation of other proteins found within PUL 36 (BT 2615-BT 2633) and 
PUL 68 (BT 3773-BT 3792). 
5.3.3.1 PUL 36 (BT 2615 - BT 2633) 
PUL 36 gene expression is regulated by a HTCS in response to α-mannan. Table 
5.3 shows the proteins encoded by PUL36; it details their predicted and 
characterised functions (if characterised) and their predicted cellular localizations. 
PUL 36 contains five enzymes that are annotated as glycoside hydrolases, with two 
of them in GH76 BT 2623 and BT 2631. BT 2620 is annotated as a GH97 member, a 
family that contains α-glucosidases and α-galactosidases  (www.cazy.org ), BT 2622 
is located in GH67, a family that contains α-glucoronidases and xylan α1,2-
glucoronidases (www.cazy.org ). Neither of these predicted enzymes have not 
currently been characterised as either part of this study or any earlier study.  
BT 2629 is annotated as a GH92 enzyme, it was characterised previously as part of 
a wider study on the extensive B. thetaiotaomicron family of GH92 proteins, however 
a specific activity for BT 2629 could not be identified. The enzyme appeared not to 
be active against any disaccharide substrates or N-glycans, although it was 
apparently active against wild type yeast mannan (Zhu et al., 2010). To further 
investigate the role of BT 2629, the enzyme was incubated at 37 °C with all the 
mutant mannans available for 16 h and the reaction visualised by TLC. Figure 5.6 
shows the results of the TLC analysis. BT 2629 was capable of releasing mannose 
from wild type yeast mannan, Mnn1, Mnn4, Mnn5 and Mnn6 mutant yeast mannans. 
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The Mnn1 mutation results in a yeast mannan produced that lacks the terminal α1,3 
linked mannose, whereas the Mnn5 mutant produces yeast mannan that lacks the 
second row of the α1,2 linked mannose branches of the outer chain (Lewis and 
Ballou, 1991). Mnn4 and Mnn6 regulate the expression of the phosphorylated 
mannotriose of the outer chain and so this decoration is absent in both of these 
mutant yeast mannans (Hernandez et al., 1989a). These results suggest that 
BT2629 is possibly a non specific α1,2 and α1,3 mannosidase that removes the 
branches of the outer chain of yeast mannan. However it could also be possible that 
BT2629 hydrolyses a specific α1,2 mannose-α1,6 mannose structure. The enzyme is 
predicated to be found within the periplasm of the cell suggesting it has a processing 
role in the deconstruction of yeast mannan polysaccharide. As it is found in the 
periplasm of the cell, BT2629 is most likely to encounter mannan oligosaccharides 
making specificity for a α1,2 man-α1,6man oligosaccharide plausible.  
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Table 5.3 Properties of proteins found in PUL 36 
 
Cellular locations predicted using SignalP and LipoP based on amino acid analysis
Protein name Characterised  Predicted function Characterised function  Predicited cellular localization  
BT 2618 NO two component system response regulator   Cytoplasm 
BT 2619 NO two component system  sensor histidine Kinase    Trans membrane  
BT 2620 NO GH97-α glucosidase and α galctosidase   Periplasm 
BT 2621 NO Hypothetical protein    Cytoplasm 
BT 2622 NO GH67- α glucoronidase and xylan α1,2 glucoronidase   Cytoplasm 
BT 2623 YES GH76- α 1, 6 mannanase  α 1, 6 mannanase  Outer membrane 
BT 2624 NO Hypothetical protein    Outer membrane 
BT 2625 NO SusD-like   Outer membrane 
BT 2626 NO SusC-like   Periplasm 
BT 2627 NO Cell surface protein    Outer membrane 
BT 2628 NO HTCS sensor/regulator (TM)   Trans membrane  
BT 2629 YES GH92 - α mannosidase  α 1,2 and α1,3 mannosidase Periplasm 
BT 2630 NO Hypothetical protein    Outer membrane 
BT 2631 YES GH76- α 1, 6 mannanase  α 1, 6 mannanase  Periplasm 
BT 2632 NO GH125- exo α 1,6 mannosidase   Periplasm 
BT 2633 NO Hypothetical protein    Cytoplasm 
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Figure 5.7 TLC analysis of BT 2629 (1 μM) vs mutant mannans (1 mM) 
 M = Mannose , 1= No Enzyme vs Wt mannan ,2= BT 2629 vs Wt mannan, 3= No Enzyme vs  Mnn1 mannan, 
4= BT 2629 vs Mnn1 mannan , 5=  No Enzyme vs Mnn2 mannan , 6= BT 2629 vs Mnn2 mannan , 7=  No 
Enzyme vs Mnn4 mannan, 8= BT 2629 vs Mnn4 mannan, 9= No Enzyme vs  Mnn5 mannan, 10= BT 2629 vs 
Mnn5 mannan, 11= No Enzyme vs Mnn6 mannan ,12= BT 2629 vs Mnn6 mannan. All experiments were 
incubated at 37 °C for 16 h.
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5.3.3.2 PUL 68 ( BT 3773- BT 3792) 
PUL 68 is the second of the GH76 containing PULs that is regulated by a HTCS that 
is activated by α-mannan. Table 5.4 shows the proteins encoded by PUL 68 and 
their predicted function and cellular localization. 
PUL 68 encodes five enzymes, which are annotated as glycoside hydrolases. There 
are two GH76 enzymes (BT 3782 and BT 3792), two GH92 (BT 3773 and BT 3784) 
and one GH38/CBM32 (BT 3774).  
BT 3774 was not characterised as part of this study but has been annotated as a 
GH38 enzyme containing a CBM32. Known activities for GH38 enzymes include 
mannosyl-oligosaccharide α1,3 α1,6 mannosidases and mannosyl- oligosaccharides 
α1,3 mannosidases (www.cazy.org ). BT 3774 is predicted to be present within the 
periplasm of the cell, indicating that it probably plays a role in deconstruction of 
oligosaccharides ready for import into the cytoplasm.   
PUL 68, unlike PUL 36, encodes two GH92 enzymes, which were both characterised 
in a previous study by Yanping Zhu (Zhu et al., 2010). The first GH92 BT 3773 was 
characterised as an α1,3 mannosidase  active both on the disaccharide and the 
polysaccharide yeast mannan. However, when tested against mannan produced 
from S. cerevisiae there appeared to be no mannose released from the wild type or 
mutant forms of the polysaccharide, Figure 5.7. The second GH92 BT 3784 was 
previously characterised as an α1,2 mannosidase which is active on the 
disaccharide and the mannan polysaccharide. TLC analyses of reactions against the 
mutant mannans reveal it is capable of releasing mannose from all of the mutant 
mannans, Figure 5.8. This may seem a little strange as it has previously been 
characterised as an α1,2-mannosidase,  however BT 3784 does retain some activity 
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against other linkages. The observation that BT 3784 appears to be highly active on 
both wild type yeast mannan and the mnn1 mutant mannan suggests that the 
enzyme’s α-1,3 mannosidase activity strips the mannose side chain exposing the 
α1,2 linked mannose units, which BT 3784 can remove more readily. The Mnn1 
mutant mannan lacks the terminal α1, 3 linked mannose therefore BT 3784 can 
readily degrade the remaining α1,2-linked mannose side chains. Both GH92 
enzymes are found within the periplasm and so have a processing role removing 
side chains prior to transport into the cytoplasm.  
BT 3783 is annotated as a hypothetical protein, when the protein sequence is 
entered in BLAST search it shows a high homology to phosphatase enzymes. To 
test if BT 3783 displayed phosphatase activity it was incubated with mannose-6-
phosphate, glucose-6-phosphate, fructose-6-phosphate and mannose-1-phosphate. 
Released monosaccharide was displayed by TLC analysis as the monosaccharide 
migrates further up the silica plate than the phosphorylated monosaccharide. Figure 
5.9  shows a time course of BT 3783 against the three sugar phosphates. As 
expected BT 3783 appears to be most active on mannose-6-phosphate, but is also 
highly active against glucose-6-phosphate. BT 3783 does not show significant 
activity against fructose-6-phosphate or mannose-1-phosphate. These data show 
that the enzyme is specific for pyranose sugars phosphorylated at O6.   
To determine the kinetic parameters of BT 3783 against both mannose-6-phosphate 
and glucose-6-phosphate, BT 3783 was incubated with various concentrations of 
each substrate and aliquots taken over a fixed time period. The aliquots were treated 
with dowex resin to remove any remaining substrate and then analysed by high 
pressure anion exchange chromatography (HPAEC). Experiments were carried out 
in 50 mM HEPES at pH 7.0 at 37 °C. Monosaccharide release was plotted in 
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Graphpad prism and initial rates were analysed by non-linear regression to calculate 
kinetic parameters. Example HPAEC traces and initial rates are shown in Figure 
5.10. Figure 5.11 shows non-linear regression plots and Table 5.5 reports the kinetic 
values for BT 3783 against mannose-6-phosphate and glucose -6-phosphate. 
The Km of BT 3783 against mannose-6-phosphate is higher than against glucose-6-
phosphate suggesting tighter binding to the glucose configured substrate. In contrast 
the turnover rate (kcat) was considerable higher for phosphorylated mannose 
compared to glucose-6-phosphate. The kcat/Km shows that the catalytic efficiency of 
the enzyme for mannose-6-phosphate is considerably higher than against glucose-6-
phosphate, although the optimum substrate may be a phosphorylated 
mannooligosaccharide. The higher activity against phosphorylated mannose was 
also apparent in the TLC time course as the disappearance of glucose-6-phosphate 
is slower than mannose-6-phosphate. Mannose-6-phosphate was fully hydrolysed 
after 10 min whereas small amounts of glucose-6-phosphate were evident after 60 
min.  
BT 3786 was predicted to be the HCTS sensor/ regulator of PUL 68, the periplasmic 
domain was cloned, expressed and purified by Carl Morland and binding studies 
carried out. Isothermal titration calriometry (ITC) was utilised to assess the ability of 
BT 3786 sensor domain to bind sugars. BT 3786 was titrated with both Mnn2 
mannan polysaccharide and a oligosaccharide assortment derived from Mnn2 
mannan.  Mnn2 oligosaccharides were generated by incubation of Mnn2 mannan 
polysaccharide with the GH76 enzyme BT 3792 at 37 °C for 1hr.  Preliminary ITC 
revealed that BT3786 was not capable of binding mnn2 mannan but was capable of 
binding oligosaccharides derived from mnn2 mannan.  BT 3786 displayed binding to 
a crude mixture of mnn2 oligosaccharides but it is not possible to calculate the 
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thermodynamics of binding as the exact concentration of sugars and the precise 
oligosaccharide BT 3786 binds to are unknown.  The ITC trace in Figure 5.12 shows 
that the titration does not go to saturation and as the heat peaks, in the upper panel, 
are very small the binding appears to be fairly weak. This may be due to a low 
concentration of ligand present within the oligosaccharide mixture.   
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Protein name  Characterised  Predicted function Characterised function  Predicted cellular localization  
BT 3773 YES GH92 - α mannosidase  α1,3 mannosidase Periplasm  
BT 3774 NO GH38 - mannosyl-oligosaccharide α-1,3-1,6-mannosidase    Periplasm 
BT 3775 NO GT32- mannosyltranferase    Cytoplasm  
BT 3776 NO GT32- mannosyltranferase    Cytoplasm  
BT 3777 NO  Hypothetical protein    Periplasm  
BT 3778 NO  Hypothetical protein    Cytoplasm  
BT 3779 NO Hypothetical protein    Cytoplasm  
BT 3780 NO Hypothetical protein    Outer membrane  
BT 3781 NO GH125 – exo α1,6 mannosidase    Periplasm  
BT 3782 YES GH76 - endo-α 1,6-mannanase  Endo-α1,6-mannanase Periplasm  
BT 3783 YES Phosphatase  mannosyl-, glucosyl phosphatase  Outer membrane  
BT 3784 YES GH92 - α mannosidase  α1,2 mannosidase  Periplasm  
BT 3785 NO Hypothetical protein    Cytoplasm  
BT 3786 NO HTCS sensor/regulator (TM)   Periplasm  
BT 3787 NO Hypothetical protein    Outer membrane  
BT 3788 NO SusC-like    Cytoplasm  
BT 3789 NO  SusD-like    Outer membrane  
BT 3790 NO Hypothetical protein    Outer membrane  
BT 3791 NO Hypothetical protein    Outer membrane  
BT 3792 YES  GH76- α 1,6 mannanase  Endo-α1,6-mannanase Outer membrane  
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Table 5.4 Properties of Proteins found in PUL 68 
Cellular locations predicted using SignalP and LipoP based on amino acid analysis.
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Figure  5.8  TLC analysis of BT 3773 vs mutant mannans 
M = Mannose , 1= No Enzyme vs Wt mannan ,2= BT 3773 vs Wt mannan, 3= No Enzyme vs  Mnn1 mannan, 
4= BT 3773 vs Mnn1 mannan , 5=  No Enzyme vs Mnn2 mannan , 6= BT 3773 vs Mnn2 mannan , 7=  No 
Enzyme vs Mnn4 mannan, 8= BT 3773 vs Mnn4 mannan, 9= No Enzyme vs  Mnn5 mannan, 10= BT 3773 vs 
Mnn5 mannan, 11= No Enzyme vs Mnn6 mannan ,12= BT 3773 vs Mnn6 mannan, 13= No Enzyme vs Mnn9 
mannan, 14= BT 3773 vs Mnn9 mannan. Enzyme concentration 1 μM and substrate concentration 1mM 
incubated for 16 hrs at 37 °C 
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Figure 5.9  TLC analysis of BT 3784 vs mutant mannans 
M = Mannose , 1= No Enzyme vs Wt mannan ,2= BT 3784 vs Wt mannan, 3= No Enzyme vs  Mnn1 mannan, 
4= BT 3784 vs Mnn1 mannan , 5=  No Enzyme vs Mnn2 mannan , 6= BT 3784 vs Mnn2 mannan , 7=  No 
Enzyme vs Mnn4 mannan, 8= BT 3784 vs Mnn4 mannan, 9= No Enzyme vs  Mnn5 mannan, 10= BT 3784 vs 
Mnn5 mannan, 11= No Enzyme vs Mnn6 mannan ,12= BT 3784 vs Mnn6 mannan Enzyme concentration 1 μM 
and substrarte concentration 1mM incubated for 16 hrs at 37 °C 
Figure 5.10 TLC analysis of BT 3783 activity over 60mins 
BT 3783 (1 μM) incubated with substrates (1 mM) as labelled in  50 mM HEPES pH 7.5 at 37 °C Aliquots taken 
at 0, 10, 30, 60 min. The 0 min time point shows the starting monosaccharide-6-phosphate.  
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Figure 5.11 Example HPLC traces and initial rate graphs for 1 μM BT 3783 vs mannose-6-phosphate  
HPLC traces plotted in Graphpad prism. Each graph shows the HPLC trace for each time point for the relevant substrate concentration. Peak 1 shows the fucose internal 
standard, Peak 2 shows the mannose released. Initial rate graphs show the mannose released in µM as a function of time. 
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Figure 5.12 Example Non-linear regression curves for BT 3783 
Initial rates were plotted in GraphPad prism using the Mechaelis-Menten equation. 
 
 
 
Table 5.5 Kinetic values for BT 3783 against mannose-6-phosphate (Man6-P) and glucose-6-phosphate 
 
 
Substrate  Km mM Kcat  s
-1
 Kcat /Km M
-1 
s
-1
 
Man-6-P 48.4 ± 25.1 351 ± 119 7252 
Glu-6-P 16.68 ± 2.412 26.68 ± 1.3 1575 
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Figure 5.13  ITC trace of BT 3786 
Panel A shows 50 μM BT 3786 vs 1 mg/ml Mnn2 mannan Panel B shows 50 μM BT 3786 vs 1 mg/ml Mnn2 
oligosaccharides . All ITC experiments were carried out in 50mM HEPES ph 7.5 at 20 °C
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5.4 Discussion  
This chapter attempts to dissect how B. thetaiotaomicron deconstructs the mannan 
polysaccharide produced from the yeast S.cerevisiae.  As yeast mannan is a 
complex polysaccharide with various different glycosidic linkages, understandably, 
an array of enzymes is required to deconstruct the polysaccharide into useable 
oligosaccharides. PUL 36 and 68 from B. theataiomicron are upregulated in the 
presence of yeast mannan; both PULs are controlled by a hybrid two component 
system (HTCS). Each PUL encodes a pair of GH76 enzymes located on the outer 
membrane and in the periplasm, respectively. The outer membrane localized GH76 
enzymes (BT 2623 BT 3792) both release large oligosacchairdes from the mnn2 
mannan, while the periplasmic GH76 enzymes (BT 2631 and BT 3782) generate 
small oligosaccharides from the mnn2 mannan. This difference is significant as 
studies on other PULs from B. thetaiotaomicron reveal that, along with the SusC/D 
pair localised at the outer membrane, a number of enzymes usually process the 
polysaccharide before the oligosaccharides are transported across the membrane 
into the periplasm (Bjursell et al., 2006, Martens et al., 2008). One of these enzymes 
is often an endo-acting enzyme that produces the oligosaccharides for 
transportation. BT 2623 and BT 3792 appear to be the outer membrane endo-acting 
enzymes, while BT 2631 and BT 3782 are periplasmic and thus further process the 
oligosaccharides which are ultimately converted to monosaccharides and 
transported into the cytoplasm. This type of enzyme organisation is typical of PUL-
encoded degradative systems that degrade complex polysaccharides (Sonnenburg 
et al., 2010). 
PUL 36 encodes one GH92 α- mannosidase, BT 2629, whereas PUL 68 encodes 
two GH92 enzymes, BT 3773 and BT 3784. BT 2629 appears to be a non-specific α 
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mannosidase capable of removing both the α1,2 and α1,3 mannose branches from 
the backbone of the main outer chain of wild type yeast mannan. The pair of GH92 
enzymes encoded in PUL 68 have distinct activities. BT 3773 is an α1, 3-
mannosidase, however, when BT 3773 was tested against wild type and mutant 
mannans there was no mannose released when visualised by TLC. The in activity 
observed for BT 3773 may be due to a preparation of in active protein or possibly 
that the enzyme prefers an oligosaccharide substrate rather than the polysaccharide 
substrates tested. BT 3784 shows activity against the wild type and all of the mutant 
mannans.  This is indicative of BT 3784 having mainly an α1,2 mannosidase activity 
although the enzyme can hydrolyse α1,3 mannose linkages, as reported by Yanping 
Zhu (Zhu et al., 2010). Mannose released from the mutant mannans by BT 3784 
could also be attributed to the hydrolysis of α1,2 glycosidic bonds of the core of the 
mannan polysaccharide as the side chains are not always capped with the α1,3 
linked mannose and only the mnn1 mutant effects the structure of the core 
polysaccharide. The three GH92 enzymes are all predicted to be found within the 
periplasm of the B.thetaiotaomicron cell. The presence of exo acting glycoside 
hydrolases in the periplasm is fairly typical of Sus like PULs, whereby the GH92, in 
this case, can strip the mannose from the side chains. The mannose can then be 
transported into the cytoplasm for utilization. The lack of specificity of the periplasmic 
exo acting enzymes does not seem to be unique to the yeast mannan PULs as the 
fructan utilization locus appears to display the same characteristic (Sonnenburg et 
al., 2010).   
The GH76 and GH92 enzymes encoded in PUL 36 and PUL 68 have the capability 
to hydrolyse all the major linkages found within yeast mannan; however there 
appears to be a flaw in the model. The two outer membrane endo acting GH76 
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enzymes will only produce oligosaccharides from the mannan produced by the mnn2 
mutant yeast. This mutant mannan consists of the α1,6 linked mannose backbone, 
devoid of any branches. In the human gut the bacteria would encounter wild type 
yeast mannan that retains its α1,2 branches capped with an α1,3 linked mannose. 
The GH92 enzymes are capable of processing the side chains to reveal the α1,6 
mannose linked backbone. However all three of the GH92 enzymes present within 
the two PULs are predicted to be localised in the periplasm. The enzymes in the 
periplasm will only encounter the oligosaccharides transported through the outer 
membrane by the SusC like protein which have been generated by the endo acting 
enzymes on the surface. Therefore there must be additional enzymes located at the 
cell surface capable of removing the side chains of yeast mannan in either an endo 
or exo manner.  
Previously studied sensor domains of HTCS involved in polysaccharide utilisation 
revealed that regulation of the PUL was driven by direct binding of an 
oligosaccharide to the periplasmic sensor domain. The sensor domains studied 
bound only linear oligosaccharides, suggesting that branches were not required for 
recognition of polysaccharides. BT 3786 is annotated as the HTCS sensor/regulator 
of PUL 68 and ITC showed that the periplasmic sensor domain bound 
oligosaccharides derived from the Mnn2. The oligosaccharides bound by BT 3786 
are linear α1,6 linked mannan oligosaccharides which, lack the α1,2 and α1,3 
branches found in wild type yeast mannan. Therefore it appears BT 3786 exhibits 
the characteristics previously displayed by other HTCS sensor domains in binding 
linear not branched oligosaccharides. 
Both PUL 36 and 68 encode for a number of hypothetical proteins that are yet to be 
characterised and could provide the crucial function of removing the side chains and 
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allowing the outer membrane GH76 enzymes to deconstruct the backbone. In 
addition PUL 68 encodes BT 3774 which is annotated as a GH38 enzyme. 
Unfortunately this enzyme could not be cloned and expressed in solution, so activity 
assays were not carried out. However, other enzymes in the GH38 family have been 
characterised as α mannosidases active on mannosyl-oligosaccharides. It is possible 
that the GH38 could remove the side chains in an endo manner producing α1,2- α1,3 
oligosaccharides and revealing the backbone of the yeast mannan. As BT 3774 is 
predicted to reside at the periplasm of the bacterial cell it would not be able to 
remove the side chains to aid the outer membrane GH76 enzymes. It does however 
suggest that the hypothetical proteins encoded in the PUL must provide the de-
branching role. 
In this chapter one of the hypothetical proteins from PUL 68 has been characterised. 
Bioinformatic data suggested that BT 3783 may have a phosphatase activity. To test 
this BT 3783 was cloned and expressed and tested for phosphatase activity against 
a number of substrates. As explained in the results BT 3783 is indeed capable of 
releasing a phosphate molecule from both the mannose-6-phosphate and the 
glucose-6-phosphate. Kinetic data suggest that while BT 3783 is active on both 
substrates it prefers mannose-6-phosphate.  Yeast mannan is a complicated 
polysaccharide that has varying degrees of phosphorylation ranging from 1 
phosphate for every 19 mannose residues to 1 phosphate per 13 mannose residues. 
The phosphate group can be bound through the C6 or C1 of the mannose residue. 
BT 3783 is capable of liberating mannose from mannose-6-phosphate, but a 
secondary enzyme is required to hydrolyse mannose-1-phosphate.  BT 3783 is 
predicted to reside at the outer membrane and so will most probably encounter 
mannose-6-phosphate as part of more complex oligosaccharides. 
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This chapter demonstrates how B. thetaiotaomicron possesses within PUL 36 and 
PUL 68 the enzymes needed to successfully hydrolyse all the major bonds within 
yeast mannan. Although not all of the annotated enzymes have been characterised 
as part of this study, those that have contribute to the degradation of the complex 
polysaccharide. Both PULs are upregulated in response to yeast mannan and most 
probably work simultaneously to sense, transport and utilise this polysaccharide.  
5.5 Future Work 
Future work crucial to understanding how B. thetaiotaomicron utilises yeast mannan 
would be to characterise the other annotated enzymes and also to screen the 
hypothetical proteins for potential activity against yeast mannan, Figure 5.13. Further 
binding studies with both the SusD like protein and the sensor domain from the 
HTCS of the two PULs would provide some insight into the regulation and the 
specificity of the PULs. Growth studies of B. thetaiotaomicron on simple sugars and 
yeast mannan with and without the SusC like protein knocked out would provide 
some insight into the ability of B. thetaiotaomicron to utilise yeast mannan and the 
importance of the SusC like protein.  All of the above studies would provide a more 
complete knowledge of how B. thetaiotaomicron senses, transports and utilises 
complex carbohydrates found in the human gut.  
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Figure 5.14 Diagram of PUL 36 and PUL 68 showing known and unknown activities 
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Chapter 6: Probing the Active Site of a Arabinoxylan 
Specific GH5 Xylanase  
 
6.1 Introduction 
The plant cell wall consists of various interlinked polysaccharides  whose structures 
vary with respect to  their sugar components and linkages. The major component of 
the plant cell wall is the homo-polysaccharide cellulose, which is largely crystalline 
and thus resistant to enzymatic hydrolysis. Hemicelluloses are a group of matrix 
polysaccharides that are chemically more complex than cellulose, but are not 
crystalline.  The major hemicellulose present in the secondary cell wall of dicots is 
xylan, a β1,4 xylose polymer that is decorated with various sugars, primarily 
glucuorinc acid and arabinose units, and can also be acetylated.  While the major 
xylanases found in nature, located in GH10 and GH11, efficiently degrade 
unsubstituted xylans, they are unable to deconstruct highly decorated forms of the 
polysaccharide such as arabinoxylan and glucuronoarabinoxylan. In arabinoxylan 
the xylan backbone is highly decorated with -arabinofuranose side chains that are 
linked O2 and/or O3 to the xylose residues.   
Previously Dr Yanping Zhu characterised a GH5 family arabinoxylan-specific 
xylanase enzyme, CtXyl5A, from Clostridium thermocellum (Correia et al., 2011). 
CtXyl5A has a complex molecular architecture comprising an N-terminal GH5 
catalytic module abutted onto a CBM6, while the enzyme also contains a CBM13, 
fibronectin module, a CBM62 and a C-terminal type I dockerin that facilitates the 
recruitment of the protein into the C. thermocellum cellulosome, displayed in Figure 
6.1 . The study showed that the CBM6 binds the termni of xylo- and gluco-configured 
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polymers suggesting that its role is to target the enzyme to areas of the plant cell 
wall that are being actively degraded. The CBM62 binds to terminal galactose 
decorations of polysaccharides, which may indicate that the enzyme might 
preferentially act on unusual xylans that contain galactose side chains. Structural 
and biochemical studies of the GH5 component of CtXyl5A revealed the mechanism 
by which the enzyme displayed its arabinoxylanase activity. The GH5 module 
accommodates arabinofuranose units appended to the O3 of the xylopyranose 
bound at the active site (-1 subsite), and utilizes this as a specific determinant for 
hydrolysis. The distal subsites of the enzyme are also able to accommodate 
arabinose side chains allowing for efficient hydrolysis of highly decorated 
arabinoxylans. An apo structure of GH5-CBM6 was solved, Figure 6.2. The data 
revealed a large pocket (defined as the -2NR* subsite) that abuts onto  the -1 
subsite, which could, potentially, accommodate a sugar decoration appended O3 to 
the xylose positioned in the active site. The structure also showed that GH5-CBM6 
lacks the amino acid residues that interact with the O3 of the active site sugar. In 
addition, four amino acids in the -2NR* subsite were identified that were candidates 
to interact with the arabinose attached to the xylose housed in the active site. A 
structure of GH5-CBM6 in complex with either substrate or reaction products was not 
solved and consequently the mechanism by which arabinose binds to the -2NR* 
subsite pocket could only be modelled.  
 
Figure 6.1 Molecular architecture of CtXyl5A protein  
Created in MyDomains 
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Figure 6.2 GH5 active site 
GH5 active site showing subsites, superimposed with 2-deoxy-2-fluorocellotriose. Adapted from (M A Correia, 
2011)  
 
6.2 Objectives  
The main aim of this chapter is to understand the mechanism by which arabinose 
binds to the -2NR* subsite of CtXyl5A and how these residues contributes to the 
arabinoxylanase activity displayed by the enzyme. This was achieved by site-
directed mutagenesis of the amino acids identified as candidates for interaction with 
the -2NR* arabinose and activity assays of the resultant mutants to identify their 
importance for hydrolysis. In addition the crystallisation of GH5-CBM6 in complex 
with arabinose or reaction products of the enzyme was carried out to provide insight 
into the mechanism of substrate binding at this critical subsite.  
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6.3 Results  
6.3.1 Site directed mutagenesis and protein expression and purification  
The GH5-CBM6 wild type gene was previously cloned into the pET21a vector 
supplying a C-terminal His6-tag to the recombinant protein. This construct was used 
as the template DNA for the site directed mutagenesis using the primers shown in 
Table 6.1. Site directed mutagenesis was carried out as described in Section 2.1.19. 
To generate the treble mutant, GH5-CBM6 E68A was used as template DNA to 
generate the double mutant GH5-CBM6 E68A/Y92A. This double mutant was then 
used as template DNA to generate the GH5-CBM6 E68A/Y92A/N135A mutant which 
was used as template to generate the final quadruple mutant GH5-CBM6 
E68A/Y92A/N135A/N139A. Colonies obtained were sequenced to confirm that only 
the appropriate mutations had been incorporated into the CtXyl5A gene.    
All of the recombinant proteins were expressed in E. coli BL21 (DE3) cells, which 
were cultured at 37 °C to mid-exponential phase. Recombinant protein expression 
was induced by the addition of 1 mM IPTG and incubation for a further 5 h at 37 °C 
before being harvested and purified by IMAC. For crystallography the wild type 
protein was further purified by size exclusion chromatography
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Table 6.1 Primers used for site directed mutagenesis 
Mutations are shown in bold. 
Primer name Sequence 
Gh5 E68A FWD CCA TAC ACT TCC ACG GCC TGG ACG GCG GCA GCT 
Gh5 E68A REV AGC TGC CGC CGT CCA GGC CGT GGA AGT GTA TGG 
Gh5 Y92A FWD GCA GTA CAC CTC GCC GCA GAA TGC 
Gh5 Y92A REV GCA TTC TGC GGC GAG GTG TAC TGC 
Gh5 N135A FWD GTA ATA ACC ATA GGC GCC GGT GCC AAT AAC 
Gh5 N135A REV GTT ATT GGC ACC GGC GCC TAT GGT TAT TAC 
Gh5 N139A FWD GGC AAC GGT GCC AAT GCC GGA AAT CAT AAC GCG 
Gh5 N139A REV CGC GTT ATG ATT TCC GGC ATT GGC ACC GTT GCC 
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6.3.2 Ability of GH5-CBM6 mutants to hydrolyse arabinoxyalan 
This section describes the effects of mutations made to the -2NR* subsite  on the 
ability of GH5-CBM6 to hydrolyse arabinoxylan. To do this the enzyme activity of 
each mutant was compared to that of the wild type GH5-CBM6. Enzyme activity was 
measured using the 3, 5-dinitrosalicyclic acid assay which measures the rate of 
reducing sugar released (described in more detail in Section 2.3.1.3). The Km of wild 
type GH5-CBM6  enzyme appears to be very high and the catalytic rate was directly 
proportional to a substrate concentration up to 2 mg/ml. For this reason the Km could 
not be determined and so kcat/ Km was determined using linear regression. Wild type 
GH5-CBM6 and the mutants were incubated with 1mg/ml arabinoxylan from wheat in 
50 mM sodium phosphate pH 7.5 at 50 °C. Aliquots were taken at different times and 
reducing sugar released measured. All data were analysed using GraphPad Prism 
5.0. The activities of the mutants were reported as a percentage of GH5-CBM6 wild 
type activity in Table 6.2 and the linear regression graphs are shown in Figure 6.3.  
As the binding of arabinose in the -2NR* subsite  is thought to be the specificity 
determinant for hydrolysis of arabinoxylan, alanine substitution of amino acids 
involved in arabinose recognition should render the enzyme inactive. However, the 
kinetic analysis of GH5-CBM6 single mutants, containing mutations within the 
arabinose binding pocket, showed a decrease in, but not a total loss, of activity. In 
fact only one mutation, E68A, resulted in a substantial decrease in activity; the 
mutant retained 23% of wild type activity. The other three amino acids Trp92, 
Asn135 and Asn139, when mutated to alanine, did not appear to have any significant 
effect on the activity of the enzyme; the three mutants retained >80% of wild type 
arabinoxylanase activity. This could partly be due to the hydrophobic nature of the -
2NR* subsite which would provide a number of amino acids that could interact with 
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the bound arabinose. In an effort to counter act this possible effect, a treble mutant 
of E68A/Y92A/N135A and a quadruple mutant, E68A/Y92A/N135A/N139A, were 
generated. Both of these mutants were tested for activity against wheat 
arabinoxylan. The treble mutant does show a further decrease in activity compared 
to the respective three single mutant proteins, however E68A/Y92A/N135A still 
retained 50% of wild type activity. The quadruple mutant showed a further decrease 
in activity close to that of the GH5-CBM6 E68A mutant. This is potentially surprising 
as it would be expected that the quadruple mutant would be inactive due to its 
inability to interact with the arabinose decoration of the xylose positioned in the -1 
subsite (active site).  
To assess whether GH5-CBM6 possesses any xylanase activity, the wild type, treble 
mutant and quadruple mutant were incubated with birchwood xylan and the activity 
measured. Birchwood xylan is undecorated and thus testing for activity against this 
source of xylan would reveal if there is any background xylanase activity. The results 
show that indeed the wild type GH5-CBM6 did posses a small amount of xylanase 
activity, as did the treble and quadruple mutants. The GH5-CBM6 wild type xylanase 
activity compared to the arabinoxylanase activity is very low, the quadruple mutant 
showed a higher xylanase activity compared to its arabinoxylanase activity.  Also 
worth noting is that the respective xylanase and arabinoxylanase activities displayed 
by the treble and quadruple mutants were similar. This observation would strongly 
suggest that the activity of the two mutants against arabinoxylan from wheat is 
background xylanase activity. So, in essence, the treble and quadruple mutants of 
GH5-CBM6 display little arabinoxylanase-specific activity. These data suggest that 
the proposed arabinose binding pocket, which abuts onto the -1 subsite (active site) 
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is the specificity determinant for the arabinoxylanase activity displayed by GH5-
CBM6.
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Table 6.2 GH5-CBM6 and mutant activity against wheat arabinoxylan and Birchwood xylan  
*Nd; not determined. GH5-CBM6 TM = GH5-CBM6 E68A/Y92A/N135A. GH5-CBM6 QM= GH5-CBM6 E68A/Y92A/N135A/N139A 
Protein Name 
kcat/Km against Wheat 
arabinoxylan  min
-1 
mg  
ml
-1 
  
% of wild type activity against 
wheat arabinoxylan 
Kcat/Km against Birchwood 
xylan  min
-1 
mg  ml
-1 
  Birchwood/wheat arabinoxylan 
activity  
GH5-CBM6 WT 5361 100 906 0.17 
GH5-CBM6 E68A 1255 23 Nd
a 
Nd 
GH5-CBM6 Y92A 4697 87 Nd Nd 
GH5-CBM6  N135A 5207 97 Nd Nd 
GH5- CBM6 N139A 4744 88 Nd Nd 
GH5-CBM6 TM 2769 51 1335 0.48 
GH5-CBM6 QM 1135 21 776 0.68 
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Figure 6.3 Example linear regression graphs for GH5-CBM6 wild type and mutant constructs against wheat arabinoxylan and 
birchwood xylan  
All graphs were plotted in GraphPad Prism.  All experiments were carried out with 1μM enzyme and 1 mg ml substrate in 50mM so dium phosphate pH 7.5 at 50 °C. GH5-
CBM6 TM = GH5-CBM6 E68A/Y92A/N135A. GH5-CBM6 QM= GH5-CBM6 E68A/Y92A/N135A/N139A
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6.3.3 Structure of GH5-CBM6 in complex with arabinose 
To understand how GH5-CBM6 interacts with arabinose in the proposed -2NR* 
binding pocket, GH5-CBM6 (10 mgml) was co-crystallised with arabinose (300 mM) 
in 1M ammonium sulphate 0.1M bis tris 1% PEG 3350 pH 5.5. Crystals were grown 
by hanging drop vapour diffusion method at 20 °C for 14 days. The crystals were 
cryo-protected using the reservoir solution with the addition of 15% PEG 400.  The 
diffraction data was collected at the diamond light source on beam line IO4-1. 
Diffraction images were integrated using XDS and results scaled using SCALA. The 
phase problem was solved by molecular replacement using the coordinates from the 
apo wild type structure deposited in the Protein data bank (PDB) under 2Y8K.  
Molecular replacement was carried out using molrep software. The final model was 
built and improved using COOT and refinement was carried out using REFMAC. The 
fishing of crystals, data collection and solving of the GH5-CBM6 structure with 
arabinose was carried out by Dr Anaurd Basel in the structural biology lab at 
Newcastle University.  
The crystals grown were a plate like shape, shown in Figure 6.4, and diffracted to 
1.75 Å. Crystallographic statistics are shown in Table 6.3. The structure revealed the 
expected (β/α)8  barrel of the GH5 domain linked to the CBM6 domain that displays a 
β sandwich fold architecture. Unexpectedly the arabinose was bound both in the 
GH5 domain and in the CBM6 domain. The cartoon structure of GH5-CBM6 in 
complex with arabinose is shown in Figure 6.5. 
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Figure 6.4 Crystals of GH5-CBM6 co-crystallised with arabinose  
Crystals grown in 1M ammonium sulphate 0.1M bis tris 1% PEG 3350 pH 5.5 at 20°C for 14 days. 
 
Figure 6.5 Cartoon structure of GH5-CBM6 in complex with arabinose  
The protein structure shows arabinose bound within the active site of the GH5 domain and the conserved 
binding site of the CBM6 domain. Created using PyMol. 
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  GH5-CBM6 arabinose complex 
Data collection   
Space group  P 212121 
Unit cell (Å) 67.0920   72.3660  109.1130    
Wavelenth (Å) 0.9173 
Resolution (Å) 44.85-1.84 (1.75-1.75) 
Number of observations  188803 (25099) 
Total number unique 53296 (7590) 
Multiplicity 3.5 (3.3) 
Completeness 98.3 (97.2) 
Average I/sigma I 15.3 (2.5) 
Rmerge 0.066 (0.466) 
Refinement   
R work (%) 17.74 
R free (%) 21 
Number of protein atoms 3766 
Number of water atoms 248 
Number of ligand atoms 10 
Number of solvent atoms 8 
Rmsd   
Bond lengths (Å) 0.124 
Bond angle (°) 1.45 
Ramachandran   
Allowed + favoured (%) 100 
B-factors   
Protein (Å
2
) 17 
Water (Å
2
) 24 
ligand (Å
2
) 19 
other solvent  (Å
2
) 37.2 
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Table 6.3 Crystallographic data and refinement statistics  
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Binding of the arabinose to the CBM6 domain was evident in the conserved sugar 
binding region. The sugar was sandwiched between the two conserved residues 
found within the CBM6 family, Trp424 and Phe478.  Both conserved residues make 
hydrophobic interactions with arabinose and, in addition, Trp 424 makes polar 
contacts with the O2 of the arabinose. The O2 of the arabinose also makes polar 
contacts with Asp507, while O1 interacts with Glu411. Figure 6.6 shows binding of 
arabinose, in its pyranose configuration, to CBM6.  
  
Figure 6.6 CBM6 in complex with arabinose 
A shows surface representation of CBM6 in complex with arabinose. B shows amino acids that interact with 
arabinose. Created using PyMol. 
The GH5 domain has an arabinose bound in the -2NR*subsite. Figure 6.7 shows 
binding of arabinose to the GH5 domain. The structure shows that the arabinose 
interacts with various amino acids found within the pocket; Glu68 and Gly136 make 
polar interaction with O3 of the sugar and Asn135 makes hydrogen bonds with the 
O3 and O2 of the arabinose. Asn139 and Asn170 also make polar interactions and 
Tyr92 makes hydrophobic contacts with the arabinose. The C1 of the arabinose ring 
points out towards the catalytic apparatus, Glu171 and Glu279 of the active site 
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where in fact it would be linked to the O3 of the xylan backbone. Unexpectedly the 
arabinose bound in the structure adopts a pyranose conformation, as opposed to the 
furanose form of the sugar found in the arabinoxylans described todate.  In solution, 
arabinose exists in equilibrium between the pyranose and furanose conformations, 
which highly favours the pyranose conformation.  It appears that the -2NR* subsite is 
not specific for either the pyranose or the furanose form of arabinose and so has 
bound the dominant arabinopyranose conformation.  
 
Figure 6.7 GH5 in complex with arabinose 
A shows surface representation of the GH5 domain with arabinose bound in the +2NR* subsite. Catalytic 
residues are coloured in magenta. . B shows the amino acids interact with arabinose.  Created using PyMol. 
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6.3 Discussion  
The objective of this chapter was to assess if the arabinoxylanse activity of GH5-
CBM6 was determined by the binding of arabinose to the proposed -2NR* subsite. 
Two approaches were deployed; site directed mutation of the arabinose binding 
amino acids in the -2NR* subsite and subsequent assays of the resultant mutants. In 
the second approach the crystal structure of GH5-CBM6 in complex with arabinose 
was determined.  
The activity assays showed that single mutations were not capable of fully 
inactivating the enzyme. In fact, with the exception of E68A, the single mutations had 
little if any effect on catalytic activity. The GH5-CBM6 in complex with arabinose 
reveals why the single mutants have such little effect. The arabinopyranose bound in 
the -2NR* subsite makes extensive interactions with the amino acids found within the 
pocket. With such a wealth of interactions mutation of just one amino acid makes 
very little difference to the ability of arabinose to bind in the pocket. The treble and 
quadruple GH5-CBM6 mutants showed a considerable decrease in activity against 
wheat arabinoxylan compared to the wild type enzyme. While the preferred substrate 
for GH5-CBM6 is arabinoxylan, the enzyme still retains a background xylanase 
against birchwood xylan. The treble and quadruple GH5-CBM6 mutants also display 
xylanase activity against birchwood xylan. When the xylanase activity of the wild type 
enzyme is compared to the treble and quadruple mutants, it becomes evident that a 
significant amount of the activity displayed by the GH5-CBM6 variants is actually 
background xylanase activity. The treble and quadruple mutants thus display, 
effectively, no significant arabinoxylanase-specific activity. From the structural data it 
is not surprising that the treble and quadruple mutant are almost inactive as virtually 
all of the interactions made by arabinose to the protein are eliminated. Without the 
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occupation of arabinose in the -2NR* pocket the arabinoxylan specific activity is lost 
leaving only residual xylanase activity.  
In the GH5-CBM6 complex arabinose is bound in the pyranose conformation. The 
pyranose conformation is the favoured form of arabinose in solution and so has 
bound in the pocket as there appears to be no specificity for the furanose 
conformation that would be found in the arabinoxylan decoration. As the protein does 
not confer any specificity for the conformation of arabinose it would be less 
energetically favourable for it to bind in the furanose form as a free monosaccharide. 
However in the arabinoxylan polysaccharide the arabinose decoration is held in the 
furanose conformation eradicating the energetic issue. Therefore the arabinose 
binding pocket appears to be non-specific for either the furanose or pyranose form of 
the monosaccharide. The active site of a GH5 cellulase from Bacillus agaradharens 
(BaCel5A) interacts with the O3 of -1Glc through a histidine and tyrosine residue. In 
the active site of GH5-CBM6 there is a distinct lack of residues that interact with the 
O3 of the active site sugar. Therefore it is necessary for the -2NR* subsite to make 
additional productive binding interactions with the arabinose in order to stabilise the 
complex. 
An additional arabinose is bound in the conserved sugar binding site of the CBM6 
domain of the GH5-CBM6 structure. The CBM6 domain has been characterised 
previously and was found to have affinity for various oligosaccharides including the 
reaction products of the GH5 domain, recognising the terminal region of the 
oligosaccharides. In essence the CBM6 domain is fairly non-specific in the 
oligosaccharides it binds and can accommodate a number of different sugars 
including arabinose and xylose.  
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The GH5 family of enzymes includes a range of differing activities such as 
cellulases, mannosidases and xylanases. However, GH5-CBM6 from C. 
thermocellum is the first arabinoxylan specific xylanase reported. The previous study 
on GH5-CBM6 described the arabinoxylan specific activity, whereas this chapter 
illustrates how the specificity of the enzyme is driven by the binding of arabinose in 
the -2NR* subsite.  Within the GH5 family there is a highly specific enzyme from 
Paenibacillus pabuli, named XG5, which is a xyloglucan-specific endoglucanse. XG5 
also confers specificity for defined xyloglucan oligosaccharide by interactions made 
with side chain decorations of the glucan with the negative subsites of the substrate 
binding cleft of the enzyme (Gloster et al., 2007). In addition to the highly specific 
GH5 enzymes, xylanases specific for glucuronoxylan have been reported in the 
GH30 family. Xylanase A from Erwinia chrysanthemi is a glucrononxylan specific 
xylanase from GH30, which confers specificity through interactions made with the 
methyl glucuronic acid substitution of the xylose found at the -2 sub site (Urbanikova 
et al., 2011, Vrsanska et al., 2007). The GH5 and GH30 both belong to clan GH-A as 
they share similar structural folds and closely related in sequence and function.  
Within a larger scope GH5-CBM6 is part of a large modular protein termed CtXyl5A 
which is recruited to the C. thermocellum cellulosome. The cellulosome is a large 
multi protein complex which targets the plant cell wall. Proteins are recruited to the 
large CipA scafoldin protein which is tethered to the bacterial cell wall. Within this 
complex various proteins are employed to degrade the plant cell wall. Therefore the 
unique arabinoxylan specific xylanase activity of GH5-CBM6 would complement the 
GH10 and GH11 xylanases and cellulases, which are also part of the cellulosome. 
This combination offers maximum degradation and utilization of the glycans available 
in the environment of the bacterium.  
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Chapter 7: Final Discussion  
Chapters 3 and 4 describe the characterisation of a novel non-catalytic carbohydrate 
binding module (CBMX40) that binds levan and potentiates the activity of the 
catalytic domain of the endogenous exo-acting enzyme (SacC) against the 2,6-
fructan levan, but not against fructooligosaccharides or inulin. The binding of 
CBMX40 to levan results in a marked increase in the activity of SacC against levan; 
this was observed in the full length enzyme and also in trans experiments where the 
catalytic domain and CBMX40 are not covalently attached. A fusion protein 
consisting of CBMX40 appended to a fructosidase from Bacteroides 
thetaiotaomicron, BT3082, showed a similar potentiation in activity. Indeed in in trans 
experiments BT3082 displayed an increase in levanase activity in the presence of 
CBMX40. BT 3082 is a non-specific exo-fructosidase capable of hydrolysing the β 
2,1 linkage of inulin and the β 2,6 linkage of levan. The fusion of CBMX40 to BT3082 
appears to change the non-specific enzyme into a glycoside hydrolase specific for 
levan. These data show that CBMX40 is capable of having a generic effect on non-
specific fructosidases, converting these enzymes into specific exo-levanases.  
Since CBMs were first discovered in the mid 1980s, their ability to disrupt substrate 
to aid hydrolysis by its catalytic counterpart has been proposed. The discovery of 
cellulose binding domains was heralded as the “missing” C1 factor within cellulase 
systems. The C1 factor was thought to change the complex nature of cellulose 
making it more accessible to the catalytic domain (Reese et al., 1950, Din et al., 
1994). The ability of CBMs to affect the rate of hydrolysis in trans has previously 
been viewed as evidence for CBMs potentiating enzyme function through a substrate 
disruptive mechanism. Past studies on CBMs have shown ~0.5 fold potentiation of 
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catalytic activity when studied in trans. A study of a starch binding domain (SBD) 
described a 50% increase in activity when the catalytic domain of the native 
glucoamylase enzyme was incubated with insoluble starch in the presence of the 
SBD. The increase in hydrolytic rate was attributed to the SBD disrupting the 
structure of starch making it more accessible to the enzyme (Giardina et al., 2001). 
The in trans experiments in Chapter 3 and 4 show an enhancement in rate of 
hydrolysis upwards of 25-fold .Therefore the ability of CBMX40 to enhance the rate 
by such levels in trans seems to be indicative of a disruption effect on the levan 
substrate. To fully evaluate the possibility that CBMX40 works through such a 
mechanism, potential non-covalent interactions between CBMX40 and the catalytic 
domains were investigated. Analytical ultracentrifugation (AUC) revealed CBMX40 
was able to form complexes with both the catalytic domain of SacC and BT3082. In 
contrast the starch binding domain reported no measurable interaction between the 
two proteins when measured by thermodynamics, while Dinn et al. (1994) did not 
consider possible non-covalent interactions between the cellulose binding domain 
and the cellulase catalytic domain to explain their in trans data. These studies, 
therefore, have not rigorously evaluated possible non-covalent interactions that may 
explain the observed, very modest, in trans potentiation of enzyme activity.  
Furthermore, both the amylase and cellulases are ~1000-fold more active against 
soluble substrates compared to crystalline polysaccharides. Thus, the 0.5-fold in 
increase in activity in the in trans experiments indicate that the CBMs are causing an 
extremely modest disruption of the crystalline substrate (Bolam et al., 1998, Din et 
al., 1994, Giardina et al., 2001) . To conclude, the disruptive effect of the starch and 
cellulose binding modules should be viewed with caution, and the ability of CBMX40 
to disrupt the levan structure is unlikely.  
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The CBMX40 interacts with levan through the non-reducing end of the levan chain. 
The structure of CBMX40 in complex with levanbiose revealed that the protein 
module bound the non-reducing terminal fructose. Examples of CBMs that target 
glycans at the non-reducing termini include members of CBM32 that interact with 
terminal Gal and GalNAc residues. A GH84 exo-GlcNAcase (GH84C) contains a 
CBM32 that targets the terminal Gal-GlcNAc structures presented on the surface of 
red blood cells. A model of the GH84C from Clostridium perfringes, based on crystal 
structures and solution conformations of the protein, revealed that the active site of 
the catalytic module and the binding site of the CBM32 are arranged on the same 
side of the protein, facing in the same direction (Ficko-Blean and Boraston, 2006). 
This led to a model for CBM enhancement where there is simultaneous binding and 
hydrolysis of the terminal glycans presented on the cell surface by the CBM32 and 
the catalytic module, respectively. The potentiation by CBMX40 of the GH32 catalytic 
domain is highest against complex branched levans. This enhancement in enzyme 
activity is likely achieved through an “avidity” mechanism, in which the CBMX40 
binds the terminal end of one branch, while the SacC catalytic domain hydrolyses 
the terminal of another branch of the same polysaccharide molecule. The combined 
binding of the CBMX40 and the SacC catalytic domain, compared to just the SacC 
catalytic domain, is much tighter, hence the “avidity” effect.  These data may provide 
a generic model for the role of CBMs that bind the termini of glycan chains in 
potentiating the activity of exo-acting glycoside hydrolase enzymes against branched 
substrates.  
Chapter 5 focuses on the characterisation of the GH76 enzymes encoded by the B. 
thetaiotaomicron genome, and α-mannan utilisation by two polysaccharide utilisation 
loci (PULs) that contain GH76 members. The majority of α-mannan encountered 
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within in the human gut is as part of N-glycans found on host and dietary 
glycoproteins. Studies of α-mannan degrading glycoside hydrolases including 
enzymes from GH38, GH47, GH92 and GH125 have mainly been studied in the 
context of N-glycan degradation (Hosokawa et al., 2001, Igdoura et al., 1999).  A 
recent study of the 23 GH92 enzymes encoded by the B. thetaiotaomicron genome 
described the ability of a number of the GH92 members to hydrolyse high mannose 
N-glycans. In total 20 of the characterised GH92 enzymes are reported as active on 
yeast mannan but the natural substrate in the human gut environment is proposed to 
be N-glycans found on host and dietary glycoproteins (Zhu et al., 2010). However it 
would appear that the GH76 encoding PULs target yeast mannan rather than N-
glycans as outlined below.  
In vivo studies of B. thetaiotaomicron introduced into the gut of germ free mice 
reported induction of expression of PUL 36 and PUL 68, when the mice were fed a 
diet lacking exogenous α-mannan. This induction however was modest, suggesting 
that these PULs were not involved in N-glycan foraging in the gut. In vitro studies 
used yeast mannan as a mimic for N-glycans, when B.thetaiotaomicron was cultured 
on yeast mannan again expression of PUL 36 and PUL 68 was induced to a much 
higher degree (Bjursell et al., 2006). Yeast mannan appears to be a good mimic for 
mammalian N-glycan (mN-glycan) as it contains all the linkages (α1,6, α1,3 and 
α1,2) found in mN-glycans. The linkages however, are found in a different context in 
yeast mannan to mN-glycans. The α1,6 backbone present in both glycans is much 
more extended in yeast  mannan where the α1,2 linked mannose is capped with a 
α1,3 linked mannose. These branches are reversed in mN-glycans with the α1,3 
linked mannose being capped with α1,2 linked mannose. Recent in vitro studies of B. 
thetaiotaomicron cultured in the presence of both high mannose mN-glycan and 
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yeast mannan, separately, revealed PUL 36 and PUL 68 were only up regulated in 
the presence of yeast mannan and not high mannose mN-glycans, indicating the 
PULs were dedicated to yeast mannan acquisition and not mN-glycan utilization.  
The activity assays in Chapter 5 revealed 7 of the 13 CAZy annotated glycoside 
hydrolases were active against yeast mannan. The four GH76 enzymes encoded in 
these PULs are endo α1,6 mannanases, which hydrolyse the yeast mannan 
backbone into various sized oligosaccharides. In each PUL a GH76 is located at the 
outer membrane and the second GH76 is located in the periplasmic space. The 
presence of an endo acting enzyme at the cell surface is typical of Sus like PULs. 
The three GH92 enzymes encoded within the PULs are all located in the periplasm 
and are capable of removing the α1,2 and α 1,3 linked mannose branches from the 
backbone. Both PULs also encode a predicted GH125 enzyme; while not currently 
characterised, they most probably hydryolyse α 1,6-manooligosaccharides released 
from the mannan backbone. PUL 68 also encodes a phosphatase that most probably 
removes phosphates from mannan oligosaccharides at the outer membrane. Along 
with the two GH125 enzymes there are also three other CAZy annotated enzymes 
(GH97, GH67 and GH38) that have not currently been characterised within the 
PULs. These enzymes are most probably involved in further processing of the yeast 
mannan polysaccharide. Although Chapter 5 describes a number of enzymes within 
the two PULs that contribute to yeast mannan hydrolysis, there is still a cohort of 
hypothetical proteins encoded in the PUL that may contribute to the degradation of 
the polysaccharide. For example, the GH76 enzymes only hydrolyse the yeast 
mannan backbone and not mannan with α1,2 and α1,3 linked mannose branches. 
Therefore there needs to be an enzyme at the cell surface capable of removing the 
branches to expose the α1,6 backbone for the GH76 enzyme. Analysis of the amino 
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acid sequence of these hypothetical proteins predicts that at least five of these are 
present at the cell surface and so are potential candidates for enzymes that remove 
mannan branches. Both PUL36 and PUL68 are regulated by a hybrid two 
component system (HTCS) and encode a SusC/SusD pair. Preliminary results of the 
sensor domain of the HTCS in PUL68 show that it is specific for yeast mannan as it 
binds oligosaccharides generated by digestion of mannan generated by the yeast 
mutant mnn2 by a GH76 enzyme. The results presented in Chapter 5 provide 
evidence that B. thetaiotaomicron dedicates at least two PULs to yeast mannan 
acquisition and utilisation.  
Chapter 6 probes the mechanism by which GH5-CBM6 from Clostridium 
thermocellum confers specificity for arabinoxylan. Structural and mutational studies 
revealed that the binding of arabinose to the side pocket of the active site is required 
for hydrolysis of the xylan backbone. GH5-CBM6 is part of a large multi modular 
protein, CtXyl5A, which is recruited to the cellulosome of C. thermocellum (Correia et 
al., 2011). The cellulosome is a large multi protein complex that targets the plant cell 
wall. Proteins are recruited to the large CipA scafoldin protein which is tethered to 
the bacterial cell wall (Gilbert, 2007). CtXyl5A consists of an N-terminal GH5 
arabinoxylan specific xylanase, CBM6, CBM13, CBM62 and a type I dockerin at the 
C-terminal (Bras et al., 2011). The type I dockerin interacts with the CipA protein 
through a cohesin module to tether CtXyl5A to the cellulosome complex. CBM6 
displays affinity for cellohexasoe and cellobiose along with GH5 reaction products 
and xylooligosaccharides, binding to the termini of these oligosaccharides. CBM6 
most probably targets the enzyme to areas of the plant cell wall that are undergoing 
active degradation, similar to the predicted role of a CBM9 in a GH10 xylanase. 
CBM62 binds galactose and arabinopyranose through interactions at the O4, 
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distinguishing these sugars from other netural monosaccharides. The binding of 
CBM62 to galactose containing polysaccharides suggests that it may target the 
enzyme to arabinoxylans with galactose decorations such as corn stem 
arabinoxylan, which contains a terminal galactose. Alternatively, the CBM62 may 
bind to polysaccharides found in close proximity to regions of arabinoxylan in the 
plant cell wall. The cellulosome recruits a number of plant cell wall degrading 
enzymes including cellulases, GH10 and GH 11 xylanases. The unique arabinoxylan 
specific xylanase offers a complementary activity to other enzymes recruited to the 
cellulosome.  
The complex nature of polysaccharides results in various forms of specificity at 
different levels of carbohydrate utilisation. Bacteria like B.thetaiotaomicron sense 
and utilise complex polysaccharides through genes encoded by PULs. Modular 
proteins can utilise each domain to drive specificity for a polysaccharide through the 
use of non-catalytic binding modules. Finally, glycoside hydrolases evolve subtle 
changes in the architecture of the active site and amino acid interactions with 
individual sugars of polysaccharides to confer specificity.  
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7.1 Future work  
 
CBMX40 represents a new CAZy CBM family and as such future work to study other 
members of the family would determine if the mechanism and mode of binding is 
generic to the family or unique to CBMX40. The study of other CBMX40 containing 
GH32 family enzymes could reveal a subgroup of enzymes where catalytic activity is 
significantly potentiated by the presence of a CBMX40. It may also reveal a subset of 
levan binding CBMX40s.  
To further dissect the ability of B. thetaiotaomicron  PULs to deconstruct yeast 
mannan a more complete description of the enzyme activities found within the 
regulated PULs is necessary. This could be achieved by characterisation of all CAZy 
annotated encoded proteins and also by the study of hypothetical proteins which 
may have the potential for novel catalytic activities.  To understand the importance of 
yeast mannan utilisation to B.thetaiotaomicron’s survival, knockouts of the mannan 
PULs could be used to assess the bacterium’s ability to grow on complex mannans.  
To further investigate the specificity of CtXyl5A kinetic studies against a range of 
arabinoxylans from different sources would reveal the specificity of the enzyme and 
the substrate targeted.  
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Appendix A 
 
A1 Chemicals 
Amersham-Boehringer Mannheim 
 2’-Deoxyadenosine 5’-triphosphate (dATP) 
 2’-Deoxycytidine 5’-triphosphate (dCTP) 
 2’-Deoxyguanosine 5’-triphosphate (dGTP) 
 2’-Deoxythymidine 5’-triphosphate (dTTP) 
 
BioGene  
Electrophoresis grade Agarose  
 
British Drug Houses (BDH) 
 Acetic acid (Glacial) 
 Acrylamide solution (40% (w/v); Electran) 
Boric acid 
 Bromophenol Blue 
Citric acid 
 Calcium chloride 
 Chloroform 
 Dimethylformamide 
 Ethanol (industrial grade) 
 Hydrochloric acid 
 Isopropanol 
 Magnesium chloride 
 Magnesium sulphate 
 Mineral oil 
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 Methanol 
 Polyethelene glycol MW 8000 (PEG-8000) 
 Polyethelene glycol MW 550 monomethyl ether (PEG 550 mme) 
 Potassium dihydrogen orthophosphate 
 Sodium acetate 
 Sodium chloride  
Sulphuric acid 
 Triton X-100            
 
Fisons 
 46/48% (w/v) NaOH 
 Sodium acetate trihydrate 
 
James Burrough (F.A.D.) Ltd 
 Ethanol 
 
Megazyme 
Rye Arabinoxylan (low viscosity) 
        Wheat Arabionoxylan (medium viscosity) 
Inulin From Chicory 
Melford Laboratories 
 Isopropyl-β-D-thiogalactoside (IPTG) 
 CAPS 
HEPES 
  
GE Health Care 
 Adenosine 5’-triphosphate (ATP) 
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 Agarose (ultrapure) 
 
Sigma 
             
 2,4-Dinitrophenol 
 3,5-Dinitrosalasylic acid (DNSA) 
 Ammonium persulphate 
 Ampicillin 
            Beechwood xylan 
            Birchwood xyaln 
 Bis tris propane 
 Bovine serum albumin, fraction V (BSA) 
 Chloramphenicol 
 Coomassie Brilliant Blue G 
D-Glucose 
 Dimethylsulphoxide 
 di-Sodium hydrogen phosphate 
 Dithiothrietol (DTT) 
 D-Mannose 
 Ethelene diamine tetra-acetic acid, disodium salt (EDTA) 
 Ethidium bromide 
 Ethylene glycol 
 Glucose-6-Phosphate 
 Glycerol 
 Imidazole 
 Kanamycin 
 L-Fucose 
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 Levan from E.herbicola 
  
           Mannose-6-phosphate 
 Mineral oil (light) 
 N,N,N’,N,-Tetramethylethylene diamine (TEMED) 
Nicotinamide adenine dinucleotide-reduced 
Phenol 
 Polyethylene glycol MW 3350 
 Sodium bicarbonate  
 Sodium carbonate 
 Sodium dihydrogen orthophosphate 
 Sodium dodecyl sulphate (SDS) 
 Sucrose (nuclease free) 
        
 Trizma base (Tris) 
 Yeast mannan 
β-Mercaptoethanol 
A2 Media 
Difco 
 Bacto®tryptone 
Bacto®yeast extract 
 
Oxoid 
 Bacteriological Agar No.1 
A3 Enzymes 
MBI Fermentas 
 DNA restriction endonucleases  
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Invitrogen 
 Bacteriophage T4 DNA ligase 
  
 
Novagen 
 KOD HotStart DNA polymerase 
 
Sigma 
           Glucose-6-phosphate dehydrogenase 
           Hexokinase 
           Phosphoglucose isomerase 
           Phosphomannose isomerase 
 
Stratagene 
 PfuTurbo DNA polymerase 
 DpnI restriction endonuclease 
A4 DNA 
MBI Fermaentas 
 Lambda bacteriophage DNA, digested with EcoRI and HindIII 
  
MWG Biotech 
 All primers 
A5 Kits 
 
Qiagen 
 Plasmid Mini kit 
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 Plasmid Midi kit 
 Qiaquik Gel Extraction kit 
 Qiaquik PCR Purification kit 
 
Stratagene 
 QuikChange™ Site-Directed Mutagenesis kit 
 
Megazyme 
            D-Mannose/D-Fructose/D-Glucose assay kit 
 
 
 
